UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q10-Q/A
(Amendment No. 1)
 
 [X]QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 For the quarterly period ended SeptemberJune 30, 20172019
 
 [   ]TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Commission file number: 000-54900001-38116
 
YOUNGEVITY INTERNATIONAL, INC.
(Exact nameName of registrantRegistrant as specifiedSpecified in its charter)Its Charter)
 
Delaware 90-0890517
(State or Other Jurisdictionother jurisdiction of Incorporationincorporation or Organization)organization) (I.R.S. Employer Identification No.)
   
2400 Boswell Road, Chula Vista, CA 
91914
(Address of Principal Executive Offices) (Zip Code)
 
Registrant’s Telephone Number, including area code:Including Area Code:  (619) 934-3980
 
  Not applicable
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report
Securities registered pursuant to Section 12(b) of the Act:None
Title of each classTrading Symbol(s)Name of each exchange on which registered
 Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value
9.75% Series D Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X]  No [   ]  No [X] 
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [X]  No [   ]
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer[   ]Accelerated filer[   ]
Non-accelerated filer[  ]X]Smaller reporting company[X]
(Do not check if a smaller reporting company) Emerging growth company[X]   ]
    
If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [ ] 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [   ]  No [X]
 
As of November 10, 2017,August 12, 2019, the issuer had 19,723,28530,081,040 shares of its Common Stock, par value $0.001 per share, issued and outstanding.

 
EXPLANATORY NOTE
On October 13, 2020, the Audit Committee of the Board of Directors (the “Board”) of Youngevity International, Inc., (together with its subsidiaries, the “Company”, “we”, “our” or “us”), following discussion with management, determined that the unaudited condensed consolidated financial statements (the “Previously Issued Financial Statements”) presented in the Company’s Quarterly Report for the quarterly periods ended March 31, 2019, June 30, 2019 and September 30, 2019 filed with the Securities and Exchange Commission (the “SEC”) should no longer be relied upon as a result of the following error:
During the three months ended March 31, 2019 and the three and six months ended June 30, 2019 certain revenues related to green coffee sales, within the Company’s commercial coffee segment, that were recognized at gross should have been recorded at net.
During the Company’s 2019 annual audit, it was determined that the Company had not fairly valued certain assets acquired in its acquisition of Khrysos Global, Inc., as of the closing date. As a result, the Company is restating its financial statements related to its commercial hemp segment detailed below for the following error:
During the three months ended March 31, 2019, the fair value of certain fixed assets acquired in the acquisition of Khrysos Global, Inc., and the share price valuation for the common stock issued as consideration for the acquisition were not fairly valued as of the closing date.
During the Company’s 2019 annual audit, the Company reviewed revenues related to its commercial coffee segment related to green coffee sales and concluded that certain green coffee sales were recorded in error. As a result, the Company is restating revenues related to its commercial coffee segment for the following revenue recognition error:
During the three and six months ended June 30, 2019 certain revenues related to green coffee sales, within the Company’s commercial coffee segment, were recognized in error. As a result, the Company is restating its revenue and costs of revenue related to the three and six months ended June 30, 2019 for sales recorded during the three months ended June 30, 2019.
A description of the restatement is presented in Note 2 under the caption Restatement of previously reported unaudited condensed consolidated financial statements.
Accordingly, the Company is filing this Amendment No. 1 (this “Form 10–Q/A”) to amend our Quarterly Report on Form 10–Q for the quarterly period ended June 30, 2019, originally filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2019 (the “Original Filing”), to reflect the amendment and restatement of our Unaudited Condensed Consolidated Balance Sheet at June 30, 2019, Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2019, Unaudited Condensed Consolidated Statement of Comprehensive Loss for the three and six months ended June 30, 2019, the Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three and six months ended June 30, 2019 and the Unaudited Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2019 and the related notes thereto and related disclosures as of June 30, 2019.  This Form 10–Q/A also amends certain other items in the Original Filing, as listed in “Items Amended in This Filing” below.
As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the Company’s principal executive officer and principal financial officer are filed as exhibits 31.1, 31.2, 32.1 and 32.2 to this Form 10-Q/A.
Background and Effects of the Restatement
On October 16, 2020, the Company filed a Current Report on Form 8-K under Item 4.02 with the Securities and Exchange Commission relating to Previously Issued Financial Statements as described below. As indicated in the Current Report on Form 8-K under Item 4.02, the Company determined that a restatement was necessary due to a change in the accounting treatment of its revenue derived from its green coffee sales, which had been accounted for on a gross basis and is now being accounted for on a net basis reflecting the deduction of cost of revenue related to such revenue.During the Company’s 2019 annual audit, the Company reassessed its accounting for revenue derived from its CLR Roasters LLC., (“CLR”) commercial coffee segment, specifically the 2019 green coffee sales program, for sales made by the Company to its joint venture partner, H&H Coffee Group Export Corp. (“H&H Export”), which was the provider of the “wet” green coffee and the buyer of the processed coffee for the three and six months ended June 30, 2019.
-i-
Based on its assessment, management has determined that for green coffee sales made by CLR to its joint venture partner, H&H Export, for sales originally recorded at gross (revenue recorded without reduction for cost to purchase the inventory) should have recorded these sales at net. See Note 1, to the condensed consolidated financial statements under “Other Relationship Transactions” for further discussion related to H&H Export.
In addition, during the Company’s 2019 annual audit, the Company reviewed revenues related to CLR, the Company’s coffee segment, with regard to sales made to major independent customers, the Company focused on if recognition of revenue thresholds were met and if the Company had satisfied its performance obligation and could reasonably expect payment for fulfilling these performance obligations. The Company determined that for certain sales made to Rothfos Corporation, these thresholds were not met, and therefore revenue should not have been recognized. As a result, the Company is restating its revenue and costs of revenue related to the three and six months ended June 30, 2019 for sales recorded during the three months ended June 30, 2019 in the aggregate of approximately $2,116,000 and approximately $1,874,000 related to the costs of revenues. The related inventory for the green coffee was returned to CLR’s supplier H&H Export, as such the related costs of $1,874,000 were credited back to CLR and accounts payable has been adjusted for this amount.
On February 15, 2019, the Company and Khrysos Industries, Inc., closed its acquisition of Khrysos Global, Inc., detailed further in Note 5 to the unaudited condensed consolidated financial statements below. In conjunction with the Company’s 2019 annual audit the Company concluded that certain fixed assets acquired in the acquisition and the share price valuation for the common stock issued as consideration were not fairly valued as of the closing date including; i) $1,127,000 related to the certain fixed assets, and ii) $1,351,000 related to a change in the fair value of common stock issuance resulting in an increase to goodwill of $2,478,000 acquired and an adjusted aggregate purchase price if $15,894,000. In addition, this Form 10-Q/A has added to Note 12, to the accompanying notes to the condensed consolidated financial statements disclosure that includes the disclosure of capital expenditures recorded as the result of the acquisition of Khrysos Global Inc., reflecting the change in the fair value of the fixed assets from approximately $2,260,000 to $1,133,000.
Accordingly, this Form 10–Q/A restates the Company’s unaudited condensed consolidated financial statements; i) Unaudited Condensed Consolidated Balance Sheet at June 30, 2019, ii) Unaudited Condensed Consolidated Statement of Operations for the three and six months ended June 30, 2019; iii) Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2019; iv) Unaudited Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2019, and v) the Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three and six months ended June 30, 2019.
For a description of the effect of the restatement as of June 30, 2019 and for the three and six months ended June 30, 2019, see “Note 2. Restatement of Previously Reported Unaudited Condensed Consolidated Financial Statements” to the Company’s unaudited condensed consolidated financial statements in “Item 1. Financial Statements” contained herein.  In connection with the restatement of the Company’s condensed consolidated financial statements in this Form 10–Q/A, management determined that material weaknesses exist in the Company’s internal control over financial reporting and that the Company’s disclosure controls and procedures were ineffective during this reporting period. For a description of the material weaknesses identified by management and managements implemented and planned remediations for those material weaknesses, please see “Item 4. Controls and Procedures” contained herein.

-ii-
Items Amended in This Filing
This Form 10–Q/A sets forth the Original Filing, in its entirety, as amended to reflect the restatement. No attempt has been made in this Form 10–Q/A to modify or update other disclosures presented in the Original Filing to reflect events occurring after the original filing date, except as required to reflect the effects of the restatement.
This Form 10–Q/A should be read in conjunction with our filings made with the SEC subsequent to the filing of the Original Filing.
The following items have been amended as a result of this restatement:
Part I
Item 1. Financial Statements;
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations;
Item 4. Controls and Procedures;
Part II
Item 1A. Risk Factors.


Item 6. Exhibits
Our Principal Executive Officer and Principal Financial Officer are providing currently dated certifications in connection with this Form 10–Q/A.  These certifications are filed as Exhibits 31.1, 31.2, 32.1 and 32.2. 

-iii-
 
 
YOUNGEVITY INTERNATIONAL, INC.
TABLE OF CONTENTS

  Page
 PART I. FINANCIAL INFORMATION 
   
1
 20181
 2
 3
 4
Condensed Consolidated Statements of Cash Flows for the ninesix months ended SeptemberJune 30, 2017 & 2016 (restated)2019 and 2018 (unaudited)4
8
 5
9
2648
3463
3463
   
 PART II. OTHER INFORMATION 
    
3565
3565
3666
3666
3666
3766
3767
 3868
 
 
-iv-
 
 
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
 
 
Youngevity International, Inc. and Subsidiaries
 
 
Condensed Consolidated Balance Sheets
 
 
(In thousands, except share amounts)
 
 
 
 
As of
 
 
 
September 30,
2017
 
 
December 31,
2016
 
ASSETS
 
(Unaudited)
 
 
 
 
Current Assets
 
 
 
 
 
 
Cash and cash equivalents
 $1,373 
 $869 
Accounts receivable, due from factoring company
  3,088 
  1,078 
Trade accounts receivable, net
  513 
  1,071 
Income tax receivable
 311
  311 
Inventory
  21,052 
  21,492 
Prepaid expenses and other current assets
  3,327 
  3,087 
Total current assets
 29,664
  27,908 
 
    
    
Property and equipment, net
  13,908 
  14,006 
Deferred tax assets
 5,703
  2,857 
Intangible assets, net
  18,399 
  14,914 
Goodwill
  6,323 
  6,323 
Total assets
 $73,997 
 $66,008 
 
    
    
LIABILITIES AND STOCKHOLDERS' EQUITY
    
    
 
    
    
Current Liabilities
    
    
Accounts payable
 $10,317 
 $8,174 
Accrued distributor compensation
  4,678 
  4,163 
Accrued expenses
  5,452 
  3,701 
Deferred revenues
  1,999 
  1,870 
Other current liabilities
  3,652 
  2,389 
Capital lease payable, current portion
  997 
  821 
Notes payable, current portion
  175 
  219 
Warrant derivative liability
  4,128 
  3,345 
Contingent acquisition debt, current portion
  422 
  628 
Total current liabilities
  31,820 
  25,310 
 
    
    
Capital lease payable, net of current portion
  934 
  1,569 
Notes payable, net of current portion
  4,452 
  4,431 
Convertible notes payable (See Note 6)
  10,766 
  8,327 
Contingent acquisition debt, net of current portion
  11,405 
  7,373 
Total liabilities
  59,377 
  47,010 
 
    
    
Commitments and contingencies, Note 1
    
    
 
    
    
Stockholders’ Equity
    
    
Convertible Preferred Stock, $0.001 par value: 5,000,000 shares authorized; 161,135 shares issued and outstanding at September 30, 2017 and December 31, 2016
  - 
  - 
Common Stock, $0.001 par value: 50,000,000 shares authorized; 19,723,285 and 19,634,345 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively (1)
  20 
  20 
Additional paid-in capital
  171,693 
  170,212 
Accumulated deficit
  (156,873)
  (151,016)
Accumulated other comprehensive loss
  (220)
  (218)
Total stockholders’ equity
  14,620 
  18,998 
Total Liabilities and Stockholders’ Equity
 $73,997 
 $66,008 
 
    
    
Youngevity International, Inc. and Subsidiaries
(1) Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
 
 
As of
 
 
 
 June 30,
2019
 
 
 December 31,
2018
 
ASSETS
 
(Unaudited) (Restated)*
 
 
 
 
Current Assets
 
 
 
 
 
 
       Cash and cash equivalents
 $2,088 
 $2,879 
       Accounts receivable trade (Note 1)
  10,302 
  4,028 
       Income tax receivable
  231 
  74 
       Inventory
  24,797 
  21,776 
       Advances (Note 1)
  - 
  5,000 
       Notes receivable (Note 1)
  5,097 
  - 
       Prepaid expenses and other current assets
  5,686 
  5,263 
Total current assets
  48,201 
  39,020 
 
    
    
Property and equipment, net
  20,122 
  15,105 
Operating lease right-of-use assets
  5,481 
  - 
Deferred tax assets
  75 
  148 
Intangible assets, net
  23,332 
  15,377 
Goodwill
  13,154 
  6,323 
Other assets – notes receivable
  949 
  - 
Total assets
 111,314 
 $75,973 
 
    
    
LIABILITIES AND STOCKHOLDERS' EQUITY
    
    
 
    
    
Current Liabilities
    
    
Accounts payable
 7,742 
 $8,478 
Accrued distributor compensation
  3,740 
  3,289 
Accrued expenses
  9,259 
  6,582 
Deferred revenues
  2,260 
  2,312 
Line of credit
  2,002 
  2,256 
Other current liabilities
  983 
  1,912 
Operating lease liabilities, current portion
  772 
  - 
Finance lease liabilities, current portion
  1,103 
  1,168 
Notes payable, current portion
  159 
  141 
Convertible notes payable, current portion
  716 
  647 
Warrant derivative liability
  4,969 
  9,216 
Contingent acquisition debt, current portion
  695 
  795 
Total current liabilities
  34,400 
  36,796 
 
    
    
Operating lease liabilities, net of current portion
  4,708 
  - 
Finance lease liabilities, net of current portion
  778 
  1,107 
Notes payable, net of current portion
  10,525 
  7,629 
Convertible notes payable, net of current portion
  2,358 
  - 
Contingent acquisition debt, net of current portion
  6,898 
  7,466 
Total liabilities
  59,667 
  52,998 
 
    
    
Commitments and contingencies (Note 1)
    
    
 
    
    
Stockholders’ Equity
    
    
Preferred Stock, $0.001 par value: 5,000,000 shares authorized
    
    
    Convertible Preferred Stock, Series A – 161,135 shares issued and outstanding at June 30, 2019 and December 31, 2018
  - 
  - 
    Convertible Preferred Stock, Series B – 129,437 shares issued and outstanding at June 30, 2019 and December 31, 2018; $1.254 million liquidation preference as of June 30, 2019.
  - 
  - 
Common Stock, $0.001 par value: 50,000,000 shares authorized; 29,316,445 and 25,760,708 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively
  29 
  26 
Additional paid-in capital
  247,935 
  206,757 
Accumulated deficit
  (196,312)
  (183,763)
Accumulated other comprehensive loss
  (5)
  (45)
    Total stockholders’ equity
  51,647 
  22,975 
 Total Liabilities and Stockholders’ Equity
 111,314 
 $75,973 
* The Unaudited Condensed Consolidated Balance Sheet as of June 30, 2019 has been restated. See Note 1, “Reverse Stock Split.” All share data have been retroactively adjusted to reflect Youngevity’s 1-for-20 reverse stock split, which was effective on June 7, 2017.  
2.
 
See accompanying notes to condensed consolidated financial statements. 
 
-1-

 
Youngevity International, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of OperationsOperations
(In thousands, except share and per share amounts)
(Unaudited)
 
 
Three Months Ended
June 30,
 
 
Six Months Ended
June 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
(Restated)* 
 
 
 
 
 
 (Restated)*
 
 
 
 
Revenues
 $38,217 
 $44,255 
 $79,409 
 $87,249 
Cost of revenues
  12,537 
  18,873 
  26,880 
  36,855 
Gross profit
  25,680 
  25,382 
  52,529 
  50,394 
Operating expenses
    
    
    
    
Distributor compensation
  14,497 
  16,487 
  29,387 
  32,065 
Sales and marketing
  2,786 
  3,076 
  6,805 
  6,575 
General and administrative
  8,251 
  5,166 
  28,132 
  11,077 
Total operating expenses
  25,534 
  24,729 
  64,324 
  49,717 
Operating income (loss)
  146 
  653 
  (11,795)
  677 
Interest expense, net
  (1,062)
  (1,549)
  (2,569)
  (3,261)
Change in fair value of warrant derivative liability
  401 
  192 
  1,887 
  904 
Extinguishment loss on debt
  - 
  - 
  - 
  (1,082)
Total other expense
  (661)
  (1,357)
  (682)
  (3,439)
Loss before income taxes
  (515)
  (704)
  (12,477)
  (2,762)
Income tax (benefit) provision
  (226)
  (90)
  72 
  160 
Net loss
  (289)
  (614)
  (12,549)
  (2,922)
Preferred stock dividends
  (28)
  (42)
  (42)
  (45)
Net loss attributable to common stockholders
 $(317)
 $(656)
 $(12,591)
 $(2,967)
 
    
    
    
    
Net loss per share, basic
 $(0.01)
 $(0.03)
 $(0.44)
 $(0.14)
Net loss per share, diluted (Note 3)
 $(0.02)
 $(0.03)
 $(0.49)
 $(0.14)
 
    
    
    
    
Weighted average shares outstanding, basic
  29,133,150 
  21,506,833 
  28,359,660 
  20,630,383 
Weighted average shares outstanding, diluted
  29,357,347 
  21,506,833 
  28,700,295 
  20,630,383 
 
 
 
Three Months Ended
September 30,
 
 
Nine Months Ended
September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 $44,395 
 $43,562 
 $124,655 
 $124,264 
Cost of revenues
  18,631 
  17,194 
  52,923 
  49,102 
Gross profit
  25,764 
  26,368 
  71,732 
  75,162 
Operating expenses
    
    
    
    
Distributor compensation
  17,391 
  18,101 
  49,496 
  50,871 
Sales and marketing
  4,074 
  3,181 
  10,650 
  7,619 
General and administrative
  6,116 
  4,510 
  16,479 
  13,409 
Total operating expenses
  27,581 
  25,792 
  76,625 
  71,899 
Operating (loss) income
  (1,817)
  576 
  (4,893)
  3,263 
Interest expense, net
  (1,752)
  (946)
  (4,207)
  (3,139)
Change in fair value of warrant derivative liability
  1,519 
  369 
  788 
  535 
Extinguishment loss on debt
  (308)
  - 
  (308)
  - 
Total other expense
  (541)
  (577)
  (3,727)
  (2,604)
(Loss) income before income taxes
  (2,358)
  (1)
  (8,620)
  659 
Income tax (benefit) provision
  (1,290)
  (68)
  (2,763)
  550 
Net (loss) income
  (1,068)
  67 
  (5,857)
  109 
Preferred stock dividends
  (3)
  (3)
  (9)
  (9)
Net (loss) income available to common stockholders
 $(1,071)
 $64 
 $(5,866)
 $100 
 
    
    
    
    
Net loss per share, basic (1)
 $(0.05)
 $0.00 
 $(0.30)
 $0.00 
Net loss per share, diluted (1)
 $(0.05)
 $0.00 
 $(0.30)
 $0.00 
 
    
    
    
    
Weighted average shares outstanding, basic (1)
  19,678,577 
  19,633,731 
  19,655,312 
  19,631,195 
Weighted average shares outstanding, diluted (1)
  19,678,577 
  20,026,001 
  19,655,312 
  20,005,758 
* The Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2019 has been restated. See Note 2.
 
(1) See accompanying notes to condensed consolidated financial statements.

-2-
Youngevity International, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of Comprehensive Loss
(In thousands)

 
 
Three Months Ended
June 30,
 
 
Six Months Ended
June 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
(Restated)* 
 
 
 
 
 
(Restated)*
 
 
 
 
Net loss
 $(289)
 $(614)
 $(12,549)
 $(2,922)
Foreign currency translation
  (62)
  28��
  40 
  229 
Total other comprehensive income (loss)
  (62)
  28 
  40 
  229 
Comprehensive loss
 $(351)
 $(586)
 $(12,509)
 $(2,693)
* The Unaudited Condensed Consolidated Statement of Comprehensive Income (Loss) for the three and six months ended June 30, 2019 has been restated. See Note 1, “Reverse Stock Split.” All share data have2. 
See accompanying notes to condensed consolidated financial statements.
-3-
Youngevity International, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of Stockholders' Equity
(In thousands, except shares)
Three Months Ended June 30, 2019
 
 
  Series A
Preferred Stock
 
 
Series B
Preferred Stock
 
 
Common Stock
 
 
  
Additional
Paid-in Capital
 
 
  
Accumulated
Other
Comprehensive
 
 
  
Accumulated Deficit
 
 
  
Total Stockholders' Equity
 
 
 
Shares
 
 
Amount
 
 
  Shares  
 
 
Amount
 
 
Shares
 
 
Amount
 
 
  (Restated)*
 
 
Loss
 
 
  (Restated)*
 
 
  (Restated)*
 
Balance at March 31, 2019
  161,135 
 $- 
  129,437 
 $- 
  28,890,671 
 $29 
 $244,906 
 $57 
 $(196,023)
 $48,969 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (289)
  (289)
Foreign currency translation adjustment
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (62)
  - 
  (62)
Issuance of common stock from exercise of stock options and warrants, net
  - 
  - 
  - 
  - 
  64,524 
  - 
  293 
  - 
  - 
  293 
Issuance of common stock for services
  - 
  - 
  - 
  - 
  100,000 
  - 
  571 
  - 
  - 
  571 
Issuance of common stock in private offering, net of issuance costs
  - 
  - 
  - 
  - 
  250,000 
  - 
  1,375 
  - 
  - 
  1,375 
Issuance of common stock for convertible note financing, net of issuance costs
  - 
  - 
  - 
  - 
  11,250 
  - 
  135 
  - 
  - 
  135 
Warrant issued upon vesting for services
  - 
  - 
  - 
  - 
  - 
  - 
  270 
  - 
  - 
  270 
Dividends on preferred stock
  - 
  - 
  - 
  - 
  - 
  - 
  (28)
  - 
  - 
  (28)
Stock based compensation expense
  - 
  - 
  - 
  - 
  - 
  - 
  413 
  - 
  - 
  413 
Balance at June 30, 2019
  161,135 
 $- 
  129,437 
 $- 
  29,316,445 
 $29 
 $247,935 
 $(5)
 $(196,312)
 $51,647 
  * The Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2019 has been retroactively adjustedrestated. See Note 2.
See accompanying notes to reflect Youngevity’s 1-for-20 reverse stock split, which was effective oncondensed consolidated financial statements.

-4-
Six Months Ended June 7, 2017.30, 2019
 
 
 
Series A
Preferred Stock
 
 
Series B
Preferred Stock
 
 
 
Common Stock
 
 
 
Additional
Paid-in Capital
 
 
Accumulated
Other
Comprehensive
 
 
 
Accumulated Deficit
 
 
 
Total Stockholders' Equity
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
(Restated)*
 
 
Loss
 
 
(Restated)*
 
 
(Restated)*
 
Balance at December 31, 2018
  161,135 
 $- 
  129,437 
 $- 
  25,760,708 
 $26 
 $206,757 
 $(45)
 $(183,763)
 $22,975 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (12,549)
  (12,549)
Foreign currency translation adjustment
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  40 
  - 
  40 
Issuance of common stock from at-the-market offering and exercise of stock options and warrants, net
  - 
  - 
  - 
  - 
  374,160 
  1 
  1,747 
  - 
  - 
  1,748 
Issuance of common stock for services
  - 
  - 
  - 
  - 
  175,000 
  - 
  988 
  - 
  - 
  988 
Issuance of common stock in private offering, net of issuance costs
  - 
  - 
  - 
  - 
  505,000 
  - 
  3,125 
  - 
  - 
  3,125 
Issuance of common stock for acquisition of Khrysos
  - 
  - 
  - 
  - 
  1,794,972 
  1 
  13,999 
  - 
  - 
  14,000 
Issuance of common stock for debt financing, net of issuance costs
  - 
  - 
  - 
  - 
  40,000 
  - 
  350 
  - 
  - 
  350 
Issuance of common stock for true-up shares
  - 
  - 
  - 
  - 
  44,599 
  - 
  281 
  - 
  - 
  281 
Issuance of common stock for convertible note financing, net of issuance costs
  - 
  - 
  - 
  - 
  72,250 
  - 
  428 
  - 
  - 
  428 
Issuance of common stock related to purchase of land - H&H
  - 
  - 
  - 
  - 
  153,846 
  - 
  1,200 
  - 
  - 
  1,200 
Issuance of common stock related to purchase of trademark - H&H
  - 
  - 
  - 
  - 
  100,000 
  - 
  750 
  - 
  - 
  750 
Issuance of common stock related to advance for working capital (note receivable) net of settlement of debt
  - 
  - 
  - 
  - 
  295,910 
  1 
  2,308 
  - 
  - 
  2,309 
Release of warrant liability upon exercise of warrants
  - 
  - 
  - 
  - 
  - 
  - 
  866 
  - 
  - 
  866 
Release of warrant liability upon reclassification of liability to equity
  - 
  - 
  - 
  - 
  - 
  - 
  1,494 
  - 
  - 
  1,494 
Warrant issued upon vesting for services
  - 
  - 
  - 
  - 
  - 
  - 
  1,926 
  - 
  - 
  1,926 
Dividends on preferred stock
  - 
  - 
  - 
  - 
  - 
  - 
  (42)
  - 
  - 
  (42)
Stock based compensation expense
  - 
  - 
  - 
  - 
  - 
  - 
  11,757 
  - 
  - 
  11,757 
Balance at June 30, 2019
  161,135 
 $- 
  129,437 
 $- 
  29,316,445 
 $29 
 $247,935 
 $(5)
 $(196,312)
 $51,647 
* The Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2019 has been restated. See Note 2.
See accompanying notes to condensed consolidated financial statements.

-5-
Youngevity International, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of Stockholders' Equity
(In thousands, except shares)
Three Months Ended June 30, 2018
 
 
Series A
Preferred Stock
 
 
Series B
Preferred Stock
 
 
Common Stock
 
 
Additional Paid-in
 
 
Accumulated Other Comprehensive
 
 
Accumulated
 
 
Total Stockholders'
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Loss
 
 
Deficit
 
 
Equity
 
Balance at March 31, 2018
  161,135 
  - 
  381,173 
  - 
  21,305,755 
  21 
  181,501 
  (80)
  (166,001)
  15,441 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (614)
  (614)
Foreign currency translation adjustment
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  28 
  - 
  28 
Issuance of common stock for services
  - 
  - 
  - 
  - 
  125,000 
  - 
  518 
  - 
  - 
  518 
Issuance of common stock for conversion of Series B preferred stock
  - 
  - 
  (52,632)
  - 
  105,264 
  1 
  - 
  - 
  - 
  1 
Warrant modification
  - 
  - 
  - 
  - 
  - 
  - 
  283 
  - 
  - 
  283 
Dividends on preferred stock
  - 
  - 
  - 
  - 
  - 
  - 
  (42)
  - 
  - 
  (42)
Stock based compensation expense
  - 
  - 
  - 
  - 
  - 
  - 
  215 
  - 
  - 
  215 
Balance at June 30, 2018
  161,135 
 $- 
  328,541 
 $- 
  21,536,019 
 $22 
 $182,475 
 $(52)
 $(166,615)
 $15,830 
 See accompanying notes to condensed consolidated financial statements.
-6-
Six Months Ended June 30, 2018
 
 
Series A
Preferred Stock
 
 
Series B
Preferred Stock
 
 
Common Stock
 
 
Additional Paid-in
 
 
Accumulated Other Comprehensive
 
 
Accumulated
 
 
Total Stockholders'
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Loss
 
 
Deficit
 
 
Equity
 
Balance at
December 31, 2017
  161,135 
  - 
  - 
  - 
  19,723,285 
  20 
  171,405 
  (281)
  (163,693)
  7,451 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (2,922)
  (2,922)
Foreign currency translation adjustment
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  229 
  - 
  229 
Issuance of Series B preferred stock, net of issuance cost
  - 
  - 
  381,173 
  - 
  - 
  - 
  3,289 
  - 
  - 
  3,289 
Issuance of common stock pursuant to the exercise of stock options and warrants
  - 
  - 
  - 
  - 
  437 
  - 
  2 
  - 
  - 
  2 
Issuance of common stock for services
  - 
  - 
  - 
  - 
  130,000 
  - 
  545 
  - 
  - 
  545 
Issuance of common stock for conversion of Series B preferred stock
  - 
  - 
  (52,632)
  - 
  105,264 
  1 
  - 
  - 
  - 
  1 
Issuance of common stock for conversion of Notes – 2017 Notes
  - 
  - 
  - 
  - 
  1,577,033 
  1 
  6,544 
  - 
  - 
  6,545 
Warrant modification
  - 
  - 
  - 
  - 
  - 
  - 
  283 
  - 
  - 
  283 
Dividends on preferred stock
  - 
  - 
  - 
  - 
  - 
  - 
  (45)
  - 
  - 
  (45)
Stock based compensation expense
  - 
  - 
  - 
  - 
  - 
  - 
  452 
  - 
  - 
  452 
Balance at June 30, 2018
  161,135 
 $- 
  328,541 
 $- 
  21,536,019 
 $22 
 $182,475 
 $(52)
 $(166,615)
 $15,830 

See accompanying notes to condensed consolidated financial statements.
 
 
 
-2-

Youngevity International, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive (Loss) Income
(In thousands)
(Unaudited)
 
 
Three Months Ended
September 30,
 
 
Nine Months Ended
September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
 $(1,068)
 $67 
 $(5,857)
 $109 
Foreign currency translation
  (16)
  (28)
  (2)
  (174)
Total other comprehensive loss
  (16)
  (28)
  (2)
  (174)
Comprehensive (loss) income
 $(1,084)
 $39 
 $(5,859)
 $(65)
See accompanying notes to condensed consolidated financial statements.
-3--7-
 
 
Youngevity International, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of CashCash Flows
 (In thousands)
(Unaudited)
 
 
Six Months Ended
June 30,
 
 
 
2019
 
 
2018
 
Cash Flows from Operating Activities:
 
 (Restated)*
 
 
 
 
Net loss
 $(12,549)
 $(2,922)
Adjustments to reconcile net loss to net cash used in operating activities:
    
    
Depreciation and amortization
  2,333 
  2,594 
Stock-based compensation expense
  11,757 
  452 
Amortization of debt discounts and issuance costs
  534 
  844 
Equity issuance costs for services
  2,541 
  98 
Change in fair value of warrant derivative liability
  (1,887)
  (904)
Change in fair value of contingent acquisition debt
  (433)
  (1,459)
Extinguishment loss on debt
  - 
  1,082 
Change in inventory reserve
  159 
  (700)
Stock issuance for true-up shares
  281 
  - 
Deferred taxes
  73 
  137 
Changes in operating assets and liabilities, net of effect from business combinations:
    
    
Accounts receivable
  (5,965)
  (2,440)
Inventory
  (1,916)
  (94)
Prepaid expenses and other current assets
  (844)
  (585)
Accounts payable
  (1,065)
  (1,135)
Accrued distributor compensation
  451 
  (14)
Deferred revenues
  (52)
  1,502 
Accrued expenses and other liabilities
  1,358 
  1,958 
Income taxes receivable
  (157)
  (90)
Net Cash Used in Operating Activities
  (5,381)
  (1,676)
 
    
    
Cash Flows from Investing Activities:
    
    
Acquisitions, net of cash acquired
  (425)
  (50)
Purchases of property and equipment
  (3,269)
  (160)
Net Cash Used in Investing Activities
  (3,694)
  (210)
 
    
    
Cash Flows from Financing Activities:
    
    
Proceeds from issuance of promissory notes, net of offering costs
  5,125 
  - 
Proceeds from issuance of Series B convertible preferred stock, net of offering costs
  - 
  3,289 
Proceeds from private placement of common stock, net of offering costs
  2,684 
  - 
Proceeds from at-the-market-offering and exercise of stock options and warrants, net
  1,748 
  3 
Payments net of repayment on line of credit
  (254)
  (894)
Payments of notes payable
  (68)
  (94)
Payments of contingent acquisition debt
  (235)
  (78)
Payments of finance leases
  (734)
  (542)
Payments of dividends 
  (22)
  - 
Net Cash Provided by Financing Activities
  8,244 
  1,684 
Foreign Currency Effect on Cash
  40 
  229 
Net (decrease) increase in cash and cash equivalents
  (791)
  27 
Cash and Cash Equivalents, Beginning of Period
  2,879 
  673 
Cash and Cash Equivalents, End of Period
 $2,088 
 $700 
 
    
    
Supplemental Disclosures of Cash Flow Information
    
    
Cash paid during the period for:
    
    
Interest
 $1,858 
 $2,427 
Income taxes
 $148 
 $30 
 
    
    
Supplemental Disclosures of Noncash Investing and Financing Activities
    
    
Purchases of property and equipment funded by finance leases
 $42 
 $680 
Purchases of property and equipment funded by mortgage agreements
 $450 
 $- 
Fair value of stock issued for services (Note 11)
 $988 
 $545 
Fair value of stock issued for property and equipment (land)
 $1,200 
 $- 
Fair value of stock issued for purchase of intangibles (tradename)
 $750 
 $- 
Fair value of stock issued for note receivable, net of debt settlement
 $2,309 
 $- 
Fair value of stock issued in connection with the acquisition of Khrysos Global, Inc. (Note 5)
 $14,000 
 $- 
Change in warrant derivative liability to equity classification, warrant modification
 $- 
 $284 
Dividends declared but not paid at the end of period (Note 11)
 $25 
 $39 
Acquisitions of net assets in exchange for contingent debt, net of purchase price adjustments
 $- 
 $1,877 
Conversion of 2017 Notes to Common Stock
 $- 
 $7,254 
 
 
 
Nine Months Ended
September 30,
 
 
 
2017
 
 
2016
 
Cash Flows from Operating Activities:
 
 
 
 
(As Restated)
 
Net (loss) income
 $(5,857)
 $109 
Adjustments to reconcile net (loss) income to net cash used in operating activities:
    
    
Depreciation and amortization
  3,230 
  2,865 
Stock based compensation expense
  471 
  292 
Amortization of deferred financing costs
  281
 
  270 
Amortization of warrant issuance costs 
  172
 
  96
 
Amortization of debt discount 
  799
 
  790
 
Amortization of prepaid advisory fees
  42 
  46 
Stock issuance for services
  200 
  30 
Stock issuance related to debt financing
  106 
  - 
Fair value of warrant issuance
  341 
  - 
Change in fair value of warrant derivative liability
  (788)
  (535)
Expenses allocated in profit sharing agreement
  (195)
  (557)
Change in fair value of contingent acquisition debt
  (1,020)
  (1,185)
Extinguishment loss on debt
  308 
  - 
Deferred income taxes 
  (2,846)
  -
 
   Changes in operating assets and liabilities, net of effect from business combinations:
    
    
Accounts receivable
  (1,452)
  (1,411)
Inventory
  440 
  (1,925)
Income taxes receivable
  - 
  173 
Prepaid expenses and other current assets
  (282)
  (502)
Accounts payable
  2,143 
  293 
Accrued distributor compensation
  515 
  401 
Deferred revenues
  129 
  (652)
Accrued expenses and other liabilities
  1,480
 
  705 
Net Cash Used In Operating Activities
  (1,783)
  (697)
 
    
    
Cash Flows from Investing Activities:
    
    
Acquisitions, net
  (175)
  (88)
Purchases of property and equipment
  (690)
  (938)
Net Cash Used in Investing Activities
  (865)
  (1,026)
 
    
    
Cash Flows from Financing Activities:
    
    
Proceeds from the exercise of stock options and warrants, net
  28 
  39 
Proceeds from factoring company
  1,723 
  1,131 
Proceeds from issuance of convertible notes, net of offering cost
  2,720 
  - 
Payments of notes payable, net
  (159)
  (411)
Payments of contingent acquisition debt
  (440)
  (708)
Proceeds (payments) of capital leases
  (718)
  19 
Repurchase of common stock
  - 
  (36)
Net Cash Provided by Financing Activities
  3,154 
  34 
Foreign Currency Effect on Cash
  (2)
  (174)
Net increase (decrease) in cash and cash equivalents
  504 
  (1,863)
Cash and Cash Equivalents, Beginning of Period
  869 
  3,875 
Cash and Cash Equivalents, End of Period
 $1,373 
 $2,012 
 
    
    
Supplemental Disclosures of Cash Flow Information
    
    
Cash paid during the period for:
    
    
Interest
 $2,773 
 $1,987 
Income taxes
 $31 
 $192 
 
    
    
Supplemental Disclosures of Noncash Investing and Financing Activities
    
    
Purchases of property and equipment funded by capital leases
 $398 
 $1,416 
Acquisitions of net assets in exchange for contingent acquisition debt (see Note 4)
 $5,920
 
 $4,876 
Fair value of the bifurcated embedded conversion option recorded as a derivative liability (see Notes 6 & 7)
 $330
 
 $- 
Fair value of the warrants issued in connection with financing recorded as a derivative liability (see Notes 6 & 7)
 $2,334
 
 $- 
During the third quarter ended September 30, 2017, the purchase accounting was finalized* The Unaudited Condensed Consolidated Statement of Cash Flows for the Company’s Legacy for Life, LLC, Nature’s Pearl Corporation and Renew Interest, LLC acquisitions and reduced the initial purchase of the intangibles acquired and the contingent debt by $92,000, $266,000 and $30,000, respectively (seesix months ended June 30, 2019 has been restated. See Note 4).2.
 
See accompanying notes to condensed consolidated financial statements.
  

 
-4--8-
 
 
Youngevity International, Inc. and Subsidiaries
NotesNotes to Unaudited Condensed Consolidated Financial Statements
(Unaudited)
September 30, 2017
 
Note 1. Basis of Presentation and Description of Business
 
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to such rules and regulations.
 
Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
The statements presented as of SeptemberJune 30, 20172019 and for the three and ninesix months ended SeptemberJune 30, 20172019 and 20162018 are unaudited. In the opinion of management, these financial statements reflect all normal recurring and other adjustments necessary for a fair presentation, and to make the financial statements not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Form 10-K/A10-K for the year ended December 31, 2016.2018, filed with the SEC on April 15, 2019. The results for interim periods are not necessarily indicative of the results for the entire year.
 
Nature of Business
Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Certain reclassifications have been made to conform to the current year presentations including the Company’s adoption of Accounting Standards Update (“ASU”) 2015-17 pertaining to the presentation ofdeferred tax assets and liabilities as noncurrentwith retrospective application effective January 1, 2017. This resulted in a reclassificationfrom deferred tax assets, net current to deferred tax assets, net long-term. These reclassifications did not affect revenue, total costs and expenses, income (loss) from operations, or net income (loss). The adoption of ASU No. 2015-17 resulted in a reclassification of deferred tax assets, net current of $565,000 todeferred tax assets, net long-termon the Company’s consolidated financial statements as of December 31, 2016.
As previously reported on the Annual Report on Form 10-K/A for the year ended December 31, 2016 filed with the Securities and Exchange Commission on August 14, 2017, the Company restated the interim Consolidated Statement of Cash Flows for the quarter ended September 30, 2016 previously filed by the Company in its quarterly report on Form 10-Q for the same period. This was due to an error in the presentation of cash flow activity under the Company’s factoring facility. This quarterly report for the quarter ended September 30, 2017 reflects the restated numbers for the nine months ended September 30, 2016.
Nature of Business
The Company,, founded in 1996, develops and distributes health and nutrition related products through its global independent direct selling network, also known as multi-level marketing, and sells coffee products to commercial customers.  TheDuring the year ended December 31, 2018 the Company operatesoperated in two business segments, its direct selling segment where products are offered through a global distribution network of preferred customers and distributors and its commercial coffee segment where products are sold directly to businesses. InDuring the following text, the terms “we,” “our,” and “us” may refer, as the context requires, tofirst quarter of 2019, the Company or collectivelythrough the acquisition of the assets of Khrysos Global, Inc. added a third business segment to its operations, the commercial hemp segment.
Information on the operation of the Company's three segments is as follows:
Direct selling segment is operated through four domestic subsidiaries: AL Global Corporation, 2400 Boswell LLC, MK Collaborative LLC, and Youngevity Global LLC and nine foreign subsidiaries: Youngevity Australia Pty. Ltd., Youngevity NZ, Ltd., Youngevity Mexico S.A. de CV, Youngevity Israel, Ltd., Youngevity Russia, LLC, Youngevity Colombia S.A.S, Youngevity International Singapore Pte. Ltd., Mialisia Canada, Inc. and Legacy for Life Limited (Hong Kong). The Company also operates through the BellaVita Group LLC, with operations in Taiwan, Hong Kong, Singapore, Indonesia, Malaysia and Japan. The Company also operates subsidiary branches of Youngevity Global LLC in the Philippines and Taiwan. 
Commercial coffee segment is operated through the Company’s subsidiaries CLR Roasters LLC (“CLR”) and its wholly owned subsidiary, Siles Plantation Family Group S.A. (“Siles”).
Commercial hemp segment is operated through the Company’s subsidiaries, Khrysos Industries, Inc., a Delaware corporation (“KII”), which acquired the assets of Khrysos Global Inc. a Florida corporation (“Khrysos Global”), in February 2019 and the wholly-owned subsidiaries of Khrysos Global, INXL Laboratories, Inc., a Florida corporation (“INXL”) and INX Holdings, Inc., a Florida corporation (“INXH”).
Segment Information
The Company has three reportable segments: direct selling, commercial coffee, and commercial hemp. The direct selling segment develops and distributes health and wellness products through its global independent direct selling network also known as multi-level marketing. The commercial coffee segment is engaged in coffee roasting and distribution (specializing in gourmet coffee), mill processing of green coffee, and sales of green coffee. The commercial hemp segment manufactures proprietary systems to provide end-to-end extraction and processing that allow for the conversion of hemp feed stock into hemp oil and hemp extracts. The determination that the Company and its subsidiaries.has three reportable segments is based upon the guidance set forth in Accounting Standards Codification (“ASC”) Topic 280,“Segment Reporting.”
 
The Company operates through the following domestic wholly-owned subsidiaries: AL Global Corporation, which operates its direct selling networks, CLR Roasters, LLC (“CLR”), its commercial coffee business, 2400 Boswell LLC, MK Collaborative LLC, Youngevity Global LLC and the wholly-owned foreign subsidiaries Youngevity Australia Pty. Ltd., Youngevity NZ, Ltd., Siles Plantation Family Group S.A. (“Siles”), located in Nicaragua, Youngevity Mexico S.A. de CV, Youngevity Israel, Ltd., Youngevity Russia, LLC, Youngevity Colombia S.A.S, Youngevity International Singapore Pte. Ltd., Mialisia Canada, Inc., Legacy for Life Limited (Hong Kong). The Company also operates through the BellaVita Group LLC, with operations in; Taiwan, Hong Kong, Singapore, Indonesia, Malaysia and Japan.
The Company also operates subsidiary branches of Youngevity Global LLC in the Philippines and Taiwan.
Reverse Stock Split
On June 5, 2017, the Company filed a certificate to amend its Articles of Incorporation to effect a reverse split on a one-for-twenty basis (the “Reverse Split”), whereby, every twenty shares of the Company’s common stock, par value $0.001 per share (the “Common Stock or “common stock”), were exchanged for one share of its common stock. The Reverse Split became effective on June 7, 2017. All common stock share and per share amounts have been adjusted to reflect retrospective application of the Reverse Split, unless otherwise indicated. The Common Stock began trading on a reverse split basis at the market opening on June 8, 2017.
 
 
-5--9-
 
 
NASDAQ ListingDuring the three months ended June 30, 2019, the Company derived approximately 84.1% of its revenue from its direct selling segment and approximately 15.2% of its revenue from its commercial coffee segment and 0.7% from the commercial hemp segment. During the three months ended June 30, 2018, the Company had two reportable segments and derived approximately 83% of its revenue from its direct selling segment and approximately 17% of its revenue from its commercial coffee segment.
 
EffectiveDuring the six months ended June 21, 2017, the Common Stock began trading on the NASDAQ Stock Market LLC’s NASDAQ Capital Market, under the symbol “YGYI”. Prior to the Company’s uplisting to NASDAQ, the Company’s common stock had been traded on the OTCQX market.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires30, 2019, the Company to make estimatesderived approximately 82.5% of its revenue from its direct selling segment and assumptions that affectapproximately 17% of its revenue from its commercial coffee segment and 0.4% from the reported amountscommercial hemp segment. During the six months ended June 30, 2018, the Company had two reportable segments and derived approximately 83% of assetsits revenue from its direct selling segment and liabilities and disclosureapproximately 17% of contingent assets and liabilities at the date of the financial statements and the reported amounts ofits revenue and expense for each reporting period.  Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes, and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under our stock based compensation plan, fair value of assets and liabilities acquired in business combinations, capital leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns.  
Actual results may differ from previously estimated amounts and such differences may be material to the condensed consolidated financial statements. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected prospectively in the period they occur.its commercial coffee segment.
 
Liquidity and Going Concern
 
The accompanying condensed consolidated financial statements have been prepared and presented on a basis assuming the Company will continue as a going concern. The Company has sustained significant operatingnet losses forduring the ninesix months ended SeptemberJune 30, 20172019 and 2018 of $4,893,000, compared to operating income in the prior year of $3,263,000. The losses in the current year were primarily due to lower than anticipated revenues, increases in legal fees, distributor eventsapproximately $12,549,000 and sales and marketing costs.$2,922,000, respectively. Net cash used in operating activities was $1,783,000 inapproximately $5,381,000 and $1,676,000 for the current year.six months ended June 30, 2019 and 2018, respectively. The Company does not currently believe that its existing cash resources are sufficient to meet the Company’s anticipated needs over the next twelve months from the date hereof. Based on its current cash levels and its current rate of cash requirements, the Company will need to raise additional capital andand/or will need to significantlyfurther reduce its expenses from current levels to be ablelevels. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The Company has already commencedanticipates that revenues will grow, and it intends to make necessary cost reductions related to international operations that are not performing well and reduce non-essential expenses.
The Company is also considering multiple other fund-raising alternatives. 
On March 18, 2019, the processCompany entered into a two-year Secured Promissory Note (the “Note” or “Notes”) with two (2) accredited investors that had a substantial pre-existing relationship with the Company pursuant to increasewhich the Company raised cash proceeds of $2,000,000. (See Note 7 below.)
Between February 2019 and May 2019, the Company closed four tranches of its Crestmark lineJanuary 2019 Private Placement debt offering, pursuant to which the Company offered for sale up to $10,000,000 in principal amount of credit duringnotes (the “2019 PIPE Notes”), with each investor receiving 2,000 shares of common stock for each $100,000 invested. The Company received aggregate gross proceeds of $2,890,000 and issued the fourth quarter2019 PIPE Notes in the aggregate principal amount of this year$2,890,000. (See Note 8)
On February 6, 2019, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with one accredited investor that had a substantial pre-existing relationship with the Company pursuant to which the Company sold 250,000 shares of the Company’s common stock, par value $0.001 per share, at an offering price of $7.00 per share. Pursuant to the Purchase Agreement, the Company also issued to the investor a three-year warrant to purchase 250,000 shares of common stock at an exercise price of $7.00. The proceeds to the Company were $1,750,000. Consulting fees for arranging the Purchase Agreement include the issuance of 5,000 shares of restricted shares of the Company’s common stock, par value $0.001 per share, and a 3-year warrant priced at $10.00 per share convertible into 100,000 shares of the Company’s common stock upon exercise. No cash commissions were paid.
On January 7, 2019, the Company entered into an At-the-Market Offering Agreement (the “ATM Agreement”) with The Benchmark Company, LLC (“Benchmark”), as sales agent, pursuant to which the Company may sell from time to time, at its option, shares of its common stock, par value $0.001 per share, through Benchmark, as sales agent (the “Sales Agent”), for the sale of up to $60,000,000 of shares of the Company’s common stock. The Company is not obligated to make any sales of common stock under the ATM Agreement and the Company is considering multiple alternatives, including, butcannot provide any assurances that it will issue any shares pursuant to the ATM Agreement. The Company will pay the Sales Agent 3.0% commission of the gross sales proceeds. In February 2019, the Company sold a total of 1,000 shares of common stock under the ATM Agreement for an aggregate purchase price of $6.6118 pursuant to the ATM Agreement. The Company did not limited to, additional equity financings and debt financings. use the ATM Agreement during the three months ended June 30, 2019.
-10-
Depending on market conditions, we cannotthere can be sureno assurance that additional capital will be available when needed or that, if available, it will be obtained on terms favorable to usthe Company or to ourits stockholders.
The Company believes that legal fees will decrease in the future from the levels spent in the current year. Furthermore, the Company expects to get reimbursements from its insurance company for legal fees already incurred. The Company expects costs related to distributor events will decrease next year from current year levels as its costs in the current year were unusually high due to the twentieth anniversary convention held in Dallas in August and one-time events held at the beginning of the year to stabilize the sales force due to the departure of the previous president and high-level sales management and distributors. The Company anticipates revenues to start growing again and it intends to make necessary cost reductions related to international programs that are not performing and also reduce non-essential expenses.
 
Failure to raise additional funds from the issuance of equity securities and failure to implement cost reductions could adversely affect the Company’s ability to operate as a going concern. The financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.
  
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense for each reporting period. Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under the Company’s stock-based compensation plan, fair value of assets and liabilities acquired in business combinations, finance leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns. 
Actual results may differ from previously estimated amounts and such differences may be material to the consolidated financial statements. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected prospectively in the period they occur.
Cash and Cash Equivalents
 
The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.
 
Earnings Per ShareRelated Party Transactions
Richard Renton
 
Richard Renton is a member of the Board of Directors and owns and operates WVNP, Inc., a supplier of certain inventory items sold by the Company.  Basic earnings (loss)The Company made purchases of approximately $103,000 and $63,000 from WVNP Inc., for the three months ended June 30, 2019 and 2018, respectively, and $111,000 and $117,000 for the six months ended June 30, 2019 and 2018, respectively.
Carl Grover
Carl Grover is the sole beneficial owner of in excess of five percent (5%) of the Company’s outstanding common shares. On December 13, 2018, CLR, entered into a Credit Agreement with Mr. Grover (the “Credit Agreement”) pursuant to which CLR borrowed $5,000,000 from Mr. Grover and in exchange issued to him a $5,000,000 credit note (“Credit Note”) secured by its green coffee inventory under a Security Agreement, dated December 13, 2018 (the “Security Agreement”), with Mr. Grover and CLR’s subsidiary, Siles Family Plantation Group S.A. (“Siles”), as guarantor, and Siles executed a separate Guaranty Agreement (“Guaranty”). The Company issued to Mr. Grover a four-year warrant to purchase 250,000 shares of its common stock, exercisable at $6.82 per share, is computed by dividing net income (loss) attributableand a four-year warrant to purchase 250,000 shares of the Company’s common stockholders bystock, exercisable at $7.82 per share, pursuant to a Warrant Purchase Agreement, dated December 13, 2018, with Mr. Grover. (See Note 7 below.)
On July 31, 2019, Mr. Grover acquired 600,242 shares of the weighted-average numberCompany's common stock, $0.001 par value, upon the partial exercise at $4.60 per share of a July 31, 2014 warrant to purchase 782,608 shares of common stock held by him. In connection with such exercise, the Company received $2,761,113 from Mr. Grover, issued to Mr. Grover 50,000 shares outstanding duringof restricted common stock as an inducement fee and agreed to extend the period. Diluted earnings per share is computed by dividing net income attributable to common stockholders by the sumexpiration date of the weighted-average numberJuly 31, 2014 warrant held by him to December 15, 2020 with respect to 182,366 shares of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of in-the-money stock options, warrants and convertible preferred stock and common stock associated with the Company's convertible notes based on the average stock priceremaining for each period using the treasury stock method.
exercise thereunder.
 
 
-6--11-
 
 
SincePaul Sallwasser
Mr. Paul Sallwasser is a member of the board directors and prior to joining the Company’s Board of Directors he acquired a note (the “2014 Note”) issued in the Company’s private placement consummated in 2014 (the “2014 Private Placement”) in the principal amount of $75,000 convertible into 10,714 shares of common stock and a warrant (the “2014 Warrant”) issued, in the 2014 Private Placement, exercisable for 14,673 shares of common stock. Prior to joining the Company’s Board of Directors, Mr. Sallwasser acquired in the 2017 Private Placement a 2017 Note in the principal amount of approximately $38,000 convertible into 8,177 shares of common stock and a warrant (the “2017 Warrant”) issued, in the 2017 Private Placement, exercisable for 5,719 shares of common stock. Mr. Sallwasser also acquired in the 2017 Private Placement in exchange for the “2015 Note” that he acquired in the Company’s private placement consummated in 2015 (the “2015 Private Placement”), a 2017 Note in the principal amount of $5,000 convertible into 1,087 shares of common stock and a 2017 Warrant exercisable for 543 shares of common stock. On March 30, 2018, the Company incurredcompleted its Series B Offering, and in accordance with the terms of the 2017 Notes, Mr. Sallwasser’s 2017 Notes converted to 9,264 shares of the Company’s common stock.
2400 Boswell LLC
In March 2013, the Company acquired 2400 Boswell for approximately $4,600,000. 2400 Boswell is the owner and lessor of the building occupied by the Company for its corporate office and warehouse in Chula Vista, California. The purchase was from an immediate family member of the Company’s Chief Executive Officer and consisted of approximately $248,000 in cash, approximately $334,000 of debt forgiveness and accrued interest, and a losspromissory note of approximately $393,000, payable in equal payments over 5 years and bears interest at 5.0%.  Additionally, the Company assumed a long-term mortgage of $3,625,000, payable over 25 years with an initial interest rate of 5.75%. The interest rate is the prime rate plus 2.5%. The current interest rate as of June 30, 2019 was 8.0%. The lender will adjust the interest rate on the first calendar day of each change period or calendar quarter. The Company and its Chief Executive Officer are both co-guarantors of the mortgage. As of June 30, 2019, the balance on the long-term mortgage is approximately $3,180,000 and the balance on the promissory note is zero.
Other Relationship Transactions
Hernandez, Hernandez, Export Y Company and H&H Coffee Group Export Corp.
The Company’s wholly-owned subsidiary, CLR, is associated with Hernandez, Hernandez, Export Y Company (“H&H”), a Nicaragua company, through sourcing arrangements to procure Nicaraguan grown green coffee beans. As part of the 2014 Siles acquisition, CLR engaged the owners of H&H, Alain Piedra Hernandez (“Mr. Hernandez”) and Marisol Del Carmen Siles Orozco (“Ms. Orozco”), as employees to manage Siles.
H&H is a sourcing agent that purchases raw green coffee beans from the local producers in Nicaragua and supplies CLR’s mill with unprocessed green coffee for processing. CLR does not have a direct relationship with the local producers and is dependent on H&H to negotiate agreements with local producers for the supply of unprocessed green coffee and provide the raw unprocessed green coffee to CLR’s mill in a timely and efficient manner. Substantially all the green coffee processed through the Siles mill was coffee assigned to CLR for processing. In addition, CLR’s largest customer for green coffee beans during the three and six months ended June 30, 2019 is H&H Coffee Group Export Corp., (“H&H Export”), a Florida based company which is affiliated with H&H. In consideration for H&H's sourcing of green coffee for processing within CLR’s mill, CLR and H&H share in the green coffee profit from milling operations.
CLR made purchases from H&H of approximately $252,000 and $2,828,000 of green coffee for the three and ninesix months ended June 30, 2019, respectively, for use in the Company’s Miami roasting facilities. There were no purchases of green coffee from H&H to be sold to other third parties during the three and six months ended June 30, 2019.
CLR made purchases from H&H of approximately $3,339,000 and $7,073,000 of green coffee for the three and six months ended June 30, 2018, respectively, for use in selling processed green coffee to other third parties and for use in the Company’s Miami roasting facilities.
During the three and six months ended June 30, 2019, CLR recorded net revenues from processing services of approximately $1,561,000 and $6,387,000, respectively. There was no processing service revenue during the three and six months ended June 30, 2018.
-12-
During the three and six months ended June 30, 2018, CLR recorded processed green coffee beans gross revenues of $859,000 and $3,302,000, respectively, to H&H Export. There were no processed green coffee bean sales during the three and six months ended June 30, 2019 to H&H.
In May 2017, the Company entered a settlement agreement with Alain Piedra Hernandez, one of the owners of H&H and the operating manager of Siles, who was issued a non-qualified stock option for the purchase of 75,000 shares of the Company’s common stock at a price of $2.00 with an expiration date of three years, in lieu of an obligation due from the Company to H&H as it relates to a Sourcing and Supply Agreement with H&H. During the period ended September 30, 2017 7,506,283the Company replaced the non-qualified stock option and issued a warrant agreement with the same terms. There was no financial impact related to the cancellation of the option and the issuance of the warrant. As of June 30, 2019, the warrant remains outstanding.
In December 2018, CLR advanced $5,000,000 to H&H Export to provide services in support of a 5-year contract for the sale and processing of 41 million pounds of green coffee beans on an annual basis. The services include providing hedging and financing opportunities to producers and delivering harvested coffee to the Company’s mills.  On March 31, 2019, this advance was converted to a $5,000,000 loan agreement as a note receivable and bears interest at 9% per annum and is due and payable by H&H Export at the end of each year’s harvest season, but no later than October 31 for any harvest year. The loan is secured by H&H Export’s hedging account with INTL FC Stone, trade receivables, green coffee inventory in the possession of H&H Export and all green coffee contracts. As of June 30, 2019, the $5,097,000 note receivable remains outstanding which includes accrued interest.
Mill Construction Agreement
On January 15, 2019, CLR entered into the CLR Siles Mill Construction Agreement (the “Mill Construction Agreement”) with H&H and H&H Export, Alain Piedra Hernandez (“Hernandez”) and Marisol Del Carmen Siles Orozco (“Orozco”), together with H&H, H&H Export, Hernandez and Orozco, collectively referred to as the Nicaraguan Partner, pursuant to which the Nicaraguan Partner agreed to transfer a 45 acre tract of land in Matagalpa, Nicaragua (the “Property”) to be owned 50% by the Nicaraguan Partner and 50% by CLR. In consideration for the land acquisition the Company issued to H&H Export, 153,846 shares of common share equivalents were notstock. In addition, the Nicaraguan Partner and CLR agreed to contribute $4,700,000 each toward the construction of a processing plant, office, and storage facilities (“Mill”) on the property for processing coffee in Nicaragua. As of June 30, 2019, the Company paid $3,350,000 towards construction of a mill, which is included in construction in process within property and equipment, net on the weighted-average calculations since their effect would have been anti-dilutive.Company's condensed consolidated balance sheet.
Amendment to Operating and Profit-Sharing Agreement
 
TOn January 15, 2019, CLR entered into an amendment to the March 2014 operating and profit-sharing agreement with the he incremental dilutiveowners of H&H. CLR previously engaged Hernandez and Orozco, the owners of H&H as employees to manage Siles. In addition, CLR and H&H, Hernandez and Orozco have agreed to restructure their profit-sharing agreement in regard to profits from green coffee sales and processing that increases CLR’s profit participation by an additional 25%. Under the new terms of the agreement with respect to profit generated from green coffee sales and processing from La Pita, a leased mill, or the new mill, now will provide for a split of profits of 75% to CLR and 25% to the Nicaraguan Partner, after certain conditions are met. The Company issued 295,910 shares of the Company’s common share equivalentsstock to H&H Export to pay for certain working capital, construction and other payables. In addition, H&H Export has sold to CLR its espresso brand Café Cachita in consideration of the threeissuance of 100,000 shares of the Company’s common stock. Hernandez and nine months ended September 30, 2016Orozco are employees of CLR. The shares of common stock issued were 392,720 and 374,563, respectively.valued at $7.50 per share.
 
Income and loss per share amounts and weighted average shares outstanding for all periods have been retroactively adjusted to reflect the Company’s 1-for-20 Reverse Split, which was effective June 7, 2017.
Stock Based Compensation
The Company accounts for stock based compensation in accordance with ASC Topic 718, “Compensation – Stock Compensation,”which establishes accounting for equity instruments exchanged for employee services. Under such provisions, stock based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense, under the straight-line method, over the vesting period of the equity grant.Revenue Recognition
 
The Company accountsrecognizes revenue from product sales when the following five steps are completed: i) Identify the contract with the customer; ii) Identify the performance obligations in the contract; iii) Determine the transaction price; iv) Allocate the transaction price to the performance obligations in the contract; and v) Recognize revenue when (or as) each performance obligation is satisfied (see Note 4, below).
-13-
Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for equity instruments issued to non-employees in accordance with authoritative guidance for equity based payments to non-employees. Stock options issued to non-employeesthose products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for at their estimated fair value, determined usingas separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.
The transaction price for all sales is based on the Black-Scholes option-pricing model. The fair valueprice reflected in the individual customer's contract or purchase order. Variable consideration has not been identified as a significant component of options granted to non-employees is re-measured as they vest, and the resulting increase in value, iftransaction price for any of our transactions.
Independent distributors receive compensation which is recognized as Distributor Compensation in the Company’s consolidated statements of operations. Due to the short-term nature of the contract with the customers, the Company accrues all distributor compensation expense duringin the month earned and pays the compensation the following month.
The Company also charges fees to become a distributor, and earn a position in the network genealogy, which are recognized as revenue in the period received. The Company’s distributors are required to pay a one-time enrollment fee and receive a welcome kit specific to that country or region that consists of forms, policy and procedures, selling aids, access to the related services are rendered.
Factoring AgreementCompany’s distributor website and a genealogy position with no down line distributors.
 
The Company has determined that most contracts will be completed in less than one year. For those transactions where all performance obligations will be satisfied within one year or less, the Company is applying the practical expedient outlined in ASC 606-10-32-18. This practical expedient allows the Company not to adjust promised consideration for the effects of a factoring agreement (“Factoring Agreement”) with Crestmark Bank (“Crestmark”)significant financing component if the Company expects at contract inception the period between when the Company transfers the promised good or service to a customer and when the customer pays for that good or service will be one year or less. For those transactions that are expected to be completed after one year, the Company has assessed that there are no significant financing components because any difference between the promised consideration and the cash selling price of the good or service is for reasons other than the provision of financing.
Deferred Revenues and Costs
As of June 30, 2019 and December 31, 2018, the balance in deferred revenues was approximately $2,260,000 and $2,312,000, respectively. Deferred revenue related to the Company’s accounts receivable resulting from sales of certain products within its commercial coffee segment. Effective May 1, 2016, the Company entered into a third amendmentdirect selling segment is attributable to the factoring agreement (“Agreement”). Under the termsHeritage Makers product line and also for future Company convention and distributor events.
Deferred revenues related to Heritage Makers were approximately $2,065,000 and $2,153,000, as of the Agreement, all new receivables assigned to Crestmark shall be “Client Risk Receivables”June 30, 2019, and no further credit approvals will be providedDecember 31, 2018, respectively. The deferred revenue represents Heritage Maker’s obligation for points purchased by Crestmark. Additionally, the Agreement expands the factoring facility to include advanced borrowings against eligible inventory up to 50% of landed cost of finished goods inventorycustomers that meet certain criteria,have not to exceed the lesser of $1,000,000 or 85% of the value of the accounts receivables already advanced with a maximum overall borrowing of $3,000,000. Interest accrues on the outstanding balance and a factoring commission is chargedyet been redeemed for each invoice factored which is calculated as the greater of $5.00 or 0.75% to 0.875% of the gross invoice amount andproduct. Cash received for points sold is recorded as interest expense. In addition,deferred revenue. Revenue is recognized when customers redeem the Companypoints and the Company’s CEO, Mr. Wallach have entered into a Guaranty and Security Agreement with Crestmark Bank guaranteeing payments in the event that CLR were to default. This Agreementproduct is effective until February 1, 2019.shipped.
 
The Company accounts forDeferred costs relate to Heritage Makers prepaid commissions that are recognized in expense at the sale of receivables under the Factoring Agreement as secured borrowings with a pledge of the subject inventories and receivables as well as all bank deposits as collateral, in accordance with the authoritative guidance for accounting for transfers and servicing of financial assets and extinguishments of liabilities. The caption “Accounts receivable, due from factoring company” on the accompanying condensed consolidated balance sheets in the amount of approximately $3,088,000 and $1,078,000 as of September 30, 2017 and December 31, 2016, respectively, reflectstime the related collateralized accounts.
The Company's outstanding liability related torevenue is recognized. As of June 30, 2019 and 2018, the Factoring Agreementbalance in deferred costs was approximately $3,014,000$295,000 and $1,290,000 as of September 30, 2017 and December 31, 2016,$455,000, respectively, and is included in otherprepaid expenses and current liabilities onassets.
Deferred revenues related to pre-enrollment in upcoming conventions and distributor events of approximately $173,000 and $159,000 as of June 30, 2019 and December 31, 2018, respectively, relate primarily to the condensed consolidated balance sheets.Company’s 2019 and 2018 events. The Company does not recognize this revenue until the conventions or distributor events occur.
  
Plantation Costs
 
The Company’s commercial coffee segment CLR includes the results of the Siles, Plantation Family Group (“Siles”), which is a 500 acre500-acre coffee plantation and (ii) a dry-processing facility located on 26 acres both located in Matagalpa, Nicaragua. Siles is a wholly-owned subsidiary of CLR, and the results of CLR include the depreciation and amortization of capitalized costs, development and maintenance and harvesting costs of Siles. In accordance with US generally accepted accounting principles (“GAAP”),GAAP, plantation maintenance and harvesting costs for commercially producing coffee farms are charged against earnings when sold. Deferred harvest costs accumulate and are capitalized throughout the year and are expensed over the remainder of the year as the coffee is sold. The difference between actual harvest costs incurred and the amount of harvest costs recognized as expense is recorded as either an increase or decrease in deferred harvest costs, which is reported as an asset and included with prepaid expenses and other current assets in the condensed consolidated balance sheets. Once the harvest is complete, the harvest cost iscosts are then recognized as the inventory value.
As of December 31, 2016, the inventory related to the 2016 harvest was $112,000. As of September 30, 2017, all previously harvested coffee from the 2016 harvest had been sold.
In April 2017, the Company completed the 2017 harvest in Nicaragua and approximately $552,000 of deferred harvest Deferred costs were reclassified as inventory during the quarter ended June 30, 2017. The remaining inventory as of September 30, 2017 is $361,000.
-7-
Costs associated with the 2018 harvest as of SeptemberJune 30, 2017 total2019 and December 31, 2018 are approximately $200,000$150,000 and $400,000, respectively, and are included in prepaid expenses and other current assets as deferred harvest costs on the Company’s condensed consolidated balance sheets.
 
Related Party Transactions
Richard Renton
Richard Renton is a member of the Board of Directors and owns and operates with his wife Roxanna Renton, Northwest Nutraceuticals, Inc., a supplier of certain inventory items sold by the Company. The Company made purchases of approximately $61,000 and $33,000 from Northwest Nutraceuticals Inc., for the three months ended September 30, 2017 and 2016, respectively, and $142,000 and $83,000 for the nine months ended September 30, 2017 and 2016, respectively. In addition, Mr. Renton and his wife are distributors of the Company and can earn commissions on product sales.
Other Relationship Transactions
Hernandez, Hernandez, Export Y Company
The Company’s coffee segment, CLR, is associated with Hernandez, Hernandez, Export Y Company (“H&H”), a Nicaragua company, through sourcing arrangements to procure Nicaraguan green coffee beans and in March 2014 as part of the Siles acquisition, CLR engaged the owners of H&H as employees to manage Siles. The Company made purchases of approximately $3,533,000 and $2,700,000 from this supplier for the three months ended September 30, 2017 and 2016, respectively and $8,707,000 and $7,400,000 for the nine months ended September 30, 2017 and 2016, respectively.
In addition, CLR sold approximately $2,387,000 and $0 for the three months ended September 30, 2017 and 2016, respectively and $3,934,000 and $2,200,000 for the nine months ended September 30, 2017 and 2016, respectively, of green coffee beans to H&H Coffee Group Export, a Florida based company which is affiliated with H&H.
In March 2017, the Company entered a settlement agreement and release with H&H Coffee Group Export pursuant to which it was agreed that $150,000 owed to H&H Coffee Group Export for services that had been rendered would be settled by the issuance of Common Stock. In May 2017, the Company issued to H&H Coffee Group Export 27,500 shares of Common Stock in accordance with this agreement.
In May 2017, the Company entered a settlement agreement with Alain Piedra Hernandez, one of the owners of H&H and the operating manager of Siles, who was issued a non-qualified stock option for the purchase of 75,000 shares of the Company’s Common Stock at a price of $2.00 with an expiration date of three years, in lieu of an obligation due from the Company to H&H as relates to a Sourcing and Supply Agreement with H&H. During the three months ended September 30, 2017 the Company replaced the non-qualified stock option and issued a warrant agreement with the same terms. There was no financial impact related to the cancellation of the option and the issuance of the warrant. As of September 30, 2017 the warrant remains outstanding.
Revenue Recognition
The Company recognizes revenue from product sales when the following four criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. The Company ships the majority of its direct selling segment products directly to the distributors primarily via UPS, USPS or FedEx and receives substantially all payments for these sales in the form of credit card transactions. The Company regularly monitors its use of credit card or merchant services to ensure that its financial risk related to credit quality and credit concentrations is actively managed. Revenue is recognized upon passage of title and risk of loss to customers when product is shipped from the fulfillment facility. The Company ships the majority of its coffee segment products via common carrier and invoices its customer for the products. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point.
Sales revenue and a reserve for estimated returns are recorded net of sales tax when product is shipped.
Deferred Revenues and Costs
Deferred revenues relate primarily to the Heritage Makers product line and represent the Company’s obligation for points purchased by customers that have not yet been redeemed for product. Cash received for points sold is recorded as deferred revenue. Revenue is recognized when customers redeem the points and the product is shipped. As of September 30, 2017 and December 31, 2016, the balance in deferred revenues was approximately $1,999,000 and $1,870,000 respectively, of which the portion attributable to Heritage Makers was approximately $1,800,000 and $1,662,000, respectively. The remaining balance of approximately $199,000 and $208,000 as of September 30, 2017 and December 31, 2016, related primarily to the Company’s 2018 and 2017 conventions, respectively, whereby attendees pre-enroll in the events and the Company does not recognize this revenue until the conventions occur.
 
 
-8--14-
 
 
Deferred costs relate to Heritage Makers prepaid commissions that are recognized in expense at the time the related revenue is recognized. As of September 30, 2017 and December 31, 2016, the balance in deferred costs was approximately $414,000 and $415,000 respectively, and was included in prepaid expenses and current assets.
Commitments and Contingencies
We are, from time to time, the subject of claims and suits arising out of matters occurring during the operation of our business. We are not presently party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, current legal proceedings are having an adverse impact on us because of litigation costs, diversion of management resources and other factors.
Recently Issued Accounting Pronouncements
In January 2017, the FASB issued Accounting Standard Update (“ASU”) No. 2017-04, Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies the test for goodwill impairment by removing Step 2 from the goodwill impairment test. Companies will now perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value not to exceed the total amount of goodwill allocated to that reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendments in this update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019, with early adoption permitted for goodwill impairment tests performed after January 1, 2017. The Company is evaluating the potential impact of this adoption on its consolidated financial statements.Stock-based Compensation
 
In October 2016,The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation – Stock Compensation,”which establishes accounting for equity instruments exchanged for employee services. Under such provisions, stock-based compensation cost is measured at the FASB issued ASU 2016-17,Consolidation(Topic 810): Interests Held through Related Parties That Are under Common Control. This standard amendsgrant date, based on the guidance issued with ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis in order to make it less likely that a single decision maker would individually meet the characteristics to be the primary beneficiary of a Variable Interest Entity ("VIE"). When a decision maker or service provider considers indirect interests held through related parties under common control, they perform two steps. The second step was amended with this ASU to say that the decision maker should consider interests held by these related parties on a proportionate basis when determining the primary beneficiarycalculated fair value of the VIE rather than in their entiretyaward, and is recognized as was called for inan expense, under the previous guidance. This ASU was effective for fiscal years beginning after December 15, 2016, and early adoption was not permitted. The Company adopted ASU 2016-17 effectivestraight-line method, over the quarter ended March 31, 2017. The adoptionvesting period of ASU 2016-17 did not have a significant impact on its consolidated financial statements.the equity grant.
 
In February 2016, the FASB issued ASU 2016-02,Leases(Topic 842). The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. The Company expectsaccounts for equity instruments issued to adoptnon-employees in accordance with authoritative guidance for equity-based payments to non-employees. Stock options issued to non-employees are accounted for at their estimated fair value, determined using the standard no later than January 1, 2019.Black-Scholes option-pricing model. The Companyfair value of options granted to non-employees is currently assessingre-measured as they vest, and the impact thatresulting increase in value, if any, is recognized as expense during the new standard will have onperiod the Company’s consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases. The Company has not evaluated the impact that this new standard will have on its consolidated financial statements; however, it is expected to gross-up the consolidated balance sheet as a result of recognizing a lease asset along with a similar lease liability.related services are rendered.
 
In November 2015, the FASB issued ASU 2015-17,Income Taxes(Topic 740): Balance Sheet Classification of Deferred Taxes. This guidance requires that entities with a classified statement of financial position present all deferred tax assets and liabilities as noncurrent. This update is effective for annual and interim periods for fiscal years beginning after December 15, 2016, which required the Company to adopt the new guidance in the first quarter of fiscal 2017. Early adoption was permitted for financial statements that have not been previously issued and may be applied on either a prospective or retrospective basis. The Company adoptedASU 2015-17 effective the quarter ended March 31, 2017. The adoption of ASU 2015-17 did not have a significant impact on its consolidated financial statements other than the netting of current and long-term deferred tax assets and liabilities in the non-current section of the balance sheet and footnote disclosures.
In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory (Topic 330): Simplifying the Measurement of Inventory.”  The amendments in ASU 2015-11 require an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. The amendments do not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method.  The amendments apply to all other inventory, which includes inventory that is measured using first-in, first-out (FIFO) or average cost.  The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.  Management is currently assessing the effect that ASU 2015-11 will have on the Company’s condensed consolidated financial statements and related disclosures.  Included in management’s assessment is the determination of an effective adoption date and transition method for adoption. The Company expects to complete the initial assessment process, including the selection of an effective adoption date and transition method for adoption, by December 31, 2017.  
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). The new revenue recognition standard provides a five-step analysis of contracts to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB deferred the effective date of ASU No. 2014-09 for all entities by one year to annual reporting periods beginning after December 15, 2017. The FASB has issued several updates subsequently including implementation guidance on principal versus agent considerations, on how an entity should account for licensing arrangements with customers, and to improve guidance on assessing collectability, presentation of sales taxes, noncash consideration, and contract modifications and completed contracts at transition. The amendments in this series of updates shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. Early adoption is permitted. The Company continues to assess the impact of this ASU, and related subsequent updates, will have on its consolidated financial statements. As of September 30, 2017, the Company is in the process of reviewing the guidance to identify how this ASU will apply to the Company’s revenue reporting process. The final impact of this ASU on the Company’s financial statements will not be known until the assessment is complete. The Company will update its disclosure in future periods as the analysis is completed.
-9-
In August 2014, the FASB issued ASU No. 2014-15 regarding ASC topic No. 205, Presentation of Financial Statements - Going Concern. The standard requires all companies to evaluate if conditions or events raise substantial doubt about an entity’s ability to continue as a going concern and requires different disclosure of items that raise substantial doubt that are, or are not, alleviated as a result of consideration of management’s plans. The new guidance is effective for annual periods ending after December 15, 2016. The adoption of ASU No. 2014-15 did not have a significant impact on the Company’s consolidated financial statements.  
Note 2.  Income Taxes
 
The Company accounts for income taxes in accordance with ASC Topic 740,"Income Taxes," under the asset and liability method which includes the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this approach, deferred taxes are recorded for the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial statement and tax basis of assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. The effects of future changes in income tax laws or rates are not anticipated.
 
Income taxes for the interim periods are computed using the effective tax rates estimated to be applicable for the full fiscal year, as adjusted for any discrete taxable events that occur during the period.
 
The Company files income tax returns in the United States (“U.S.”) on a federal basis and in many U.S. state and foreign jurisdictions. Certain tax years remain open to examination by the major taxing jurisdictions to which the Company is subject.
 
Commitments and Contingencies
Litigation
The Company is from time to time, the subject of claims and suits arising out of matters related to the Company’s business. The Company is party to litigation at the present time and may become party to litigation in the future. In general, litigation claims can be expensive, and time consuming to bring or defend against and could result in settlements or damages that could significantly affect financial results. It is not possible to predict the final resolution of the current litigation to which the Company is party to, and the impact of certain of these matters on the Company’s business, results of operations, and financial condition could be material. Regardless of the outcome, litigation has adversely impacted the Company’s business because of defense costs, diversion of management resources and other factors.
Other
Vendor Concentration
The Company purchases its inventory from multiple third-party suppliers at competitive prices. For the three months ended June 30, 2019, the Company’s commercial coffee segment made purchases from four vendors, H&H Export, Intl FC Stone Merchant Services, Sixto Packaging, and The Serengeti Trading Co., that individually comprised more than 10% of total purchases and in aggregate approximated 74% of total segment purchases. For the six months ended June 30, 2019, the Company’s commercial coffee segment made purchases from two vendors, H&H Export and Intl FC Stone Merchant Services, that individually comprised more than 10% of total purchases and in aggregate approximated 66% of total purchases.
-15-
For the three months ended June 30, 2018, the Company’s commercial coffee segment made purchases from three vendors, H&H Export, Rothfos Corporation and Sixto Packaging that individually comprised more than 10% of total purchases and in aggregate approximated 64% of total purchases. For the six months ended June 30, 2018, the Company’s commercial coffee segment made purchases from two vendors, H&H Export and Rothfos Corporation, that individually comprised more than 10% of total purchases and in aggregate approximated 86% of total purchases.
For the three months ended June 30, 2019, the Company’s direct selling segment made purchases from two vendors, Global Health Labs, Inc. and Michael Schaeffer, LLC., that individually comprised more than 10% of total purchases and in aggregate approximated 46% of total purchases. For the six months ended June 30, 2019, the Company’s direct selling segment made purchases from two vendors, Global Health Labs, Inc. and Michael Schaeffer, LLC., that individually comprised more than 10% of total purchases and in aggregate approximated 41% of total purchases.
For the three months ended June 30, 2018, the Company’s direct selling segment made purchases from three vendors, Global Health Labs, Inc., Purity Supplements and Nutritional Engineering, that individually comprised more than 10% of total purchases and in aggregate approximated 58% of total purchases. For the six months ended June 30, 2018, the Company’s direct selling segment made purchases from two vendors, Global Health Labs, Inc. and Purity Supplements, that individually comprised more than 10% of total purchases and in aggregate approximated 45% of total purchases.
For the three months ended June 30, 2019, the Company’s hemp segment made purchases from three vendors, Lab1st, Bio Processing Corp., and ADM Labs, that individually comprised more than 10% of total purchases and in aggregate approximated 63% of total purchases. For the six months ended June 30, 2019, the Company’s hemp segment made purchases from two vendors, Lab1st and Bio Processing Corp., that individually comprised more than 10% of total purchases and in aggregate approximated 41% of total purchases.
Customer Concentration
For the three months ended June 30, 2019, the Company’s commercial coffee segment had two customers, H&H Export and Rothfos Corporation that individually comprised more than 10% of revenue and in aggregate approximated 43% of total revenue. For the six months ended June 30, 2019, the Company’s commercial coffee segment had one customer, H&H Export that individually comprised more than 10% of revenue and in aggregate approximated 47.2% of total revenue.
For the three months ended June 30, 2018, the Company’s commercial coffee segment had two customers, H&H Export and Rothfos Corporation that individually comprised more than 10% of revenue and in aggregate approximated 62% of total revenue. For the six months ended June 30, 2018, the Company’s commercial coffee segment had two customers, H&H Export and Rothfos Corporation that individually comprised more than 10% of revenue and in aggregate approximated 62% of total revenue.
For the three months ended June 30, 2019, the Company’s hemp segment had three customers, Xtraction Services, Air Spec and David Shin that individually comprised more than 10% of revenue and in aggregate approximated 50% of total revenue. For the six months ended June 30, 2019, the Company’s hemp segment had three customers, Xtraction Services, Air Spec and David Shin that individually comprised more than 10% of revenue and in aggregate approximated 54% of total revenue.
The direct selling segment did not have any customers during the three and six months ended June 30, 2019 that comprised more than 10% of revenue.
The Company has purchase obligations related to minimum future purchase commitments for green coffee to be used in the Company’s commercial coffee segment. Each individual contract requires the Company to purchase and take delivery of certain quantities at agreed upon prices and delivery dates.  The contracts as of June 30, 2019, have minimum future purchase commitments of approximately $5,680,000, which are to be delivered in 2019. The contracts contain provisions whereby any delays in taking delivery of the purchased product will result in additional charges related to the extended warehousing of the coffee product.  The fees can average approximately $0.01 per pound for every month of delay. To date the Company has not incurred such fees.
-16-
Recently Issued Accounting Pronouncements
In August 2018,the Financial Accounting Standards Board (FASB)issuedAccounting Standards Update (ASU) No. 2018-15,Intangibles — Goodwill and Other — Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. Subtopic 350-40 clarifies the accounting for implementation costs of a hosting arrangement that is a service contract and aligns that accounting, regardless of whether the arrangement conveys a license to the hosted software. The amendments in this update are effective for reporting periods beginning after December 15, 2019, with early adoption permitted. The Company does not expect this new guidance to have a material impact on its condensed consolidated financial statements. 
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. Topic 820 removes or modifies certain current disclosures and adds additional disclosures. The changes are meant to provide more relevant information regarding valuation techniques and inputs used to arrive at measures of fair value, uncertainty in the fair value measurements, and how changes in fair value measurements impact an entity's performance and cash flows. Certain disclosures in Topic 820 will need to be applied on a retrospective basis and others on a prospective basis. Topic 820 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. The Company expects to adopt the provisions of this guidance on January 1, 2020 and is currently evaluating the impact that Topic 820 will have on its related disclosures.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies the test for goodwill impairment by removing Step 2 from the goodwill impairment test. Companies will now perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value not to exceed the total amount of goodwill allocated to that reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendments in this update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019 for public companies, with early adoption permitted for goodwill impairment tests performed after January 1, 2017. The Company does not expect this new guidance to have a material impact on its condensed consolidated financial statements.
Recently Adopted Accounting Pronouncements
In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployees Share-Based Payment Accounting. The intention of ASU 2018-07 is to expand the scope of Topic 718 to include share-based payment transactions in exchange for goods and services from nonemployees. These share-based payments will now be measured at grant-date fair value of the equity instrument issued. Upon adoption, only liability-classified awards that have not been settled and equity-classified awards for which a measurement date has not been established should be remeasured through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. Topic 718 is effective for fiscal years beginning after December 15, 2018 and is applied retrospectively. The Company adopted the provisions of this guidance on January 1, 2019 and the adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.
In February 2018, the FASB issued ASU No. 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220), Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, Topic 220. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (H.R.1) (the Act). Consequently, the amendments eliminate the stranded tax effects resulting from the Act and will improve the usefulness of information reported to financial statement users. However, because the amendments only relate to the reclassification of the income tax effects of the Act, the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations is not affected. The amendments in this Update also require certain disclosures about stranded tax effects. Topic 220 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company adopted the provisions of this guidance on January 1, 2019 and the adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.
-17-
In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. Topic 260 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity’s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted classified as liabilities. A company will recognize the value of a down round feature only when it is triggered, and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, such as warrants, an entity will treat the value of the effect of the down round, when triggered, as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. The guidance in Topic 260 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and the guidance is to be applied using a full or modified retrospective approach. The Company adopted Topic 260, Topic 480 and Topic 815 effective January 1, 2019 and determined that it’s 2018 warrants were to no longer be classified as a derivative, as a result of the adoption and subsequent change in classification of the 2018 warrants, the company reclassed approximately $1,494,000 of warrant derivative liability to equity.
In February 2016, FASB established Topic 842, Leases, by issuing ASU No. 2016-02, Leases (Topic 842)which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic842; ASU No. 2018-10, Codification Improvements to Topic842,Leases; ASU No. 2018-11, Targeted Improvements; ASU No. 2018-20,Narrow-Scope Improvements for Lessors; andASU 2019-01,Codification Improvements. The new standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The amendments were adopted by the Company on January 1, 2019. A modified retrospective transition approach is required, applying the standard to all leases existing at the date of initial application. The Company elects to use its effective date as its date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the “package of practical expedients”, which permits the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direction costs. In addition, the Company elected the practical expedient to use hindsight when determining lease terms.  The practicable expedient pertaining to land easement is not applicable to the Company. The Company continues to assess all of the effects of adoption, with the most significant effect relating to the recognition of new ROU assets and lease liabilities on the Company’s balance sheet for real estate operating leases.  The Company adopted the provisions of this guidance on January 1, 2019 and accordingly recognized additional operating liabilities of approximately $5,509,000 with corresponding ROU assets of the same amount based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases.
Following the expiration of the Company’s Emerging Growth Company filing status (“EGC”) on December 31, 2018 the Company adopted the following accounting pronouncements effective January 1, 2018.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), to supersede nearly all existing revenue recognition guidance under GAAP. Topic 606 also requires new qualitative and quantitative disclosures, including disaggregation of revenues and descriptions of performance obligations. The Company adopted the provision of this guidance using the modified retrospective approach. The Company has performed an assessment of its revenue contracts as well as worked with industry participants on matters of interpretation and application and has not identified any material changes to the timing or amount of its revenue recognition under Topic 606. The Company’s accounting policies did not change materially as a result of applying the principles of revenue recognition from Topic 606 and are largely consistent with existing guidance and current practices applied by the Company. (See Note 4, below.)
-18-
Note 2.  Restatement of previously reported unaudited condensed consolidated financial statements
Background of the Restatement
During the Company’s 2019 annual audit, the Company reviewed revenues related to CLR specifically the 2019 green coffee sales program, for sales made by the Company to its joint venture partner, H&H Coffee Group Export Corp. (“H&H Export”). These sales were originally recorded at gross, along with the respective cost of revenue.
As part of the review, the Company assessed whether the 2019 green coffee sales to H&H Export depicted the transfer of promised goods or services to H&H Export in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps were applied to review if the core revenue recognition principles were met as such the Company concluded is had not met all the criteria when applying these steps:

Step 1: Identify the contract with the customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance obligations in the contract
Step 5: Recognize revenue when the company satisfies a performance obligation
During this review process the Company focused on identifying the performance obligations in the contracts with H&H Export (the provider of the “wet” green coffee and the buyer of the processed coffee). The Company’s assessment indicated that according to the underlying terms and conditions of the contracts that CLR entered into with H&H Export, that CLR had been assigned the green coffee beans as coffee was delivered to its mill processing facility. Assignment of the coffee is defined as taking of physical possession of the green coffee for the purpose of processing the green coffee. Under the assignment CLR was responsible for insuring all reasonable and necessary actions to ensure the coffee beans are safeguarded during processing at the Company’s coffee mill. CLR, however, does not take ownership and does not incur financial risk associated with the coffee as it is delivered to its mill for the purpose of processing.
Therefore, management has determined that for green coffee sales made by the Company to its joint venture partner, H&H Export, the Company should have recorded these sales at net, which reflects the value of the performance obligation to provide milling services as opposed to on a gross basis. 
In addition, during the Company’s 2019 annual audit, the Company reviewed revenues related to CLR, the Company’s coffee segment, with regard to sales made to major independent customers, the Company focused on if recognition of revenue thresholds were met and if the Company had satisfied its performance obligation and could reasonably expect payment for fulfilling these performance obligations. The Company determined that for certain sales made to Rothfos Corporation, these thresholds were not met, and therefore revenue should not have been recognized. As a result, the Company is restating its revenue related to the three and six months ended June 30, 2019 for sales recorded during the three months ended June 30, 2019 in the aggregate of approximately $2,116,000 and approximately $1,874,000 related to the costs of revenues. The related inventory for the green coffee was returned to CLR’s supplier H&H Export, as such the related costs $1,874,000 was credited back to CLR and accounts payable has been adjusted for this amount.
On February 15, 2019, the Company and Khrysos Industries, Inc., completed the acquisition of Khrysos Global, Inc., detailed further in Note 5 to the unaudited condensed consolidated financial statements below. In conjunction with the Company’s 2019 annual audit the Company concluded that certain fixed assets acquired in the acquisition and the share price valuation for the common stock issued as consideration were not fairly valued as of the closing date including; i) $1,127,000 related to the certain fixed assets, and ii) $1,351,000 related to a change in the fair value of common stock issuance resulting in an increase to goodwill of $2,478,000 acquired and an adjusted aggregate purchase price if $15,894,000.  As a result, the Company is restating the items listed above related to the period ended March 31, 2019.
-19-
The tables below summarize the effects of the restatement on our (i) unaudited condensed consolidated balance sheet at June 30, 2019; (ii) unaudited condensed consolidated statements of operations for the three and six months ended June 30, 2019; (iii) unaudited condensed consolidated statements of compressive loss for the three and six months ended June 30, 2019; and (iv) unaudited condensed consolidated statement of cash flows for the six months ended June 30, 2019. A summary of the effect of the restatement on the unaudited condensed consolidated statements of changes to stockholders’ equity for the three and six months ended June 30, 2019 are not presented because the impact to additional paid-in-capital are reflected below in the unaudited condensed consolidated balance sheet summaries.
Summary of Restatement – Unaudited Condensed Consolidated Balance Sheet
The effects of the restatement on the Company’s unaudited condensed consolidated balance sheet are as follows:
 
 
June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
       Cash and cash equivalents
 $2,088 
 $- 
 $2,088 
       Accounts receivable, trade
  36,863 
  (26,561)
  10,302 
       Income tax receivable
  231 
  - 
  231 
       Inventory
  24,797 
  - 
  24,797 
       Notes receivable (Note 1)
  5,097 
  - 
  5,097 
       Prepaid expenses and other current assets
  5,686 
  - 
  5,686 
Total current assets
  74,762 
  (26,561)
  48,201 
 
    
    
    
Property and equipment, net
  21,249 
  (1,127)
  20,122 
Operating lease right-of-use assets
  5,481 
  - 
  5,481 
Deferred tax assets
  75 
  - 
  75 
Intangible assets, net
  23,332 
  - 
  23,332 
Goodwill
  10,676 
  2,478 
  13,154 
Other assets – notes receivable
  949 
  - 
  949 
Total assets
 $136,524 
 (25,210)
 111,314 
 
    
    
    
LIABILITIES AND STOCKHOLDERS' EQUITY
    
    
    
 
    
    
    
Current Liabilities
    
    
    
Accounts payable
 $34,061 
 (26,319)
 7,742 
Accrued distributor compensation
  3,740 
  - 
  3,740 
Accrued expenses
  9,259 
  - 
  9,259 
Deferred revenues
  2,260 
  - 
  2,260 
Line of credit
  2,002 
  - 
  2,002 
Other current liabilities
  983 
  - 
  983 
Operating lease liabilities, current portion
  772 
  - 
  772 
Finance lease liabilities, current portion
  1,103 
  - 
  1,103 
Notes payable, current portion
  159 
  - 
  159 
Convertible notes payable, current portion
  716 
  - 
  716 
Warrant derivative liability
  4,969 
  - 
  4,969 
Contingent acquisition debt, current portion
  695 
  - 
  695 
Total current liabilities
  60,719 
  (26,319)
  34,400 
 
    
    
    
Operating lease liabilities, net of current portion
  4,708 
  - 
  4,708 
Finance lease liabilities, net of current portion
  778 
  - 
  778 
Notes payable, net of current portion
  10,525 
  - 
  10,525 
Convertible notes payable, net of current portion
  2,358 
  - 
  2,358 
Contingent acquisition debt, net of current portion
  6,898 
  - 
  6,898 
Total liabilities
  85,986 
  (26,319)
  59,667 
 
    
    
    
Commitments and contingencies (Note 1)
    
    
    
 
    
    
    
Stockholders’ Equity
    
    
    
Preferred Stock, $0.001 par value: 5,000,000 shares authorized
  - 
  - 
  - 
    Convertible Preferred Stock, Series A – 161,135 shares issued and outstanding at June 30, 2019 and December 31, 2018
  - 
  - 
  - 
    Convertible Preferred Stock, Series B – 129,437 shares issued and outstanding at June 30, 2019 and December 31, 2018; $1.254 million liquidation preference as of June 30, 2019.
  - 
  - 
  - 
Common Stock, $0.001 par value: 50,000,000 shares authorized; 29,316,445 and 25,760,708 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively
  29 
  - 
  29 
Additional paid-in capital
  246,584 
  1,351 
  247,935 
Accumulated deficit
  (196,070)
  (242)
  (196,312)
Accumulated other comprehensive loss
  (5)
  - 
  (5)
    Total stockholders’ equity
  50,538 
  1,109 
  51,647 
 Total Liabilities and Stockholders’ Equity
 $136,524 
 (25,210)
 111,314 
-20-
Summary of Restatement – Unaudited Condensed Consolidated Statements of Operations
The effects of the restatement on our unaudited condensed consolidated statements of operations are as follows:
 
 
Three Months Ended June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
Revenues
 $53,687 
 $(15,470)
 $38,217 
Cost of revenues
  27,765 
  (15,228)
  12,537 
Gross profit
  25,922 
  (242)
  25,680 
Operating expenses
    
    
    
Distributor compensation
  14,497 
  - 
  14,497 
Sales and marketing
  2,786 
  - 
  2,786 
General and administrative
  8,251 
  - 
  8,251 
Total operating expenses
  25,534 
  - 
  25,534 
Operating income
  388 
  (242)
  146 
Interest expense, net
  (1,062)
  - 
  (1,062)
Change in fair value of warrant derivative liability
  401 
  - 
  401 
Extinguishment loss on debt
  - 
  - 
  - 
Total other expense
  (661)
  - 
  (661)
Loss before income taxes
  (273)
  (242)
  (515)
Income tax benefit
  (226)
  - 
  (226)
Net loss
  (47)
  (242)
  (289)
Preferred stock dividends
  (28)
  - 
  (28)
Net loss attributable to common stockholders
 $(75)
 $(242)
 $(317)
 
    
    
    
Net loss per share, basic
 $(0.00)
 $(0.01)
 $(0.01)
Net loss per share, diluted (Note 3)
 $(0.02)
 $- 
 $(0.02)
 
    
    
    
Weighted average shares outstanding, basic
  29,133,150 
  - 
  29,133,150 
Weighted average shares outstanding, diluted
  29,357,347 
  - 
  29,357,347 
 
 
Six Months Ended June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
Revenues
 $109,987 
 $(30,578)
 $79,409 
Cost of revenues
  57,216 
  (30,336)
  26,880 
Gross profit
  52,771 
  (242)
  52,529 
Operating expenses
    
    
    
Distributor compensation
  29,387 
  - 
  29,387 
Sales and marketing
  6,805 
  - 
  6,805 
General and administrative
  28,132 
  - 
  28,132 
Total operating expenses
  64,324 
  - 
  64,324 
Operating loss
  (11,553)
  (242)
  (11,795)
Interest expense, net
  (2,569)
  - 
  (2,569)
Change in fair value of warrant derivative liability
  1,887 
  - 
  1,887 
Extinguishment loss on debt
  - 
  - 
  - 
Total other expense
  (682)
  - 
  (682)
Loss before income taxes
  (12,235)
  (242)
  (12,477)
Income tax provision
  72 
  - 
  72 
Net loss
  (12,307)
  (242)
  (12,549)
Preferred stock dividends
  (42)
  - 
  (42)
Net loss attributable to common stockholders
 $(12,349)
 $(242)
 $(12,591)
 
    
    
    
Net loss per share, basic
 $(0.44)
 $- 
 $(0.44)
Net loss per share, diluted (Note 3)
 $(0.48)
 $(0.01)
 $(0.49)
 
    
    
    
Weighted average shares outstanding, basic
  28,359,660 
  - 
  28,359,660 
Weighted average shares outstanding, diluted
  28,700,295 
  - 
  28,700,295 
-21-

Summary of Restatement – Unaudited Condensed Consolidated Statement of Comprehensive Loss
The effect of the restatement on our unaudited condensed consolidated statements of comprehensive loss are as follows:
 
 
Three Months Ended June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
Net loss
 $(47)
 $(242)
 $(289)
Foreign currency translation
  (62)
  - 
  (62)
Total comprehensive income
  (62)
  - 
  (62)
Comprehensive loss
 $(109)
  (242)
 $(351)
 
 
Six Months Ended June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
Net loss
 $(12,307)
 $(242)
 $(12,549)
Foreign currency translation
  40 
  - 
  40 
Total comprehensive income
  40 
  - 
  40 
Comprehensive loss
 $(12,267)
  (242)
 $(12,509)
-22-
Summary of Restatement – Unaudited Condensed Consolidated Statement of Cash Flows
The effect of the restatement on our unaudited condensed consolidated statement of cash flows are as follows:
 
 
Six Months Ended June 30, 2019
 
 
 
Previously Reported
 
 
Adjustments
 
 
Restated
 
 
 
 
 
 
 
 
 
 
 
Cash Flows from Operating Activities:
 
 
 
 
 
 
 
 
 
Net loss
 $(12,307)
 $(242)
 $(12,549)
Adjustments to reconcile net loss to net cash used in operating activities:
    
    
    
Depreciation and amortization
  2,333 
  - 
  2,333 
Stock-based compensation expense
  11,757 
  - 
  11,757 
Amortization of debt discounts and issuance costs
  534 
  - 
  534 
Equity issuance costs for services
  2,541 
  - 
  2,541 
Change in fair value of warrant derivative liability
  (1,887)
  - 
  (1,887)
Change in fair value of contingent acquisition debt
  (433)
  - 
  (433)
Change in inventory reserve
  159 
  - 
  159 
Stock issuance for true-up shares
  281 
  - 
  281 
Deferred taxes
  73 
  - 
  73 
Changes in operating assets and liabilities, net of effect from business combinations:
    
    
    
Accounts receivable
  (32,526)
  26,561 
  (5,965)
Inventory
  (1,916)
    
  (1,916)
Prepaid expenses and other current assets
  (844)
  - 
  (844)
Accounts payable
  25,254 
  (26,319)
  (1,065)
Accrued distributor compensation
  451 
  - 
  451 
Deferred revenues
  (52)
  - 
  (52)
Accrued expenses and other liabilities
  1,358 
  - 
  1,358 
Income taxes receivable
  (157)
  - 
  (157)
Net Cash Used in Operating Activities
  (5,381)
  - 
  (5,381)
 
    
    
    
Cash Flows from Investing Activities:
    
    
    
Acquisitions, net of cash acquired
  (425)
  - 
  (425)
Purchases of property and equipment
  (3,269)
  - 
  (3,269)
Net Cash Used in Investing Activities
  (3,694)
  - 
  (3,694)
 
    
    
    
Cash Flows from Financing Activities:
    
    
    
Proceeds from issuance of promissory notes, net of offering costs
  5,125 
  - 
  5,125 
Proceeds from private placement of common stock, net of offering costs
  2,684 
  - 
  2,684 
Proceeds from at-the-market-offering and exercise of stock options and warrants, net
  1,748 
  - 
  1,748 
Payments net of repayment on line of credit
  (254)
  - 
  (254)
Payments of notes payable
  (68)
  - 
  (68)
Payments of contingent acquisition debt
  (235)
  - 
  (235)
Payments of finance leases
  (734)
  - 
  (734)
Payments of dividends 
  (22)
  - 
  (22)
Net Cash Provided by Financing Activities
  8,244 
  - 
  8,244 
Foreign Currency Effect on Cash
  40 
  - 
  40 
Net decrease in cash and cash equivalents
  (791)
  - 
  (791)
Cash and Cash Equivalents, Beginning of Period
  2,879 
  - 
  2,879 
Cash and Cash Equivalents, End of Period
 $2,088 
 $- 
 $2,088 
 
    
    
    
Supplemental Disclosures of Cash Flow Information
    
    
    
Cash paid during the period for:
    
    
    
Interest
 $1,858 
 $- 
 $1,858 
Income taxes
 $148 
 $- 
 $148 
 
    
    
    
Supplemental Disclosures of Noncash Investing and Financing Activities
    
    
    
Purchases of property and equipment funded by finance leases
 $42 
 $- 
 $42 
Purchases of property and equipment funded by mortgage agreements
 $450 
 $- 
 $450 
Fair value of stock issued for services (Note 11)
 $988 
 $- 
 $988 
Fair value of stock issued for property and equipment (land)
 $1,200 
 $- 
 $1,200 
Fair value of stock issued for purchase of intangibles (tradename)
 $750 
 $- 
 $750 
Fair value of stock issued for note receivable, net of debt settlement
 $2,309 
 $- 
 $2,309 
Fair value of stock issued in connection with the acquisition of Khrysos Global, Inc. (Note 5) (1)
 $12,649 
  1,351 
 $14,000 
Dividends declared but not paid at the end of period (Note 11)
 $25 
 $- 
 $25 
(1) The Fair value of stock issued in connection with the acquisition of Khrysos Global, Inc., was previously reported in Note 4 to the original filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 as filed with the SEC on August 14, 2019.
-23-
Note 3. Basic and Diluted Net Loss Per Share
Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of stock options, restricted stock, warrants, convertible preferred stock and common stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net loss per share when their effect is anti-dilutive. In periods where a net loss is presented, all potentially dilutive securities are anti-dilutive and are excluded from the computation of diluted net loss per share.
Potentially dilutive securities for the three and six months ended June 30, 2019 were 12,731,372. Potentially dilutive securities were 6,560,761 for the three and six months ended June 30, 2018.
The calculation of diluted loss per share requires that, to the extent the average market price of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to loss per share for the period, an adjustment to net loss used in the calculation is required to remove the change in fair value of the warrants, net of tax from the numerator for the period. Likewise, an adjustment to the denominator is required to reflect the related dilutive shares, if any, under the treasury stock method. During the three and six months ended June 30, 2019, the Company recorded net of tax gain of $357,000 and $1,478,000, on the valuation of the Warrant Derivative Liability which has a dilutive impact on loss per share, respectively.
 
 
Three Months Ended
June 30,
(unaudited)
 
 
Six Months Ended
June 30,
(unaudited)
 
 
 
2019
(Restated)*
 
 
2018
 
 
2019
(Restated)*
 
 
2018
 
Loss per Share – Basic
 
 
 
 
 
 
 
 
 
 
 
 
Numerator for basic loss per share
 $(317,000)
 $(656,000)
 $(12,591,000)
 $(2,967,000)
Denominator for basic loss per share
  29,133,150 
  21,506,833 
  28,359,660 
  20,630,383 
Loss per common share - basic
 $(0.01)
 $(0.03)
 $(0.44)
 $(0.14)
 
    
    
    
    
Loss per Share - Diluted
    
    
    
    
Numerator for basic loss per share
 $(317,000)
 $(656,000)
 $(12,591,000)
 $(2,967,000)
Adjust: Fair value of dilutive warrants outstanding
  (357,000)
  - 
  (1,478,000)
  - 
Numerator for dilutive loss per share
 $(674,000)
 $(656,000)
 $(14,069,000)
 $(2,967,000)
 
    
    
    
    
Denominator for basic loss per share
  29,133,150 
  21,506,833 
  28,359,660 
  20,630,383 
Adjust: Incremental shares underlying “in the money” warrants outstanding
  224,197 
  - 
  340,635 
  - 
Denominator for dilutive loss per share
  29,357,347 
  21,506,833 
  28,700,295 
  20,630,383 
Loss per common share - diluted
 $(0.02)
 $(0.03)
 $(0.49)
 $(0.14)
 * Loss per share for the three and six months ended June 30, 2019 has been restated. See Note 2.
-24-
Note 4.  Balance Sheet Account Detail
Inventory and CostsCost of Revenues
 
Inventory is stated at the lower of cost or market value.net realizable value, net of a valuation allowance. Cost is determined using the first-in, first-out method. The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover, market conditions and assumptions about future demand for its products. When applicable, expiration dates of certain inventory items with a definite life are taken into consideration.
 
Inventories consist of the following (in thousands):
 
 
As of
 
 
As of
 
 
September 30,
2017
 
 
December 31,
2016
 
 
June 30,
2019
(unaudited)
 
 
December 31,
2018
 
Finished goods
 $10,935 
 $11,550 
 $12,602 
 $11,300 
Raw materials
  11,181 
  11,006 
  14,622 
  12,744 
  22,116 
  22,556 
Total inventory
  27,224 
  24,044 
Reserve for excess and obsolete
  (1,064)
  (2,427)
  (2,268)
Inventory, net
 $21,052 
 $21,492 
 $24,797 
 $21,776 
 
Cost of revenues includes the cost of inventory, shipping and handling costs, royalties associated with certain products, transaction banking costs, warehouse labor costs and depreciation on certain assets.
Leases
Generally, the Company leases certain office space, warehouses, distribution centers, manufacturing centers, and equipment. A contract is or contains a lease if the contract conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration.
In general, the Company’s leases include one or more options to renew, with renewal terms that generally vary from one to ten years. The exercise of lease renewal options is generally at the Company’s sole discretion. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.
The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Leases with an initial term of twelve months or less are not recorded on the Company’s condensed consolidated balance sheets, and the Company does not separate nonlease components from lease components. The Company’s lease assets and liabilities recognized within its condensed consolidated balance sheets were as follows (in thousands):
LeasesClassification
June 30,
2019
(unaudited)
Assets
Operating lease right-of-use assetsOperating Lease Right-of-Use Assets
$5,481
Finance lease right-of-use assets
Property, plant and equipment, net at cost, net of Accumulated Depreciation(1)
1,283
Total leased assets
$6,764
Liabilities
Current
OperatingOther Current Liabilities
$772
FinanceCurrent Portion of Long-term Debt
1,103
Noncurrent
OperatingNon-current Operating Lease Liabilities
4,708
FinanceLong-term Debt, net of current portion
778
Total lease liabilities
$7,361
(1)Finance lease assets are recorded net of accumulated amortization of approximately $525,000 as of June 30, 2019.

-25-
Lease cost is recognized on a straight-line basis over the lease term (in thousands):
  
 
Three Months Ended
 
 
Six Months Ended
 
Lease CostClassification
 
June 30, 2019
 (unaudited)
 
 
June 30, 2018
 (unaudited)
 
 
June 30, 2019
 (unaudited)
 
 
June 30,2018
 (unaudited) 
 
Operating lease costSG&A Expenses
 $271 
 $- 
 $542 
 $- 
Finance lease cost 
    
    
    
    
Amortization of leased assetsDepreciation and Amortization
  94 
  - 
  190 
  - 
Interest on lease liabilitiesNet Interest Expense
  34 
  - 
  71 
  - 
Net lease cost 
 $399 
 $- 
 $803 
 $- 
As of June 30, 2019, annual scheduled lease payments were as follows (unaudited) (in thousands):
 
 
Operating Leases
 
 
Finance Leases
 
2019
 $1,055 
 $1,213 
2020
  764 
  699 
2021
  657 
  95 
2022 
  391 
  15 
2023
  628 
  9 
Thereafter
  3,490 
  8 
Total lease payments
  6,985 
  2,039 
Less imputed interest
  1,505 
  158 
Present value of lease liabilities
 $5,480 
 $1,881 
Finance lease right-of-use assets are amortized over their estimated useful life, as the Company does believe that it is reasonably certain that options which transfer ownership will be exercised. In general, for the majority of the Company’s material leases, the renewal options are not included in the calculation of its right-of-use assets and lease liabilities, as the Company does not believe that it is reasonably certain that these renewal options will be exercised. Periodically, the Company assesses its leases to determine whether it is reasonably certain that these options and any renewal options could be reasonably expected to be exercised.
The majority of the Company’s leases are for real estate and equipment. In general, the individual lease contracts do not provide information about the rate implicit in the lease. Because the Company is not able to determine the rate implicit in its leases, it instead generally uses its incremental borrowing rate to determine the present value of lease liabilities. In determining its incremental borrowing rate, the Company reviewed the terms of its leases, its senior secured credit facility, swap rates, and other factors. The weighted-average remaining lease term and weighted-average discount rate used to calculate the present value of lease liabilities are as follows:
Lease Term and Discount Rate
June 30, 2019
(unaudited)
Weighted-average remaining lease term (years)
Operating leases
5.6
Finance leases
1.98
Weighted-average discount rate
Operating leases
5.5%
Finance leases
9.0%
-26-
Revenue Recognition
Direct Selling
Direct distribution sales are made through the Company’s network (direct selling segment), which is a web-based global network of customers and distributors. The Company’s independent sales force markets a variety of products to an array of customers, through friend-to-friend marketing and social networking. The Company considers itself to be an e-commerce company whereby personal interaction is provided to customers by its independent sales network. Sales generated from direct distribution includes health and wellness, beauty product and skin care, scrap booking and story booking items, packaged food products and other service-based products.
Revenue is recognized when the Company satisfies its performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues.
Commercial Coffee - Coffee Roaster
The Company engages in the commercial sale of roasted coffee through its subsidiary CLR, which is sold under a variety of private labels through major national sales outlets and to customers including cruise lines and office coffee service operators, and under its own Café La Rica brand, Josie’s Java House Brand, Javalution brands and Café Cachita as well as through its distributor network within the direct selling segment.
Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues.
Commercial Coffee - Green Coffee
The commercial coffee segment includes the sale of green coffee beans, which are sourced from the Nicaraguan rainforest and providing milling services to H&H.
Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Revenues derived from the sales of green coffee beans by the Company that it has milled, and it has determined it is the agent with regard to such green coffee beans is recorded at net of costs to purchase inventory or recorded to reflect only the revenue derived from the milling services provided. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues.
Commercial Hemp
The commercial hemp segment provides end to end extraction and processing via the Company's proprietary systems that allow for the conversion of hemp feed stock into hemp oil and hemp extracts.  The primary focus of the segment is to generate revenue through sales of extraction services and end to end processing services for the conversion of Hemp and Hemp oil into sellable ingredients.  Additionally, the Company offers various rental, sales, and service programs of the Company's extraction and processing systems.
-27-
Segment Revenue
Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues.
The Company operates in three primary segments: the direct selling segment where products are offered through a global distribution network of preferred customers and distributors, the commercial coffee segment where products are sold directly to businesses and the Hemp segment.
The following table summarizes revenue disaggregated by segment (in thousands):
 
 
Three Months Ended
June 30,
(unaudited)
 
 
Six Months Ended
June 30,
(unaudited)
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
(Restated)* 
 
 
 
 
 
(Restated)* 
 
 
 
 
Direct selling
 $32,124 
 $36,846 
 $65,544 
 $72,157 
Commercial coffee: 
    
    
    
    
Processed green coffee
  968 
  4,527 
  1,068 
  5,580 
Milling and processing services
  1,561 
  - 
  6,387 
  - 
Roasted coffee and other
  3,290 
  2,882 
  6,069 
  9,512 
Total commercial coffee
  5,819 
  7,409 
  13,524 
  15,092 
Commercial hemp
  274 
  - 
  341 
  - 
Total revenue
 $38,217 
 $44,255 
 $79,409 
 $87,249 
* Revenue for the three and six months ended June 30, 2019 has been restated. See Note 2.
Contract Balances  
Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records contract assets when performance obligations are satisfied prior to invoicing.
Contract liabilities are reflected as deferred revenues in current liabilities on the Company’s condensed consolidated balance sheets and include deferred revenue and customer deposits. Contract liabilities relate to payments invoiced or received in advance of completion of performance obligations, and are recognized as revenue upon the fulfillment of performance obligations. Contract liabilities are classified as short-term as all performance obligations are expected to be satisfied within the next 12 months.
As of June 30, 2019 and December 31, 2018, the balance in deferred revenues was approximately $2,260,000 and $2,312,000, respectively. The Company records deferred revenue related to its direct selling segment which is primarily attributable to the Heritage Makers product line and represents Heritage Maker’s obligation for points purchased by customers that have not yet been redeemed for product. In addition, deferred revenues include future Company convention and distributor events.
Deferred revenue related to the commercial coffee segment represents deposits on customer orders that have not yet been completed and shipped. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement FOB shipping point. (See Note 1, above.)
Of the deferred revenue from the year ended December 31, 2018, the Company recognized revenue of approximately $341,000 and $732,000 from the Heritage Makers product line during the three and six months ended June 30. 2019, respectively. There was no other deferred revenue recognized in direct selling segment for the six months ended June 30, 2019.
There were no deferred revenues recognized with the commercial coffees segment and the commercial hemp for the six months ended June 30, 2019.
-28-
 
Note 4.5. Acquisitions and Business Combinations
 
The Company accounts for business combinations under the acquisition method and allocates the total purchase price for acquired businesses to the tangible and identified intangible assets acquired and liabilities assumed, based on their estimated fair values. When a business combination includes the exchange of the Company’s Common Stock,common stock, the value of the Common Stockcommon stock is determined using the closing market price as of the date such shares were tendered to the selling parties. The fair values assigned to tangible and identified intangible assets acquired and liabilities assumed are based on management or third-party estimates and assumptions that utilize established valuation techniques appropriate for the Company’s industry and each acquired business. Goodwill is recorded as the excess, if any, of the aggregate fair value of consideration exchanged for an acquired business over the fair value (measured as of the acquisition date) of total net tangible and identified intangible assets acquired. A liability for contingent consideration, if applicable, is recorded at fair value as of the acquisition date. In determining the fair value of such contingent consideration, management estimates the amount to be paid based on probable outcomes and expectations on financial performance of the related acquired business. The fair value of contingent consideration is reassessed quarterly, with any change in the estimated value charged to operations in the period of the change. Increases or decreases in the fair value of the contingent consideration obligations can result from changes in actual or estimated revenue streams, discount periods, discount rates and probabilities that contingencies will be met.
 
During the ninesix months ended SeptemberJune 30, 2017,2019, the Company entered into three acquisitions,one acquisition, which areis detailed below. The acquisitions wereacquisition was conducted in an effort to expand the Company’s distributor network, enhanceoperations into the field of commercial hemp business.
2019 Acquisitions
Khrysos Global, Inc.
On February 12, 2019, the Company and expand its product portfolio,Khrysos Industries, Inc., a Delaware corporation and diversify its product mix. As such, the major purpose for allwholly owned subsidiary of the Company (“KII”) entered into an Asset and Equity Purchase Agreement (the “AEPA”) with, Khrysos Global, Inc., a Florida corporation (“Seller”), Leigh Dundore (“LD”), and Dwayne Dundore (the “Representing Party”) for KII to acquire substantially all the assets of Seller and all the outstanding equity of INXL Laboratories, Inc., a Florida corporation (“INXL”) and INX Holdings, Inc., a Florida corporation (“INXH”). The business combinations wasof the Seller, INXL and INXH collectively acquired by us provide end to increaseend extraction and processing via the company's proprietary systems that allow for the conversion of hemp feed stock into hemp oil and hemp extracts.  Additionally, KII offers various rental, sales, and service programs of KII’s extraction and processing systems.
The consideration payable for the assets of the Seller and the equity of INXL and INXH is an aggregate of $16,000,000, to be paid as set forth under the terms of the AEPA and allocated between the Seller and LD in such manner as they determine at their discretion.
At the closing, on February 15, 2019, the Seller, LD and the Representing Party received an aggregate of 1,794,972 shares of the Company’s common stock which have a value of $14,000,000 for the purposes of the AEPA or $12,649,000 fair value for the acquisition valuation and $500,000 in cash. Thereafter, we agree to pay the Seller, LD and the Representing Party an aggregate of: $500,000 in cash thirty (30) days following the date of closing; $250,000 in cash ninety (90) days following the date of closing; $250,000 in cash one hundred and eighty (180) days following the date of closing; $250,000 in cash two hundred and seventy (270) days following the date of closing; and $250,000 in cash one (1) year following the date of closing.
In addition, the Company agreed to issue to Representing Party, subject to the approval of the holders of at least a majority of the issued and outstanding shares of the Company’s common stock and the approval of The Nasdaq Stock Market (collectively, the “Contingent Consideration Warrants”) consisting of six (6) six-year warrants, to purchase 500,000 shares of common stock each, for an aggregate of 3,000,000 shares of common stock at an exercise price of $10 per share exercisable upon reaching certain levels of cumulative revenue and profitability. The acquisitions were structured as asset purchases which resulted inor cumulative net income before taxes by the recognitionbusiness during the any of certain intangible assets.the years ending December 31, 2019, 2020, 2021, 2022, 2023 or 2024.
 
 
-10--29-
 
 
Sorvana International, LLCThe AEPA contains customary representations, warranties and covenants of the Company, KII, the Seller, LD and the Representing Party. Subject to certain customary limitations, the Seller, LD and the Representing Party have agreed to indemnify the Company and KII against certain losses related to, among other things, breaches of the Seller’s, LD’s and the Representing Party’s representations and warranties, certain specified liabilities and the failure to perform covenants or obligations under the AEPA.
 
Effective July 1, 2017,On February 28, 2019, KII purchased a 45-acre tract of land in Groveland, Florida, upon which KII intends to build a R&D facility, greenhouse and allocate a portion for farming.
Restatement Note - related to the Acquisition of Khrysos Global, Inc.
In conjunction with the Company’s 2019 annual audit the Company concluded that certain fixed assets acquired in the acquisition and the share price valuation for the common stock issued as consideration were not fairly valued as of the closing date February 15, 2019 including; a) $1,127,000 related to the certain fixed assets, and assumed certain liabilitiesb) $1,351,000 related to a change in the fair value of Sorvana International, LLC “Sorvana”. Sorvana wascommon stock issuance resulting in an increase to goodwill of $2,478,000 acquired and an adjusted aggregate purchase price if $15,894,000. As such, the result ofCompany restated its Quarterly Reports on Form 10-Q for the unification of the two companies FreeLife International, Inc. “FreeLife”, and L’dara. Sorvana offers a variety of products with the addition of the FreeLife and L’dara product lines. Sorvana offers an extensive line of health and wellness product solutions including healthy weight loss supplements, energy and performance products and skin care product lines as well as organic product options. As a result of this business combination, the Company’s distributors and customers will have access to Sorvana’s unique line of products and Sorvana’s distributors and clients will gain access to products offered by the Company. quarter ended June 30, 2019.
 
The contingent consideration’sCompany has estimated fair value at the date of acquisition was $3,487,000of the acquired tangible and intangible assets and liabilities as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. In addition,follows including the Company has assumed certain liabilitiesresulting adjustments in accordance withchanges to the agreement.aggregate purchase price (in thousands):
 
The Company is obligated to make monthly payments based on a percentage of the Sorvana distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of Sorvana’s products until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid to Sorvana aggregate cash payments of the Sorvana distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price.
 
 
 
Consideration as Originally Reported
 
 
Adjustments
 
 
 
Consideration as Currently Reported
 
Present value of cash consideration
 $1,894 
 $ 
 $1,894 
Estimated fair value of common stock issued
  12,649 
  1,351 
  14,000 
Aggregate purchase price
 $14,543 
 $1,351 
 $15,894 
 
The assets acquired were recorded atfollowing table summarizes the estimated fair valuespreliminary and as of the date of the acquisition. Theadjusted fair values of the assets acquired assets have not been finalized pending further information that may impactand liabilities assumed during the valuation of certain assets or liabilities. The preliminary purchase price allocation is as followsperiod ended March 31, 2019 (in thousands):
 
Distributor organization
$1,187
Customer-related intangible
1,300
Trademarks and trade name
1,000
Total purchase price
$3,487
 
 
 
Fair Value as Originally Reported
 
 
Adjustments
 
 
 
Fair Value as Currently Reported
 
Current assets
 $636 
 $- 
 $636 
Inventory
  1,264 
  - 
  1,264 
Property, plant and equipment
  2,260 
  (1,127)
  1,133 
Trademarks and trade name
  1,876 
  - 
  1,876 
Customer-related intangible
  5,629 
  - 
  5,629 
Non-compete intangible
  956 
  - 
  956 
Goodwill
  4,353 
  2,478 
  6,831 
Current liabilities
  (1,904)
  - 
  (1,904)
Notes payable
  (527)
  - 
  (527)
Net assets acquired
 $14,543 
 $1,351 
 $15,894 
 
The preliminary estimated fair value of intangible assets acquired in the amount of $8,461,000 was determined through the use of a discounted cash flow methodology.third-party valuation firm using various income and cost approach methodologies. Specifically, the intangibles identified in the acquisition were trademarks and trade name, customer-related intangible and non-compete agreement. The trademarks and trade name, customer-related intangible and distributor organization intangiblenon-compete are being amortized over their estimated useful life of ten (10)8 years, using the7 years and 6 years, respectively. The straight-line method whichis being used and is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
 
The Company expects to finalize the valuations within one (1) year from the acquisition date.
The revenue impact from the Sorvana acquisition, included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2017 was approximately $2,082,000.
The pro-forma effect assuming the business combination with Sorvana discussed above had occurred at the beginning of the yearGoodwill acquired as currently reported if $6,831,000 is not presentedrecognized as the information was not available.
BellaVita Group, LLC
Effective March 1, 2017,excess purchase price over the Company acquired certain assets of BellaVita Group, LLC “BellaVita” a direct sales company and producer of health and beauty products with locations and customers primarily in the Asian market.
The contingent consideration’s estimated fair value at the date of acquisition was $1,750,000 as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. In addition, the Company has assumed certain liabilities in accordance with the agreement.
During the three months ended September 30, 2017 the Company determined that the initial estimatedacquisition-date fair value of net assets acquired. Goodwill is estimated to represent the acquisition shouldsynergistic values expected to be reduced by $15,000realized from $1,750,000 to $1,735,000.
The Company is obligated to make monthly payments based on a percentagethe combination of the BellaVita distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of BellaVita products until the earlier of the date thattwo businesses. The goodwill is twelve (12) years from the closing date or such time as the Company has paidexpected to BellaVita aggregate cash payments of the BellaVita distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price.be deductible for tax purposes.
 
 
-11--30-
 
 
The fair valuesContingent Consideration Warrants discussed above are subject to vesting based upon the achievement of various sales milestones and only if the acquired assets havesellers do not been finalized pending further information that may impactterminate their services.  As such, the valuation of certain assets or liabilities. The preliminary purchase price allocation is as follows (in thousands):
Distributor organization
$810
Customer-related intangible
525
Trademarks and trade name
400
Total purchase price
$1,735
The preliminary fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarkswarrants were considered equity-based compensation for future services and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
The Company expects to finalize the valuations within one (1) year from the acquisition date.
The revenue impact from the BellaVita acquisition, includednot considered contingent consideration in the condensed consolidated statementscalculation of operations for the three and nine months ended September 30, 2017 was approximately $736,000 and $1,608,000, respectively.
The pro-forma effect assuming the business combination with BellaVita discussed above had occurred at the beginning of the year is not presented as the information was not available.
Ricolife, LLC
Effective March 1, 2017, the Company acquired certain assets of Ricolife, LLC “Ricolife” a direct sales company and producer of teas with health benefits contained within its tea formulas.
The contingent consideration’s estimated fair value at the date of acquisition was $920,000 as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. In addition, the Company has assumed certain liabilities in accordance with the agreement.
During the three months ended September 30, 2017 the Company determined that the initial estimated fair value of the acquisition should be reduced by $222,000 from $920,000 to $698,000.
The Company is obligated to make monthly payments based on a percentage of the Ricolife distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of Ricolife products until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid to Ricolife aggregate cash payments of the Ricolife distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price.
 
The fair values of the acquired assets have not been finalized pending further information that may impact the valuation of certain assets or liabilities. The preliminary purchase price allocation is as follows (in thousands):
Distributor organization
$218
Customer-related intangible
280
Trademarks and trade name
200
Total purchase price
$698
The preliminary fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believedcosts related to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
The Company expects to finalize the valuations within one (1) year from the acquisition date.
The revenue impact from the Ricolife acquisition,are included in the condensed consolidated statements of operations for the threelegal and nine months ended September 30, 2017 was approximately $268,000accounting fees and $683,000, respectively.
The pro-forma effect assuming the business combination with Ricolife discussed above had occurred at the beginning of the year is not presented as the information was not available.
2016 Acquisitions
Legacy for Life, LLC
On August 18, 2016, with an effective date of September 1, 2016 the Company entered into an agreement to acquire certain assets of Legacy for Life, LLC, an Oklahoma based direct-sales company and entered into an agreement to acquire the equity of two wholly owned subsidiaries of Legacy for Life, LLC; Legacy for Life Taiwan and Legacy for Life Limited (Hong Kong) collectively referred to as (“Legacy for Life”).
-12-
Legacy for Life is a science-based direct seller of i26, a product made from the patented IgY Max formula or hyperimmune whole dried egg, which is the key ingredient in Legacy for Life products. Additionally, the Company has entered into an Ingredient Supply Agreement to market i26 worldwide. IgY Max promotes healthy gut flora and healthy digestion and was created by exposing a specially selected flock of chickens to natural elements from the human world, whereby the chickens develop immunity to these elements. In a highly patented process, these special eggs are harvested as a whole food and are processed as a whole food into i26 egg powder, an all-natural product. Nothing is added to the egg nor does any chemical extraction take place.
As a result of this acquisition, the Company’s distributors and customers have access to the unique line of the Legacy for Life products and the Legacy for Life distributors and customers have gained access to products offered by the Company. The Company purchased certain inventories and assumed certain liabilities. The Company is obligated to make monthly payments based on a percentage of the Legacy for Life distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of the Legacy for Life products until the earlier of the date that is fifteen (15) years from the closing date or such time as the Company has paid to Legacy for Life aggregate cash payments of Legacy for Life distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price.
The acquisition of Legacy for Life was accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed by the Company were recognized at their estimated fair values as of the acquisition date. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred.
 
During the three months ended September 30, 2017 the purchase accounting was finalized and the Company determined that the initial purchase price for the related intangibles should be reduced by $92,000 from $825,000 to $733,000. The final purchase price allocation for the acquisition of Legacy for Life (in thousands) is as follows:
Cash paid for the equity in Legacy for Life Taiwan and Legacy for Life Limited (Hong Kong)
$26
Cash paid for inventory
195
Total cash consideration
221
Trademarks and trade name
185
Customer-related intangible
250
Distributor organization
298
Total intangible assets acquired, non-cash
733
Total purchase price
$954
The fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
The revenue impact from the Legacy for Life acquisition,Revenues included in the consolidated statement of operations for the three and ninesix months ended SeptemberJune 30, 2017 was2019 were approximately $505,000$274,000 and $1,501,000,$341,000, respectively.
 
The revenue impact from the Legacy for Life acquisition, included in the consolidated statement of operations for the three and nine months ended September 30, 2016 was approximately $137,000.
The pro-forma effect assuming the business combination with Legacy for Life discussed above had occurred at the beginning of 2016 is not presented as the information was not available.
Nature’s Pearl Corporation
On August 1, 2016, the Company entered into an agreement to acquire certain assets of Nature’s Pearl Corporation, (“Nature’s Pearl”) with an effective date of September 1, 2016. Nature’s Pearl is a direct-sales company that produces nutritional supplements and skin and personal care products using the muscadine grape grown in the southeastern region of the United States that are deemed to be rich in antioxidants. As a result of this acquisition, the Company’s distributors and customers have access to the unique line of Nature’s Pearl products and Nature’s Pearl distributors and customers have gained access to products offered by the Company. The Company is obligated to make monthly payments based on a percentage of Nature’s Pearl distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of Nature’s Pearl products until the earlier of the date that is ten (10) years from the closing date or such time as the Company has paid to Nature’s Pearl aggregate cash payments of Nature’s Pearl distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price. The Company paid approximately $200,000 for certain inventories, which payment was applied against the maximum aggregate purchase price.
-13-
The acquisition of Nature’s Pearl was accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed by the Company were recognized at their estimated fair values as of the acquisition date. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred.
During the three months ended December 31, 2016, the Company determined that the initial estimated fair value of the acquisition should be reduced $1,290,000 from the initial purchase price of $2,765,000 to $1,475,000. During the three months ended September 30, 2017 the purchase accounting was finalized and the Company determined that the purchase price should be reduced by $266,000 to $1,209,000.
The final purchase price allocation for the acquisition of Nature’s Pearl (in thousands) is as follows:
Distributor organization
$559
Customer-related intangible
400
Trademarks and trade name
250
Total purchase price
$1,209
The fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
The revenue impact from the Nature’s Pearl acquisition, included in the consolidated statement of operations for the three and nine months ended September 30, 2017 was approximately $939,000 and $3,014,000, respectively.
The revenue impact from the Nature’s Pearl acquisition, included in the consolidated statement of operations for the three and nine months ended September 30, 2016 was approximately $452,000.
The pro-forma effect assuming the business combination with Nature’s Pearl discussed above had occurred at the beginning of 2016 is not presented as the information was not available.
Renew Interest, LLC (SOZO Global, Inc.)
On July 29, 2016, the Company acquired certain assets of Renew Interest, LLC (“Renew”) formerly owned by SOZO Global, Inc. (“SOZO”), a direct-sales company that produces nutritional supplements, skin and personal care products, weight loss products and coffee products. The SOZO brand of products contains CoffeeBerry a fruit extract known for its high level of antioxidant properties. As a result of this business combination, the Company’s distributors and customers have access to the unique line of the Renew products and Renew distributors and customers have gained access to products offered by the Company. The Company is obligated to make monthly payments based on a percentage of Renew distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue until the earlier of the date that is twelve (12) years from the closing date or such time as the Company has paid to Renew, aggregate cash payments of Renew distributor revenue and royalty revenue equal to a predetermined maximum aggregate purchase price. The Company paid approximately $300,000 for certain inventories and assumed liabilities, which payment was applied to the maximum aggregate purchase price.
The acquisition of Renew was accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed by the Company were recognized at their estimated fair values as of the acquisition date. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred.
During the three months ended September 30, 2017 the purchase accounting was finalized and the Company determined that the initial purchase price should be reduced by $30,000 from $465,000 to $435,000. The final purchase price allocation for the acquisition of Renew (in thousands) is as follows:
Distributor organization
$170
Customer-related intangible
155
Trademarks and trade name
110
Total purchase price
$435
The fair value of intangible assets acquired was determined through the use of a discounted cash flow methodology. The trademarks and trade name, customer-related intangible and distributor organization intangible are being amortized over their estimated useful life of ten (10) years using the straight-line method which is believed to approximate the time-line within which the economic benefit of the underlying intangible asset will be realized.
The revenue impact from the Renew acquisition, included in the consolidated statement of operations for the three and nine months ended September 30, 2017 was approximately $214,000 and $695,000, respectively.
-14-
The revenue impact from the Renew acquisition, included in the consolidated statement of operations for the three and nine months ended September 30, 2016 was approximately $198,000.
The pro-forma effect assuming the business combination with Renew discussed above had occurred at the beginning of 2016 is not presented as the information was not available.
Note 5.6. Intangible Assets and Goodwill
 
Intangible Assets
 
Intangible assets are comprised of distributor organizations, trademarks and tradenames, customer relationships and internally developed software.  The Company's acquired intangible assets, which are subject to amortization over their estimated useful lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. An impairment loss is recognized when the carrying amount of an intangible asset exceeds its fair value.
 
Intangible assets consist of the following (in thousands):
 
 
September 30, 2017
 
 
December 31, 2016
 
 
June 30, 2019
(unaudited)
 
 
December 31, 2018
 
 
Cost
 
 
Accumulated
Amortization
 
 
Net
 
 
Cost
 
 
Accumulated
Amortization
 
 
Net
 
 
 
Cost
 
 
Accumulated
Amortization
 
 
 
Net
 
 
 
Cost
 
 
Accumulated
Amortization
 
 
 
Net
 
Distributor organizations
 $14,757 
 $8,059 
 $6,698 
 $12,930 
 $7,162 
 $5,768 
 $14,559 
 $10,010 
 $4,549 
 $14,559 
 $9,575 
 $4,984 
Trademarks and trade names
  6,994 
  1,109 
  5,885 
  5,394 
  815 
  4,579 
  9,963 
  2,209 
  7,754 
  7,337 
  1,781 
  5,556 
Customer relationships
  9,951 
  4,422 
  5,529 
  7,846 
  3,642 
  4,204 
  16,028 
  6,068 
  9,960 
  10,398 
  5,723 
  4,675 
Internally developed software
  720 
  433 
  287 
  720 
  357 
  363 
  720 
  607 
  113 
  720 
  558 
  162 
Non-compete agreement
  956 
  - 
  956 
  - 
Intangible assets
 $32,422 
 $14,023 
 $18,399 
 $26,890 
 $11,976 
 $14,914 
 $42,226 
 $18,894 
 $23,332 
 $33,014 
 $17,637 
 $15,377 
 
Amortization expense related to intangible assets was approximately $712,000$586,000 and $537,000$857,000 for the three months ended SeptemberJune 30, 20172019 and 2016,2018, respectively. Amortization expense related to intangible assets was approximately $2,047,000$1,256,000 and $1,746,000$1,692,000 for the ninesix months ended SeptemberJune 30, 20172019 and 2016,2018, respectively.
 
Trade names, which do not have legal, regulatory, contractual, competitive, economic, or other factors that limit the useful lives are considered indefinite lived assets and are not amortized but are tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Approximately $2,267,000As of June 30, 2019 and December 31, 2018, approximately $1,649,000 in trademarks from business combinations have been identified as having indefinite lives.
 
Goodwill
 
Goodwill is recorded as the excess, if any, of the aggregate fair value of consideration exchanged for an acquired business over the fair value (measured as of the acquisition date) of total net tangible and identified intangible assets acquired. In accordance with Financial Accounting Standards Board (“FASB”) ASCAccounting Standards Codification (“ASC”) Topic 350, “Intangibles — Goodwill and Other”, goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company conducts annual reviews for goodwill and indefinite-lived intangible assets in the fourth quarter or whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be fully recoverable.
-31-
 
The Company first assesses qualitative factors to determine whether it is more likely than not (a likelihood of more than 50%) that goodwill is impaired. After considering the totality of events and circumstances, the Company determines whether it is more likely than not that goodwill is not impaired.  If impairment is indicated, then the Company conducts the two-step impairment testing process. The first step compares the Company’s fair value to its net book value. If the fair value is less than the net book value, the second step of the test compares the implied fair value of the Company’s goodwill to its carrying amount. If the carrying amount of goodwill exceeds its implied fair value, the Company would recognize an impairment loss equal to that excess amount. The testing is generally performed at the “reporting unit” level. A reporting unit is the operating segment, or a business one level below that operating segment (referred to as a component) if discrete financial information is prepared and regularly reviewed by management at the component level. The Company has determined that its reporting units for goodwill impairment testing are the Company’s reportable segments. As such, the Company analyzedanalyzes its goodwill balances separately for the commercial coffee reporting unit, and the direct selling reporting unit and the commercial hemp reporting unit. The goodwill balance as of SeptemberJune 30, 20172019 and December 31, 2016 was $6,323,000.2018 is approximately $13,154,000 and $6,323,000, respectively, which includes an adjustment to the KII acquisition goodwill during the period ended March 31, 2019, discussed above in Note 5, which increased the goodwill for KII in the amount of $2,478,000. There were no triggering events indicating impairment of goodwill or intangible assets during the three and ninesix months ended SeptemberJune 30, 20172019 and 2016.
-15-
2018.
 
Goodwill intangible assets consistconsists of the following (in thousands):
 
 
September 30,
2017
 
 
December 31,
2016
 
 
June 30,
2019
 
 
December 31,
2018
 
Goodwill, commercial coffee
 $3,314 
 $3,314 
Goodwill, direct selling
  3,009 
  3,009 
Goodwill, commercial hemp
  6,831 
  - 
Total goodwill
 $6,323 
 $13,154 
 $6,323 
 
Note 6.7.  Notes Payable and Other Debt
 
Short-term Debt
On July 18, 2018, the Company entered into lending agreements (the “Lending Agreements”) with three (3) separate entities and received loans in the total amount of $1,907,000, net of loan fees to be paid back over an eight-month period on a monthly basis. Payments are comprised of principal and accrued interest with an effective interest rate between 15% and 20%. The Company’s outstanding balance related to the Lending Agreements was approximately $504,000 as of December 31, 2018 and was included in other current liabilities on the Company’s balance sheet as of December 31, 2018. In March 2019 the loans were paid in full.
Notes Payable
Promissory Notes
On March 18, 2019, the Company entered into a two-year Secured Promissory Note (the “8% Note” or “Notes”) with two (2) accredited investors that had a substantial pre-existing relationship with the Company pursuant to which the Company raised cash proceeds of $2,000,000. The Company also issued 20,000 shares of the Company’s common stock par value $0.001 for each $1,000,000 invested and a five-year warrant to purchase 20,000 shares of the Company’s common stock at a price per share of $6.00. The 8% Notes pay interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due at maturity on March 18, 2021.
The Company recorded debt discounts of approximately $139,000 related to the fair value of warrants issued in the transaction and $212,000 of transaction issuance costs to be amortized to interest expense over the life of the Notes. As of June 30, 2019, the remaining balance of the debt discounts is approximately $309,000. The Company recorded approximately $42,000 amortization of the debt discounts during the six months ended June 30, 2019 and is recorded as interest expense.
-32-
Credit Note
On December 13, 2018, the Company’s wholly owned subsidiary, CLR, entered into a Credit Agreement with Mr. Carl Grover pursuant to which CLR borrowed $5,000,000 from Mr. Grover and in exchange issued to him a $5,000,000 Credit Note (the “Credit Note”) secured by its green coffee inventory under a Security Agreement, dated December 13, 2018, with Mr. Grover and CLR’s subsidiary, Siles.
The Credit Note accrues interest at eight percent (8%) per annum. All principal and accrued interest under the Credit Note is due and payable on December 12, 2020. The Credit Note contains customary events of default including the Company or Siles failure to pay its obligations, commencing bankruptcy or liquidation proceedings, and breach of representations and warranties. Upon the occurrence of an event of default, the unpaid balance of the principal amount of the Credit Note together with all accrued but unpaid interest thereon, may become, or may be declared to be, due and payable by Mr. Grover and shall bear interest from the due date until such amounts are paid at the rate of ten percent (10%) per annum. In connection with the Credit Agreement, the Company issued to Mr. Grover a four-year warrant to purchase 250,000 shares of its common stock, exercisable at $6.82 per share (“Warrant 1”), and a four-year warrant to purchase 250,000 shares of its common stock, exercisable at $7.82 per share (“Warrant 2”).
Also in connection with the Credit Note, the Company also entered into an advisory agreement with a third party not affiliated with Mr. Grover, pursuant to which the Company agreed to pay to the advisor a 3% fee on the transaction with Mr. Grover and issued to the advisor (or it’s designees) a four-year warrant to purchase 50,000 shares of the Company’s common stock, exercisable at $6.33 per share.
All fees, warrants and costs paid to Mr. Grover and the advisor and all direct costs incurred by the Company are recognized as a debt discount to the funded Credit Note and are amortized to interest expense using the effective interest method over the term of the Credit Note. The Company recognized an initial debt discount of approximately $1,469,000 related to the initial fair value of warrants issued in the transaction and $175,000 of transaction issuance costs. As of June 30, 2019, the remaining unamortized debt discount is approximately $1,293,000. The Company recognized approximately $321,000 amortization of the debt discount during the six months ended June 30, 2019 which was included in interest expense in the Condensed Consolidated Statements of Operations.
2400 Boswell Mortgage
In March 2013, the Company acquired 2400 Boswell for approximately $4,600,000. 2400 Boswell is the owner and lessor of the building occupied by the Company for its corporate office and warehouse in Chula Vista, California. The purchase was from an immediate family member of our Chief Executive Officer and consisted of approximately $248,000 in cash, $334,000 of debt forgiveness and accrued interest, and a promissory note of approximately $393,000, payable in equal payments over 5 years with interest at 5.0%.  Additionally, the Company assumed a long-term mortgage of $3,625,000, payable over 25 years with an initial interest rate of 5.75%. The interest rate is the prime rate plus 2.5%. As of June 30, 2019, the interest rate was 8.0%. The lender will adjust the interest rate on the first calendar day of each change period. The Company and its Chief Executive Officer are both co-guarantors of the mortgage. As of June 30, 2019, the balance on the long-term mortgage is approximately $3,180,000 and the balance on the promissory note is zero.
M2C Purchase Agreement
In March 2007, the Company entered into an agreement to purchase certain assets of M2C Global, Inc., a Nevada corporation, for $4,500,000.  The agreement required payments totaling $500,000 in three installments during 2007, followed by monthly payments in the amount of 10% of the sales related to the acquired assets until the entire note balance is paid. As of June 30, 2019 and December 31, 2018, the carrying value of the liability was approximately $1,049,000 and $1,071,000, respectively. The interest associated with the note for the three and six months ended June 30, 2019 and 2018 was minimal.
Khrysos Mortgage Notes
In conjunction with the Company’s acquisition of Khrysos, the Company assumed an interest only mortgage note in the amount of $350,000, due in September 2021, and bears an interest rate of 8.0%. In addition, the Company assumed a mortgage note of approximately $177,000, due in June 2023, and bears an interest rate of 7.0% per annum. As of June 30, 2019, the remaining aggregate mortgage balance is approximately $526,000.
-33-
In February 2019, Khrysos purchased a 45-acre tract of land in Groveland, Florida, for $750,000, upon which Khrysos intends to build a R&D facility, greenhouse and allocate a portion for farming. Khrysos paid approximately $303,000 as a down payment and assumed a mortgage of $450,000. The entire balance is due in February 2024 and bears interest at 6.0% per annum. As of June 30, 2019, the remaining mortgage balance is approximately $446,000.
Khrysos Acquisition Liability Payable
In conjunction with the Company’s acquisition of Khrysos, the Company agreed to pay the sellers in cash $2,000,000 towards the AEPA with an initial payment of $500,000 which was paid at closing in February 2019. Thereafter, the sellers are to receive an aggregate of: $500,000 in cash thirty (30) days following the date of closing; $250,000 in cash ninety (90) days following the date of closing; $250,000 in cash one hundred and eighty (180) days following the Date of closing; $250,000 in cash two hundred and seventy (270) days following the date of closing; and $250,000 in cash one (1) year following the date of closing. As of June 30, 2019, the Company’s remaining liability of $1,500,000 is outstanding and is recorded on the balance sheet in accrued expenses. (See Note 5, above.)
Other Notes
The Company’s other notes relate to loans for commercial vans at CLR in the amount of $85,000 as of June 30, 2019 which mature at various dates through 2023.
Line of Credit - Loan and Security Agreement
On November 16, 2017, CLR entered into a Loan and Security Agreement (“Agreement”) with Crestmark Bank (“Crestmark”) providing for a line of credit related to accounts receivables resulting from sales of certain products that includes borrowings to be advanced against acceptable eligible inventory related to CLR. Effective December 29, 2017, CLR entered into a First Amendment to the Agreement, to include an increase in the maximum overall borrowing to $6,250,000. The loan amount may not exceed an amount which is the lesser of (a) $6,250,000 or (b) the sum of up (i) to 85% of the value of the eligible accounts; plus, (ii) the lesser of $1,000,000 or 50% of eligible inventory or 50% of (i) above, plus (iii) the lesser of $250,000 or eligible inventory or 75% of certain specific inventory identified within the Agreement.
The Agreement contains certain financial and nonfinancial covenants with which the Company must comply to maintain its borrowing availability and avoid penalties. As of June 30, 2019, the Company is in compliance with all financial and nonfinancial covenants.
The outstanding principal balance of the Agreement will bear interest based upon a year of 360 days with interest being charged for each day the principal amount is outstanding including the date of actual payment. The interest rate is a rate equal to the prime rate plus 2.50% with a floor of 6.75%. As of June 30, 2019, the interest rate was 7.5%. In addition, other fees are incurred for the maintenance of the loan in accordance with the Agreement. Other fees may be incurred in the event the minimum loan balance of $2,000,000 is not maintained. The Agreement is effective until November 16, 2020.
The Company and the Company’s CEO, Stephan Wallach, have entered into a Corporate Guaranty and Personal Guaranty, respectively, with Crestmark guaranteeing payments in the event that the Company’s commercial coffee segment CLR were to default. In addition, the Company’s President and Chief Financial Officer, David Briskie, personally entered into a Guaranty of Validity representing the Company’s financial statements so long as the indebtedness is owing to Crestmark, maintaining certain covenants and guarantees.
The Company’s outstanding line of credit liability related to the Agreement was approximately $2,002,000 as of June 30, 2019 and $2,256,000 as of December 31, 2018.
Contingent Acquisition Debt
The Company has contingent acquisition debt associated with its business combinations.  The Company accounts for business combinations under the acquisition method and allocates the total purchase price for acquired businesses to the tangible and identified intangible assets acquired and liabilities assumed, based on their estimated fair values as of the acquisition date. A liability for contingent consideration, if applicable, is recorded at fair value as of the acquisition date and evaluated each period for changes in the fair value and adjusted as appropriate.
The Company’s contingent acquisition debt as of June 30, 2019 and December 31, 2018 is $7,593,000 and $8,261,000, respectively, and is attributable to debt associated with the Company’s direct selling segment. (See Note 10 below.)
-34-
Note 8. Convertible Notes Payable
 
Our totalTotal convertible notes payable as of SeptemberJune 30, 20172019 and December 31, 2016,2018, net of debt discount outstanding consisted of the amount set forth in the following table (in thousands):
 
 
 
September 30,
2017
 
 
December 31,
2016
 
8% Convertible Notes due July and August 2019 (2014 Notes)
 $4,750 
 $4,750 
Debt discount
  (1,921)
  (2,707)
Carrying value of 2014 Notes
  2,829 
  2,043 
 
    
    
8% Convertible Notes due October and November 2018 (2015 Notes)
  3,000 
  7,188 
Debt discount
  (224)
  (904)
Carrying value of 2015 Notes
  2,776 
  6,284 
 
    
    
8% Convertible Notes due July and August 2020 (2017 Notes)
  7,254 
  - 
Fair value of bifurcated embedded conversion option of 2017 Notes
  330 
  - 
Debt discount
  (2,423)
  - 
Carrying value of 2017 Notes
  5,161 
  - 
 
    
    
Total long-term carrying value of convertible notes payable
 $10,766 
 $8,327 
 
 
June 30,
2019
(unaudited)
 
 
December 31,
2018
 
8% Convertible Notes due July and August 2019 (2014 Notes), principal
 $750 
 $750 
Debt discounts
  (34)
  (103)
Carrying value of 2014 Notes
  716 
  647 
 
    
    
6% Convertible Notes due February and March 2021 (2019 PIPE Notes), principal
  2,890 
  - 
Debt discounts
  (532)
  - 
Carrying value of 2019 PIPE Notes
  2,358 
  - 
 
    
    
Total carrying value of convertible notes payable
 $3,074 
 $647 

July 2014 Private Placement
 
Between July 31, 2014 and September 10, 2014 the Company entered into Note Purchase Agreements (the “Note”“2014 Note” or “Notes”“2014 Notes”) related to its private placement offering (“2014 Private Placement”) with seven accredited investors pursuant to which the Company raised aggregate gross proceeds of $4,750,000 and sold units consisting of five (5) year senior secured convertible Notesnote in the aggregate principal amount of $4,750,000 that are convertible into 678,568 shares of our Common Stock,common stock, at a conversion price of $7.00 per share, and warrants to purchase 929,346 shares of Common Stockcommon stock at an exercise price of $4.60 per share. The 2014 Notes bear interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due between July and September 2019. As
The Company has the right to prepay the 2014 Notes at any time after the one-year anniversary date of September 30, 2017the issuance of the 2014 Notes at a rate equal to 110% of the then outstanding principal balance and any unpaid accrued interest. The 2014 Notes are secured by Company pledged assets and rank senior to all debt of the Company other than certain senior debt that has been previously identified as senior to the convertible notes. Additionally, Stephan Wallach, the Company’s Chief Executive Officer, has also personally guaranteed the repayment of the 2014 Notes, subject to the terms of a Guaranty Agreement executed by him with the investors.  In addition, Mr. Wallach has agreed not to sell, transfer or pledge 1.5 million shares of the common stock that he owns so long as his personal guaranty is in effect.
On October 23, 2018, the Company entered into an agreement with Carl Grover to exchange (the “Debt Exchange”), subject to stockholder approval which was received on December 31, 20166, 2018, all amounts owed under the 2014 Note held by him in the principal amount of $4,750,000 remains outstanding.$4,000,000 which matures on July 30, 2019, for 747,664 shares of the Company’s common stock, at a conversion price of $5.35 per share and a four-year warrant to purchase 631,579 shares of common stock at an exercise price of $4.75 per share. Upon the closing the Company issued Ascendant Alternative Strategies, LLC, a FINRA broker dealer (or its designees), which acted as the Company’s advisor in connection with a Debt Exchange transaction, 30,000 shares of common stock in accordance with an advisory agreement and four-year warrants to purchase 80,000 shares of common stock at an exercise price of $5.35 per share and four-year warrants to purchase 70,000 shares of common stock at an exercise price of $4.75 per share.
The Company considered the guidance of ASC 470-20, Debt:Debt with Conversion and Other Optionsand ASC 470-60, Debt:Debt Troubled Debt Restructuring by Debtorsand concluded that the 2014 Note held by Mr. Grover should be recognized as a debt modification for an induced conversion of convertible debt under the guidance of ASC 470-20. The Company recognized all remaining unamortized discounts of approximately $679,000 immediately subsequent to October 23, 2018 as interest expense, and the fair value of the warrants and additional shares issued as discussed above were recorded as a loss on the Debt Exchange in the amount of $4,706,000 during the year ended December 31, 2018 with the corresponding entry recorded to equity.
 
 
 
-16--35-
 
 
TheIn 2014, the Company initially recorded debt discounts of $4,750,000 related to the beneficial conversion feature of $1,053,000 and $3,697,000 related to the detachable warrants. The beneficial conversion feature discount and the detachable warrants discount are amortized to interest expense over the life of the Notes. The unamortized debt discounts recognized with the Debt Exchange was approximately $679,000. As of SeptemberJune 30, 20172019 and December 31, 20162018 the remaining balance of the debt discounts is approximately $1,741,000$31,000 and $2,454,000,$94,000, respectively. The quarterlyCompany recorded approximately $63,000 and $238,000 amortization of the debt discounts is approximately $238,000during the six months ended June 30, 2019 and 2018 and is recorded as interest expense.
 
With respect to the aggregate offering,2014 Private Placement, the Company paid approximately $490,000 in expenses including placement agent fees. The issuance costs are amortized to interest expense over the term of the 2014 Notes. The unamortized issuance costs recognized with the Debt Exchange was approximately $63,000. As of SeptemberJune 30, 20172019 and December 31, 20162018 the remaining balance of the issuance costs is approximately $180,000$3,000 and $253,000,$10,000, respectively. The quarterly amortizationCompany recorded approximately $6,000 and $25,000 of the issuance costs is approximately $25,000debt discounts amortization during the six months ended June 30, 2019 and 2018, respectively, and is recorded as interest expense.
As of June 30, 2019 and December 31, 2018 the principal amount of $750,000 remains outstanding.
 
Unamortized debt discounts and issuance costs are included with convertible notes payable, net of debt discount on the condensed consolidated balance sheets.
 
November 2015January 2019 Private Placement
 
Between October 13, 2015February 15, 2019 and November 25, 2015May 23, 2019, the Company entered into Note Purchase Agreements (the “Note” or “Notes”) related toclosed four tranches of its private placement2019 January Private Placement debt offering, (“November 2015 Private Placement”) with three (3) accredited investors pursuant to which the Company raised cashoffered for sale up to $10,000,000 in principal amount $10,000,000 of notes (the “2019 PIPE Notes”), with each investor receiving 2,000 shares of common stock for each $100,000 invested. The Company entered into subscription agreements with thirty (30) accredited investors that had a substantial pre-existing relationship with the Company pursuant to which the Company received aggregate gross proceeds of $3,187,500 in the offering$2,890,000 and converted $4,000,000 of debt from the Company’s January 2015 Private Placement to this offering in consideration of the sale of aggregate units consisting of three-year senior secured convertibleissued 2019 PIPE Notes in the aggregate principal amount of $7,187,500,$2,890,000 and an aggregate of 57,800 shares of common stock. The placement agent received 14,450 shares of common stock for the closed tranches and can receive up to 50,000 shares of common stock in the offering. Each 2019 PIPE Note matures 24 months after issuance, bears interest at a rate of six percent (6%) per annum, and the outstanding principal is convertible into 1,026,784 shares of Common Stock,common stock at any time after the 180th day anniversary of the issuance of the 2019 PIPE Notes, at a conversion price of $7.00$10 per share subject(subject to adjustment as provided therein;for stock splits, stock dividends and five-year Warrants exercisable to purchase 479,166 sharesreclassification of the Company’s common stock at a price per share of $9.00. The Notes bear interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due at maturity on October 12, 2018.stock).
 
In connection with the July 2017 Private Placement, whereby three (3) investors from the November 2015 Private Placement, the Prior Investors, as discussed in the previous paragraph converted their 2015 Notes in aggregate principal amount of $4,200,349 together with accrued interest thereon into new convertible notes for an equal principal amount to the 2017 Private Placement as discussed below. The remaining principal balance in the 2015 Notes is $3,000,000 and related warrants remain outstanding as of September 30, 2017. The Company accounted for the conversionUpon issuance of the notes as an extinguishment in accordance with ASC 470-20 and ASC 470-50.
The2019 PIPE Notes, the Company recordedrecognized debt discounts of $309,000 relatedapproximately $634,000, resulting from the allocated portion of offering proceeds to the beneficial conversion feature of $15,000 and $294,000 related to the detachable warrants.separable common stock issuance. The beneficial conversion feature discount and the detachable warrants discount are amortized to interest expense over the life of the Notes. During the three and nine months ended September 30, 2017 the Company allocated approximately $75,000 for the remaining proportionate share of the unamortized debt discounts to the extinguished portion of the debt.
As of September 30, 2017 and December 31, 2016 the remaining balances of the debt discounts is approximately $47,000 and $189,000 respectively. The quarterly amortization of the remaining debt discount is approximately $12,000 and is recorded as interest expense.
With respect to the aggregate offering, the Company paid $786,000 in expenses including placement agent fees. The issuance costs arebeing amortized to interest expense over the term of the 2019 PIPE Notes. During the three and ninesix months ended SeptemberJune 30, 2017 the Company allocated approximately $190,000 for the remaining proportionate share of the unamortized issuance costs to the extinguished portion of the debt.
As of September 30, 2017 and December 31, 2016 the remaining balances of the issuance cost is approximately $119,000 and $480,000, respectively. The quarterly amortization of the remaining issuance costs is approximately $30,000 and is recorded as interest expense.
In addition the Company issued warrants to the placement agent in connection with the Notes which were valued at approximately $384,000. These warrants were not protected against down-round financing and accordingly, were classified as equity instruments and the corresponding deferred issuance costs are amortized over the term of the Notes. During the three and nine months ended September 30, 2017 the Company allocated approximately $93,000 for the remaining proportionate share of the unamortized issuance costs to the extinguished portion of the debt.
As of September 30, 2017 and December 31, 2016, the remaining balance of the warrant issuance cost is approximately $58,000 and $235,000, respectively. The quarterly amortization of the remaining warrant issuance costs is approximately $15,000 and is recorded as interest expense.
The Company recorded a non-cash extinguishment loss on debt of $308,000 in the current quarter ended September 30, 2017 as a result of the repayment of $4,200,349 in notes including accrued interest to the three investors from the November 2015 Private Placement through issuance of a new July 2017 Note. This loss represents the difference between the reacquisition value of the new debt to the holders of the notes and the carrying amount of the holders’ extinguished debt.
-17-
July 2017 Private Placement
During July and August 2017, the Company entered into note purchase agreements with accredited investors in a private placement offering (the “2017 Private Placement”) pursuant to which the Company sold notes in the aggregate principal amount of $3,054,000, convertible into 663,913 shares of the Company’s common stock, at a conversion price of $4.60 per share, subject to adjustment (the “2017 Notes), and three-year warrants to purchase 331,957 shares of the Company’s common stock at an exercise price of $5.56 (“2017 Warrants”), for gross cash proceeds of $3,054,000.

In addition, concurrent with the 2017 Private Placement, three investors in the Company’s 2015 Private Placement, exchanged their notes purchased in that offering, in the aggregate principal amount of $4,200,349, together with accrued interest thereon, and warrants to purchase an aggregate of 279,166 shares of the Company’s common stock at $9.00 per share for 2017 Notes in the aggregate principal amount of $4,200,349 and 2017 Warrants to purchase an aggregate of 638,625 shares of the Company’s common stock at $5.56 per share.
The 2017 Notes mature on July 28, 2020 and bear interest at a rate of eight percent (8%) per annum. The Company has the right to prepay the 2017 Notes at any time after the one-year anniversary date of the issuance of the 2017 Notes at a rate equal to 110% of the then outstanding principal balance and accrued interest. The 2017 Notes automatically convert to common stock if, prior to the maturity date, the Company sells common stock, preferred stock or other equity-linked securities with aggregate gross proceeds of no less than $3,000,000 for the purpose of raising capital. The 2017 Notes provide for full ratchet price protection on the conversion price for a period of nine months after their issuance and subject to adjustments.
The Company's use of the proceeds from the 2017 Private Placement was for working capital purposes. As of September 30, 2017 the aggregate principal amount of $7,254,000 remains outstanding.
For twelve (12) months following the closing, the investors in the 2017 Private Placement have the right to participate in any future equity financings by the Company including the Offering, up to their pro rata share of the maximum Offering amount in the aggregate.
The Company paid a placement fee of $321,248, issued the placement agent three-year warrants to purchase 179,131 shares of the Company’s common stock at an exercise price of $5.56 per share, and issued the placement agent 22,680 shares of the Company’s common stock.
Upon issuance of the 2017 Notes, the Company recognized an aggregate debt discount of approximately $2,565,000, resulting from the allocated portion of issuance costs to the 2017 Notes and to the allocation of offering proceeds to the separable warrant liabilities, and to the bifurcated embedded conversion option. See Notes 7 & 8 below.
The Company recorded $1,931,000 of debt discounts which included an embedded conversion feature of $330,000 and $1,601,000 related to the detachable warrants. The embedded conversion feature discount and the detachable warrants discount are amortized to interest expense over the life of the Notes. During the three and nine months ended September 30, 20172019 the Company recorded $107,000approximately $101,000 of amortization related to the debt discounts. The quarterly amortization of the debt discounts is approximately $160,000. As of September 30, 2017 the remaining balance of the unamortized debt discount is approximately $1,824,000
With respect to the aggregate offering, the Company paid $634,000 in issuance costs. The issuance costs are amortized to interest expense over the term of the Notes. During the three and nine months ended September 30, 2017 the Company recorded $36,000 amortization related to the issuance costs. The quarterly amortization of the issuance costs is approximately $53,000 and is recorded as interest expense. As of September 30, 2017 the remaining balance of the unamortized issuance cost is approximately $599,000.

In connection with the 2017 Private Placement, the Company also entered into the “Registration Rights Agreement” with the investors in the 2017 Private Placement. The Registration Rights Agreement requires that we file a registration statement (the “Registration Statement”) with the Securities and Exchange Commission within ninety (90) days of the final closing date of the Private Placement for the resale by the investors of all of the shares Common Stock underlying the senior convertible notes and warrants and all shares of Common Stock issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect thereto (the “Registrable Securities”) and that the Initial Registration Statement be declared effective by the SEC within 180 days of the final closing date of the 2017 Private Placement or if the registration statement is reviewed by the SEC 210 days after the final closing date or the 2017 Private Placement. Upon the occurrence of certain events (each an “Event”), the Company will be required to pay to the investors liquidated damages of 1.0% of their respective aggregate purchase price upon the date of the Event and then monthly thereafter until the Event is cured. In no event may the aggregate amount of liquidated damages payable to each of the investors exceed in the aggregate 10% of the aggregate purchase price paid by such investor for the Registrable Securities. The Registration Statement was declared effective on September 27, 2017.
-18-
 
Note 7.9. Derivative Liability
 
The Company recognizes and measures the warrants and the embedded conversion features issued in conjunction with our July 2017, November 2015, and July 2014 Private Placements in accordance with ASC Topic 815,Derivatives and Hedging. The accounting guidance sets forth a two-step model to be applied in determining whether a financial instrument is indexed to an entity’s own stock, which would qualify such financial instruments for a scope exception. This scope exception specifies that a contract that would otherwise meet the definition of a derivative financial instrument would not be considered as such if the contract is both (i) indexed to the entity’s own stock and (ii) classified in the stockholders’ equity section of the entity’s balance sheet. The Company determined that certain warrants and embedded conversion features issued in ourthe Company’s private placements are ineligible for equity classification due to anti-dilution provisions set forth therein.
 
Derivative liabilities are recorded at their estimated fair value (see Note 8,10, below) at the issuance date and are revalued at each subsequent reporting date. The Company will continue to revalue the derivative liability on each subsequent balance sheet date until the securities to which the derivative liabilities relate to are exercised or expire.
-36-
 
Various factors are considered in the pricing models the Company uses to value the derivative liabilities, including its current stock price, the remaining life, the volatility of its stock price, and the risk freerisk-free interest rate. Future changes in these factors may have a significant impact on the computed fair value of the liability. As such, the Company expects future changes in the fair values to continue and may vary significantly from period to period. The warrant and embedded liability and revaluations have not had a cash impact on our working capital, liquidity or business operations.
 
Warrants
 
In July and August of 2017,Effective January 1, 2019, the Company issued 1,149,712 three-year warrantsadopted ASU No. 2017-11 (see above,Recently Adopted Accounting Pronouncements).The new guidance requires companies to investors andexclude any down round feature when determining whether a freestanding equity-linked financial instrument (or embedded conversion option) is considered indexed to the placement agententity’s own stock when applying the classification guidance in the 2017 Private Placement. The exercise priceASC 815-40. Upon adoption of the new guidance, existing equity-linked financial instruments (or embedded conversion options) with down round features must be reassessed as liability classification may no longer be required. As a result, the Company determined in regard to its 2018 warrants is protected against down-round financing throughout the termappropriate treatment of these warrants that were initially classified as derivative liabilities should now be classified as equity instruments.
The Company determined that the liability associated with the 2018 warrants should be remeasured and adjusted to fair value on the date of the warrant. Pursuantchange in classification with the offset to ASC Topic 815,be recorded through earnings and then the fair value of the warrants should be reclassified to equity. The Company recorded the change in the fair value of approximately $2,334,000the 2018 warrants as of the date of change in classification on March 11, 2019 to earnings. The fair value of the 2018 warrants as of the date of change in classification, in the amount of $1,494,000 was recordedreclassified from warrant derivative liability to additional paid in capital as a derivative liability on the issuance dates.  The estimated fair valuesresult of the warrants were computed at issuance using a Monte Carlo option pricing model, withchange in classification of the following assumptions: stock price volatility 63.32%, risk-free rate 1.51%, annual dividend yield 0% and expected life 3.0 years.warrants.
 
Increases or decreases in the fair value of the derivative liability are included as a component of total other expense in the accompanying condensed consolidated statements of operations for the respective period. The changes to the derivative liability for warrants resulted in a decrease to the liability of approximately $1,519,000$401,000 and a decrease of $192,000 for the three months ended SeptemberJune 30, 2017 compared2019 and 2018, respectively. The changes to decreasethe derivative liability for warrants resulted in the liability of approximately $369,000 for the three months ended September 30, 2016. For the nine months ended September 30, 2017 the liability decreased by approximately $788,000 compared to a decrease of approximately $535,000$1,887,000 and a decrease of $904,000 for the ninesix months ended SeptemberJune 30, 2016.
2019 and 2018, respectively.
 
The estimated fair value of the outstanding warrant liabilities was $4,128,000is $4,969,000 and $3,345,000$9,216,000 as of SeptemberJune 30, 20172019 and December 31, 2016,2018, respectively. 
 
The Company did not revalue the warrants associated with the July 2017 Private Placement as of September 30, 2017 as the change in the fair value would be insignificant.
The estimated fair value of the warrants werewas computed as of SeptemberJune 30, 20172019 and as of December 31, 20162018 using Black-Scholes andthe Monte Carlo option pricing models, usingmodel with the following assumptions:
 
 
September 30,
2017
  
December 31,
2016
   
 June 30, 2019
(unaudited)
  December 31, 2018 
Stock price volatility 63.32% 60% - 65%  100.4%-106.8 83.78%-136.76% 
Risk-free interest rates 1.38%-1.51% 1.34%-1.70%  1.87%-2.18% 2.465%-2.577% 
Annual dividend yield 0% 0%  0 0% 
Expected life 1.7-3.0 years  2.6-3.9 years  0.08-1.29 years 0.58-2.76 
 
In addition, management assessed the probabilities of future financing assumptions in the valuation models.
  
 
-19--37-
 
 
Embedded Conversion Derivatives
Upon issuance of the 2017 Notes, the Company recorded a derivative for the embedded conversion option. The Company estimated the fair value of the embedded conversion option, as of the issuance date using a Monte Carlo simulation. The analysis utilized in calculating the embedded derivative upon issuance was calculated using the following assumptions:
Stock price
$4.63
Stock price volatility
63.32%
Risk-free interest rate
0.92%
The fair value estimate of the embedded conversion option is a Level 3 measurement. The roll-forward of the Level 3 fair value measurement, for the nine months ended September 30, 2017, is as follows (in thousands):
 
Balance at
Issuance
 
 
Net unrealized (gain)/loss
 
 
Balance at
September 30, 2017
 
 $330,000 
 $0.00 
 $330,000 
The Company did not revalue the embedded conversion liability associated with the July 2017 Private Placement as of September 30, 2017 as the change in the fair value would be insignificant.
Note 8.10.   Fair Value of Financial Instruments
 
Fair value measurements are performed in accordance with the guidance provided by ASC Topic 820, “Fair Value Measurements and Disclosures.” ASC Topic 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or parameters are not available, valuation models are applied.
 
ASC Topic 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities recorded at fair value in the financial statements are categorized based upon the hierarchy of levels of judgment associated with the inputs used to measure their fair value. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
  
Level 1 – Quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
 
Level 2 – Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
 
Level 3 – Unobservable inputs that are supportable by little or no market activity and that are significant to the fair value of the asset or liability.
 
The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, capital lease obligations and deferred revenue approximate their fair values based on their short-term nature. The carrying amount of the Company’s long termlong-term notes payable approximates its fair value based on interest rates available to the Company for similar debt instruments and similar remaining maturities.
 
The estimated fair value of the contingent consideration related to the Company's business combinations is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument.
   
In connection with the Company’s Private Placements, the Company issued warrants to purchase shares of its Common Stock and recorded embedded conversion features which are accounted for as derivative liabilities (see Note 7 above.) The estimated fair value of the derivatives is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument.
-20-
The following table details the fair value measurement within the fair value hierarchy of the Company’s financial instruments, which includes the Level 3 liabilities (in thousands):
 
 
Fair Value at September 30, 2017
 
 
 Fair Value at June 30, 2019
(unaudited)
 
 
Total
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Liabilities:
 
 
 
 
 
 
Contingent acquisition debt, current portion
 $422 
 $- 
 $422 
 $695 
 $- 
 $695 
Contingent acquisition debt, less current portion
  11,405 
  - 
  11,405 
  6,898 
  - 
  6,898 
Warrant derivative liability
  4,128 
  - 
  4,128 
  4,969 
  - 
  4,969 
Embedded conversion option derivative
  330 
    
  330 
Total liabilities
 $16,255 
 $- 
 $16,255 
 $12,562 
 $- 
 $12,562 
 
 
Fair Value at December 31, 2016
 
 
Fair Value at December 31, 2018
 
 
Total
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Liabilities:
 
 
 
 
 
 
Contingent acquisition debt, current portion
 $628 
 $- 
 $628 
 $795 
 $- 
 $795 
Contingent acquisition debt, less current portion
  7,373 
  - 
  7,373 
  7,466 
  - 
  7,466 
Warrant derivative liability
  3,345 
  - 
  3,345 
  9,216 
  - 
  9,216 
Total liabilities
 $11,346 
 $- 
 $11,346 
 $17,477 
 $- 
 $17,477 
-38-
The following table reflects the activity for the Company’s warrant derivative liability associated with the Company’s 2017, 2015 and 2014 Private Placements measured at fair value using Level 3 inputs (in thousands):
Warrant Derivative Liability
Balance at December 31, 2018
$9,216
Issuance
-
Adjustments to estimated fair value
(1,887)
Adjustments related to warrant exercises
(866)
Adjustments related to the reclassification of warrants to equity
(1,494)
Balance at June 30, 2019 (unaudited)
$4,969
The following table reflects the activity for the Company’s contingent acquisition liabilities measured at fair value using Level 3 inputs (in thousands):
Contingent Consideration
Balance at December 31, 2018
$8,261
Liabilities acquired
-
Liabilities settled
(235)
Adjustments to liabilities included in earnings
(433)
Adjustment to purchase price
-
Balance at June 30, 2019 (unaudited)
$7,593
 
The fair value of the contingent acquisition liabilities areis evaluated each reporting period using projected revenues, discount rates, and projected timing of revenues. Projected contingent payment amounts are discounted back to the current period using a discount rate. Projected revenues are based on the Company’s most recent internal operational budgets and long-range strategic plans. Increases in projected revenues will result in higher fair value measurements. Increases in discount rates and the time to payment will result in lower fair value measurements. Increases (decreases) in any of those inputs in isolation may result in a significantly lower (higher) fair value measurement. During the three and ninesix months ended SeptemberJune 30, 20172018, the net adjustment to the fair value of the contingent acquisition debt was a decrease of $340,000$1,246,000 and $1,020,000,$1,459,000, respectively. During the three and ninesix months ended SeptemberJune 30, 20162019, the net adjustment to the fair value of the contingent acquisition debt was a decrease of $315,000$433,000 and a decreaseis included in the Company’s statements of $1,185,000, respectively.operations in general and administrative expense.
 
Note 9.11.  Stockholders’ Equity
 
The Company’s ArticlesCertificate of Incorporation, as amended, authorizeauthorizes the issuance of two classes of stock to be designateddesignated: “Common Stock” and “Preferred Stock”.
 
Common Stock
On May 31, 2017, the Board of Directors of the Company authorized a reverse stock split in order to meet certain criteria in preparation for the Company’s uplisting on the NASDAQ Capital Market.
On June 5, 2017, the Company filed a certificate of amendment to the Company’s Articles of Incorporation with the Secretary of State of the State of Delaware to effect a one-for-twenty reverse stock split of the Company’s issued and outstanding common stock. As a result of the Reverse Split, every twenty shares of the Company issued and outstanding common stock were automatically combined and reclassified into one share of the Company’s common stock. The Reverse Split affected all issued and outstanding shares of common stock, as well as common stock underlying stock options, warrants outstanding, including common stock equivalents issuable under convertible notes and preferred shares. No fractional shares were issued in connection with the Reverse Split. Stockholders who would otherwise hold a fractional share of common stock will receive cash payment for the fractional share.
-21-
The Reverse Split became effective on June 7, 2017. All disclosures of shares and per share data in these condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the Reverse Split for all periods presented.
The total number of authorized shares of common stock was reduced from 600,000,000 to 50,000,000.The total number of shares of stock which the Company has authority to issue is 50,000,000 shares of common stock, par value $.001$0.001 per share and 5,000,000 shares of preferred stock, par value $.001$0.001 per share, of which 161,135 shares have been designated as Series A convertible preferred stock, par value $.001$0.001 per share (“Series A Convertible Preferred”), 1,052,631 has been designated as Series B convertible preferred stock (“Series B Convertible Preferred”), and 700,000 has been designated as Series C convertible preferred stock (“Series C Convertible Preferred”).
Common Stock
 
As of SeptemberJune 30, 2017,2019 and December 31, 20162018 there were 19,723,28529,316,445 and 19,634,34525,760,708 shares of Common Stockcommon stock outstanding, respectively. The holders of the Common Stockcommon stock are entitled to one vote for each share held at all meetings of stockholders (and written actions in lieu of meetings).  
 
-39-
Stock Offering
On February 7, 2019, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with one accredited investor that had a substantial pre-existing relationship with the Company pursuant to which the Company sold 250,000 shares of common stock, par value $0.001 per share, at an offering price of $7.00 per share. Pursuant to the Purchase Agreement, the Company also issued to the investor a three-year warrant to purchase 250,000 shares of common stock at an exercise price of $7.00. The proceeds were $1,750,000. Consulting fees to the Placement Agent for arranging the Purchase Agreement include the issuance of 5,000 shares of restricted shares of the Company’s common stock, par value $0.001 per share, and 100,000 three-year warrants expiring in February 2022 priced at $10.00. The Company used the Black-Scholes option-pricing model to estimate the fair value of the warrants issued to the selling agent to be $324,000 at the time of issuance as direct issuance costs and recorded in equity. No cash commissions were paid.
On June 17, 2019, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with one accredited investor that had a substantial pre-existing relationship with the Company pursuant to which the Company sold 250,000 shares of common stock, par value $0.001 per share, at an offering price of $5.50 per share. The proceeds were $1,375,000. The Company did not pay consulting fees in this transaction.
Between February 15, 2019 and May 23, 2019, the Company closed its fourth tranche of its 2019 January Private Placement debt offering, pursuant to which the Company offered for up to a maximum of $10,000,000 in principal amount of notes (the “2019 PIPE Notes”), with each investor receiving in addition to a 2019 PIPE Notes, 2,000 shares of common stock for each $100,000 invested. The Company entered into subscription agreements with thirty (30) accredited investors that had a substantial pre-existing relationship with the Company pursuant to which the Company received aggregate gross proceeds of $2,890,000 and issued 2019 PIPE Notes in the aggregate principal amount of $2,890,000 and an aggregate of 57,800 shares of common stock. The placement agent received 14,450 shares of common stock for the closed tranches and can receive up to 50,000 shares of common stock in the offering. Each 2019 PIPE Note matures 24 months after issuance, bears interest at a rate of six percent (6%) per annum, and the outstanding principal is convertible into shares of common stock at any time after the 180th day anniversary of the issuance of the 2019 PIPE Note, at a conversion price of $10 per share (subject to adjustment for stock splits, stock dividends and reclassification of the common stock).
On March 18, 2019, the Company issued 8% Notes to two accredited investors that the Company had a substantial pre-existing relationship with and from whom the Company raised cash proceeds in the aggregate of $2,000,000. In addition to the 8% Notes, the Company issued 20,000 shares of common stock par value $0.001 for each $1,000,000 invested as well as for each $1,000,000 invested five-year warrants to purchase 20,000 shares of common stock at a price per share of $6.00. The 8% Notes pay interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due at maturity on March 18, 2021. The Company issued an aggregate of 40,000 shares of common stock and warrants to purchase an aggregate of 40,000 shares of common stock with the 8% Notes in the principal amount of $2,000,000.
Issuance of additional common shares and repricing of warrants related to 2018 Private Placement
On March 13, 2019, the Company determined that three of the investors of the Company’s August 2018 Private Placement became eligible to receive additional shares of the Company’s common stock as it was referred to in their respective Purchase Agreement as True-up Shares. Total number of additional shares issued to those three investors was 44,599 shares of the Company’s common stock, par value $0.001. In addition, the exercise price of the warrants issued at their respective closings is reset pursuant to the terms of the warrants to exercise prices ranging from $4.06 to $4.44 from the exercise price at issuance of $4.75.
Convertible Preferred Stock
Series A Convertible Preferred Stock
 
The Company hadhas 161,135 shares of Series A Convertible Preferred Stock outstanding as of SeptemberJune 30, 20172019, and December 31, 2016,2018 and accrued dividends of approximately $121,000$143,000 and $112,000,$137,000, respectively. The holders of the Series A Convertible Preferred Stock are entitled to receive a cumulative dividend at a rate of 8.0% per year, payable annually either in cash or shares of the Company's Common Stockcommon stock at the Company's election.  Shares of Common Stock paid as accrued dividends are valued at $10.00 per share. Each share of Series A Convertible Preferred is convertible into two sharescommon stock at a conversion rate of the Company's Common Stock.0.10. The holders of Series A Convertible Preferred are entitled to receive payments upon liquidation, dissolution or winding up of the Company before any amount is paid to the holders of Common Stock.common stock. The holders of Series A Convertible Preferred have no voting rights, except as required by law.  
 
Repurchase of Common
-40-
Series B Convertible Preferred Stock
 
On December 11, 2012,March 30, 2018, the Company authorizedcompleted the Series B Offering, pursuant to which the Company sold 381,173 shares of Series B Convertible Preferred Stock at an offering price of $9.50 per share and received gross proceeds in aggregate of approximately $3,621,000. The net proceeds to the Company from the Series B Offering were approximately $3,289,000 after deducting commissions, closing and issuance costs. Each share of Series B Convertible Preferred Stock is initially convertible at any time, in whole or in part, at the option of the holders, at an initial conversion price of $4.75 per share, into two (2) shares of common stock and automatically converts into two (2) shares of common stock on its two-year anniversary of issuance. Holders of the Series B Convertible Preferred Stock have no voting rights, except as required by law.
The Company has 129,437 shares of Series B Convertible Preferred Stock outstanding as of June 30, 2019 and December 31, 2018. The holders of the Series B Convertible Preferred Stock are entitled to receive cumulative dividends on the Series B Convertible Preferred Stock from the date of original issue at a rate of 5.0% per annum payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning June 30, 2018. As of June 30, 2019 and December 31, 2018 accrued dividends were approximately $24,000 and $11,000, respectively.
Series C Preferred Stock
Between August 17, 2018 and October 4, 2018, the Company closed three tranches of its Series C Offering, pursuant to which the Company sold 697,363 shares of Series C Convertible Preferred Stock at an offering price of $9.50 per share repurchase programand agreed to repurchaseissue two-year warrants (the “Preferred Warrants”) to purchase up to 750,0001,394,726 shares of the Company's issued and outstandingCompany’s common stock at an exercise price of $4.75 per share to Series C Preferred holders that voluntarily convert their shares of CommonSeries C Preferred Stock to the Company’s common stock within two-years from the issuance date. Each share of Series C Convertible Preferred Stock was initially convertible at any time, in whole or in part, at the option of the holders, at an initial conversion price of $4.75 per share, into two (2) shares of common stock and was automatically convertible into two (2) shares of common stock on its two-year anniversary of issuance.
The Company issued the placement agent in connection with the Series C Offering 116,867 warrants as compensation, exercisable at $4.75 per share and expire in December 2020. The Company determined that the warrants should be classified as equity instruments and used Black-Scholes to estimate the fair value of the warrants issued to the placement agent of $458,000 as of the issuance date December 19, 2018.
The Company received aggregate gross proceeds totaling approximately $6,625,000. The net proceeds to the Company from the Series C Offering were approximately $6,236,000 after deducting commissions, closing and issuance costs.
Upon liquidation, dissolution or winding up of the Company, each holder of Series C Preferred Stock was entitled to receive a distribution, to be paid in an amount equal to $9.50 for each and every share of Series C Preferred Stock held by the holders of Series C Preferred Stock, plus all accrued and unpaid dividends in preference to any distribution or payments made or any asset distributed to the holders of common stock, the Series A Preferred Stock, the Series B Preferred Stock or any other class or series of stock ranking junior to the Series C Preferred Stock.
The shares of Series C Convertible Preferred Stock issued in the Series C Offering were sold pursuant to the Company’s Registration Statement, which was declared effective with the SEC on December 10, 2018.
Pursuant to the Certificate of Designation, the Company agreed to pay cumulative dividends on the Series C Convertible Preferred Stock from time to timethe date of original issue at a rate of 6.0% per annum payable quarterly in arrears on or about the open market or via private transactions through block trades.  Alast day of March, June, September and December of each year, beginning September 30, 2018. In 2018 a total of 196,594 shares have been repurchased to-dateapproximately $51,000 of dividends was paid to the holders of the Series C Convertible Preferred Stock. The Series C Convertible Preferred Stock ranked senior to the Company’s outstanding Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and the common stock with respect to dividend rights and rights upon liquidation, dissolution or winding up. Holders of the Series C Convertible Preferred Stock had no voting rights.
The contingent obligation to issue warrants is considered an outstanding equity-linked financial instrument and was therefore recognized as equity classified warrants, initially measured at relative fair value of September 30, 2017approximately $3,727,000, resulting in an initial discount to the carrying value of the Series C Preferred Stock.
-41-
Due to the reduction of allocated proceeds to the contingently issuable common stock warrants and Series C Preferred Stock, the effective conversion price of the Series C Preferred Stock was less than the Company’s common stock price on each commitment date, resulting in an aggregate beneficial conversion feature of approximately $3,276,000, which reduced the carrying value of the Series C Preferred Stock. Since the conversion option of the Series C Preferred Stock was immediately exercisable, the beneficial conversion feature was immediately accreted as a deemed dividend, resulting in an increase in the carrying value of the C Preferred Stock of approximately $3,276,000.
The Series C Preferred Stock was automatically redeemable at a weighted-average costprice equal to its original purchase price plus all accrued but unpaid dividends in the event the average of $5.30. Therethe daily volume weighted average price of the Company’s common stock for the 30 days preceding the two-year anniversary date of issuance is less than $6.00 per share.  As redemption was outside of the Company’s control, the Series C Preferred Stock was classified in temporary equity at issuance. All of the Series C Preferred shares were converted to common stock during 2018 and the Company has issued 1,394,726 warrants. As of June 30, 2019 and December 31, 2018, no repurchases during the nine months ended September 30, 2017. The remaining numbershares of shares authorized for repurchase under the plan as of September 30, 2017 is 553,406.Series C Convertible Preferred Stock remain outstanding.
 
Advisory Agreements
 
The Company records the fair value of common stock and warrants issued in conjunction with investor relations advisory service agreements based on the closing stock price of the Company’s common stock on the measurement date. The fair value of the stock issued is recorded through equity and prepaid advisory fees and amortized over the life of the service agreement.
ProActive CapitalResources Group, LLC.LLC
On September 1, 2015, the Company entered into an agreement with ProActive Capital Resources Group, LLC (“PCG”), pursuant to which PCG agreed to provide investor relations services for six (6) months in exchange for fees paid in cash of $6,000 per month and 5,000 shares of restricted common stock to be issued upon successfully meeting certain criteria in accordance with the agreement. Subsequent to the September 1, 2015 thisinitial agreement, has beenthe agreement was extended through August 2018 under six-month incremental service agreements under the same terms with the monthly cash payment remaining atpayments of $6,000 per month and 5,000 shares of restricted common stock for every six (6) months of service performed.
The stock issuance expense associated with the amortization of advisory fees is recorded as stock issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations for the six months ended June 30, 2018 is approximately $13,000. The Company did not further extend this agreement subsequent to August 2018.
Ignition Capital, LLC
 
On April 1, 2018, the Company entered into an agreement with AsIgnition Capital, LLC (“Ignition”), pursuant to which Ignition agreed to provide investor relations services for a period of September 30, 2017, the Company has issued 15,000twenty-one (21) months in exchange for 50,000 shares of restricted common stock in connection with this agreement and accrued forwhich were issued in advance of the estimated per share value on each subsequent six (6) month periods based on the price of Company’s common stock at each respective date. As of September 30, 2017, the Company has accrued for 10,000 shares of restricted stock that have been earned and not issued.service period. The fair value of the shares to be issued areis recorded as prepaid advisory fees and areis included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets and is amortized on a pro-rata basis over the term of the respective periods.agreement. During the three months ended SeptemberJune 30, 20172019 and 2016,2018 the Company recorded expense of approximately $14,000$30,000 and $15,000, respectively and $42,000 and $46,000, during$30,000, respectively. During the ninesix months ended SeptemberJune 30, 20172019 and 2016,2018, the Company recorded expense of approximately $60,000 and $30,000, respectively, in connection with amortization of the stock issuance. The stock issuance expense associated with the amortization of advisory fees is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
-42-
Greentree Financial Group, Inc.
On March 27, 2018, the Company entered into an agreement with Greentree Financial Group, Inc. (“Greentree”), pursuant to which Greentree agreed to provide investor relations services for a period of twenty-one (21) months in exchange for 75,000 shares of restricted common stock which were issued in advance of the service period. The fair value of the shares issued is approximately $311,000 and is recorded as prepaid advisory fees and is included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets and is amortized on a pro-rata basis over the term of the agreement. During the three months ended June 30, 2019 and 2018 the Company recorded expense of approximately $45,000 and $44,000, respectively. During the six months ended June 30, 2019 and 2018, the Company recorded expense of approximately $89,000 and $44,000, respectively in connection with amortization of the stock issuance. The stock issuance expense associated with the amortization of advisory fees is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
Capital Market Solutions, LLC.
On July 1, 2018, the Company entered into an agreement with Capital Market Solutions, LLC. (“Capital Market”), pursuant to which Capital Market agreed to provide investor relations services for a period of 18 months in exchange for 100,000 shares of restricted common stock which were issued in advance of the service period. In addition, the Company agreed to pay in cash a base fee of $300,000, payable as follows; $50,000 paid in August 2018, and the remaining balance shall be paid monthly in the amount of $25,000 through January 1, 2019. Subsequent to the initial agreement, the Company extended the term for an additional 24 months through December 31, 2021 and agreed to issue Capital Market an additional 100,000 shares of restricted common stock which were issued in advance of the service period and $125,000 of additional fees.
On January 9, 2019, the Company executed the second amendment to the agreement with Capital Market, pursuant to which, the aggregate base fee increased to $525,000, and the Company issued an additional 75,000 of restricted common stock. In addition, the Company issued to Capital Market a four-year warrant to purchase 925,000 shares of the Company’s common stock at $6.00 per share vesting 50% at issuance on January 9, 2019 and 25% on January 9, 2020 and 25% on January 9, 2021. The fair value of the vested portion of the warrant was approximately $1,927,000 and was recorded as equity on the Company’s balance sheet as of June 30, 2019. During the three and six months ended June 30, 2019, the Company recorded expense of approximately $270,000 and $1,927,000, respectively, in connection with amortization of equity issuance expense related to the vesting of the warrant. The equity issuance expense associated with the amortization of advisory fees is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
The fair value of the common stock shares issued is recorded as prepaid advisory fees and is included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets and is amortized on a pro-rata basis over the term of the agreement. During the three and six months ended June 30, 2019, the Company recorded expense of approximately $129,000 and $257,000, respectively, in connection with amortization of the stock issuance expense. The stock issuance expense associated with the amortization of advisory fees is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
During the three and six months ended June 30, 2019, the Company recorded expense of approximately $50,000 in connection with the base fee. The cash fee paid for advisory services is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
I-Bankers Securities Incorporated
On April 5, 2019, the Company entered into an agreement with I-Bankers Securities Incorporated (“I-Bankers”), pursuant to which I-Bankers agreed to provide financial advisory services for a period of 12 months in exchange for 100,000 shares of restricted common stock which were issued in advance of the service period. In addition, the Company agreed to pay in cash a base fee for debt arrangements and equity offerings in conjunction with any transactions I-Bankers closes with the Company in accordance with the agreement. During the three and six months ended June 30, 2019, the Company recorded expense of approximately $143,000, in connection with amortization of the stock issuance expense. The stock issuance expense associated with the amortization of advisory fees is recorded as equity issuance expense and is included in general and administrative expense on the Company’s condensed consolidated statements of operations.
-43-
 
Warrants
 
As of SeptemberJune 30, 2017,2019, warrants to purchase 2,710,0666,903,874 shares of the Company's common stock at prices ranging from $2.00 to $10.00 were outstanding. AllAs of June 30, 2019, 6,556,999 warrants are exercisable as of September 30, 2017 and expire at various dates through November 2020March 2024 and have a weighted average remaining term of approximately 2.372.23 years and are included in the table below as of SeptemberJune 30, 2017.
Warrants – Private Placement
During the three months ended September 30, 2017, the Company issued warrants through a Private Placement, to purchase 1,149,712 shares of its common stock, exercisable at $5.56 per share, respectively, and expire between July 2020 and August 2020. (See Note 6, above.)
-22-
Warrants – Other Issuance
In May 2017, the Company entered a settlement agreement with Alain Piedra Hernandez, one of the owners of H&H and the operating manager of Siles, who was issued a non-qualified stock option for the purchase of 75,000 shares of the Company’s Common Stock at a price of $2.00 with an expiration date of three years, in lieu of an obligation due from the Company to H&H as relates to a Sourcing and Supply Agreement with H&H. During the three months ended September 30, 2017 the Company cancelled the non-qualified stock option and issued a warrant agreement with the same terms. The fair value of the warrant was $232,000 and was recorded in general and administrative in the condensed consolidated statements of operations.
There was no financial impact change in the valuation related to the cancellation of the option and the issuance of the warrant. As of September 30, 2017 the warrant remains outstanding.
During the nine months ended September 30, 2017, the Company issued a warrant as compensation to an associated Youngevity distributor to purchase 37,500 shares of the Company’s Common Stock at a price of $4.66 with an expiration date of three years. The warrant was exercised on a cashless basis and 21,875 shares of common stock were issued during the three months ended September 30, 2017. The fair value of the warrant was $109,000 and was recorded in distributor compensation in the condensed consolidated statements of operations.
2019.
 
The Company uses the Black-Scholesa combination of option-pricing model (“Black-Scholes model”)models to estimate the fair value of the warrants. warrants including the Monte Carlo, Lattice and Black-Scholes.
 
A summary of the warrant activity for the ninesix months ended SeptemberJune 30, 20172019 is presented in the following table:
 
Number of
Warrants
Balance at December 31, 20162018
  1,899,3855,876,980 
    Issued
  1,262,2121,315,000 
    Expired / cancelled
  (414,031-)
    Exercised
  (37,500288,106)
Balance at SeptemberJune 30, 20172019, outstanding
  2,710,0666,903,874
Balance at June 30, 2019, exercisable
6,556,999 
 
Stock Options
 
On May 16, 2012, the Company established the 2012 Stock Option Plan (“Plan”) authorizing the granting of options for up to 2,000,000 shares of Common Stock. On February 23, 2017, the Company’s board of directors received the approval of our stockholders, to amend the 2012 Stock Option Plan (“Plan”) to increase the number of9,000,000 shares of common stock available for grant and to expand the types of awards available for grant under the Plan. The amendment of the Plan increased the number of authorized shares of the Company’s common stock that may be delivered pursuant to awards granted during the life of the plan from 2,000,000 to 4,000,000 shares.stock.
 
The purpose of the Plan is to promote the long-term growth and profitability of the Company by (i) providing key people and consultants with incentives to improve stockholder value and to contribute to the growth and financial success of the Company and (ii) enabling the Company to attract, retain and reward the best available persons for positions of substantial responsibility. The Plan allows for the grant of: (a) incentive stock options; (b) nonqualified stock options; (c) stock appreciation rights; (d) restricted stock; and (e) other stock-based and cash-based awards to eligible individuals qualifying under Section 422 of the Internal Revenue Code, in any combination (collectively, “Options”). At SeptemberJune 30, 2017,2019, the Company had 1,874,380 3,732,820 shares of Common Stockcommon stock available for issuance under the Plan. 
 
A summary of the Plan stock option activity for the ninesix months ended SeptemberJune 30, 20172019 is presented in the following table: 
 
 
Number of
Shares
 
 
Weighted
Average
Exercise Price
 
 
Aggregate
Intrinsic Value 
(in thousands)
 
 
Number of
Shares
 
 
Weighted
Average
Exercise Price
 
 
Weighted
Average
Remaining Contract Life (years)
 
 
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding December 31, 2016
  1,660,964 
 $4.74 
 $1,346 
Outstanding December 31, 2018
  2,394,379 
 $4.45 
  6.94 
 $3,049 
Issued
 21,624
 4.53
    
  2,540,062 
  6.66 
    
Canceled / expired
  (79,711)
  4.35 
    
  (133,085)
  4.75 
    
Exercised
  (6,885)
  4.28 
  - 
  (85,054)
  4.36 
    
  - 
Outstanding September 30, 2017
  1,595,932 
 $4.76 
 $503 
Exercisable September 30, 2017
  878,657 
 $4.55 
 $339 
Outstanding June 30, 2019
  4,716,302 
 $5.63 
  8.13 
 $2,907 
Exercisable June 30, 2019
  3,719,801 
 $5.96 
  8.03 
 $1,642 
 
-23-
The weighted-average fair value per share of the granted options for the ninesix months ended SeptemberJune 30, 2017 and 20162019 was approximately $3.05 and $1.80, respectively.
$4.26.
 
Stock based
-44-
Stock-based compensation expense included in the condensed consolidated statements of operations was a credit of $46,000$393,000 and $166,000$123,000 for the three months ended SeptemberJune 30, 20172019 and 2016,2018, respectively, and $440,000$11,642,000 and $292,000$245,000 for the ninesix months ended SeptemberJune 30, 20172019 and 2016,2018, respectively.
 
As of SeptemberJune 30, 2017,2019, there was approximately $1,702,000 $1,543,000 of total unrecognized compensation expense related to unvested stock options granted under the Plan. The expense is expected to be recognized over a weighted-average period of 3.68 1.44 years.
 
The Company uses the Black-Scholes option-pricing model (“Black-Scholes model”) to estimate the fair value of stock options. The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the historical volatility of the Company’s stock price over the expected term of the option. The expected life is based on the contractual life of the option and expected employee exercise and post-vesting employment termination behavior. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of the grant. 
 
Restricted Stock Units
 
On August 9, 2017, the Company issued restricted stock units for an aggregate of 500,000 shares of common stock, to its employees board members and consultants. These shares of common stock will be issued upon vesting of the restricted stock units. Vestingunit (“RSU’s”). Full vesting occurs on the sixth yearsixth-year anniversary of the grant date, over a six-year period, with 10% vesting on the third-year, 15% on the fourth-year, 50% on the fifth-year and 25% on the sixth-year anniversary of the vesting commencement date. As of June 30, 2019, none of the RSU’s have vested. There were no grants during the six months ended June 30, 2019 and 2018.
The Company adopted ASU 2018-07 on January 1, 2019 and the stock-based compensation expense for non-employee grants is based on the closing price of our common stock of $5.72 on December 31, 2018, which was the last business day before we adopted ASU 2018-07. See Note 1 above,
Recently Adopted Accounting Pronouncementsfor further discussion of the Company’s adoption of ASU 2018-07.
 
The fair value of each restricted stock unitRSU’s issued to employees is based on the closing stock price on the grant date of $4.53 and is recognized as stock basedstock-based compensation expense over the vesting term of the award. Restricted stock based
Number of
Shares
Balance at December 31, 2018
475,000
    Issued
-
    Canceled
(50,000)
Balance at June 30, 2019
425,000
Stock-based compensation expense related to the RSU’s included in the condensed consolidated statements of operations was $32,000$20,000 and $92,000 for the three and nine months ended SeptemberJune 30, 2017.2019 and 2018, respectively, and $115,000 and $207,000 for the six months ended June 30, 2019 and 2018, respectively.
 
As of SeptemberJune 30, 2017,2019, total unrecognized stock-based compensation expense related to restricted stock units to employees and consultants was approximately $1,309,000$1,383,000, which will be recognized over a weighted average period of 5.864.11 years.
 
-45-
Note 10.12.  Segment and Geographical Information
 
The Company is a leading omni-directmulti-channel lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Streetmain street of products and services under one corporate entity, Youngevity offers products from top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The Company operates in twothree segments: the direct selling segment where products are offered through a global distribution network of preferred customers and distributors, and the commercial coffee segment where roasted and green coffee bean products are sold directly to businesses.businesses, and commercial hemp segment provides end to end extraction and processing via the Company’s proprietary systems that allow for the conversion of hemp feed stock into hemp oil and hemp extracts.  The primary focus of the segment will be to generate revenue through sales of extraction services and end to end processing services for the conversion of Hemp and Hemp oil into sellable ingredients.  Additionally, the Company offers various rental, sales, and service programs of the company's extraction and processing systems.
 
The Company’s segments reflect the manner in which the business is managed and how the Company allocates resources and assesses performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company’s chief operating decision maker evaluates segment performance primarily based on revenue and segment operating income. The principal measures and factors the Company considered in determining the number of reportable segments were revenue, gross margin percentage, sales channel, customer type and competitive risks. In addition, each reporting segment has similar products and customers, similar methods of marketing and distribution and a similar regulatory environment.
-24-
 
The accounting policies of the segments are consistent with those described in the summary of significant accounting policies. Segment revenue excludes intercompany revenue eliminated in the consolidation. The following tables present certain financial information for each segment (in thousands):
 
 
Three months ended
 
 
Nine months ended
 
 
Three months ended
 
 
Six months ended
 
 
September 30,
 
 
June 30,
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
Revenues
 
 
 
 
(Restated)*
 
 
 
 
 
(Restated)*
 
 
 
 
Direct selling
 $37,954 
 $38,576 
 $106,734 
 $110,393 
 $32,124 
 $36,846 
 $65,544 
 $72,157 
Commercial coffee
  6,441 
  4,986 
  17,921 
  13,871 
  5,819 
  7,409 
  13,524 
  15,092 
Commercial hemp
  274 
  - 
  341 
  - 
Total revenues
 $44,395 
 $43,562 
 $124,655 
 $124,264 
 $38,217 
 $44,255 
 $79,409 
 $87,249 
Gross profit
    
Gross profit (loss)
    
Direct selling
 $25,472 
 $26,233 
 $71,522 
 $74,690 
 $22,240 
 $25,087 
 $44,995 
 $49,822 
Commercial coffee
  292 
  135 
  210 
  472 
  3,489 
  295 
  7,556 
  572 
Commercial hemp
  (49)
  - 
  (22)
  - 
Total gross profit
 $25,764 
 $26,368 
 $71,732 
 $75,162 
 $25,680 
 $25,382 
 $52,529 
 $50,394 
Operating income (loss)
    
    
Direct selling
 $(1,233)
 $1,171 
 $(2,392)
 $4,903 
 $(785)
 $1,376 
 $(13,093)
 $2,157 
Commercial coffee
  (584)
  (595)
  (2,501)
  (1,640)
  1,842 
  (723)
  2,726 
  (1,480)
Total operating income
 $(1,817)
 $576 
 $(4,893)
 $3,263 
Net (loss) income
    
Commercial hemp
  (911)
  - 
  (1,428)
  - 
Total operating income (loss)
 $146 
 $653 
 $(11,795)
 $677 
Net income (loss)
    
Direct selling
 $(1,311)
 $822 
 $(2,958)
 $1,912 
 $(1,250)
 $723 
 $(14,627)
 $132 
Commercial coffee
  243 
  (755)
  (2,899)
  (1,803)
  1,906 
  (1,337)
  3,539 
  (3,054)
Total net (loss) income
 $(1,068)
 $67 
 $(5,857)
 $109 
Commercial hemp
  (945)
  - 
  (1,461)
  - 
Total net loss
 $(289)
 $(614)
 $(12,549)
 $(2,922)
Capital expenditures
    
    
Direct selling
 $223 
 $590 
 $697 
 $1,339 
 $63 
 $28 
 $80 
 $115 
Commercial coffee
  110 
  145 
  391 
  863 
  843 
  51 
  3,415 
  730 
Commercial hemp
  99 
  - 
  1,482 
  - 
Total capital expenditures
 $333 
 $735 
 $1,088 
 $2,202 
 $1,005 
 $79 
 $4,977 
 $845 
Capital expenditures acquired through acquisitions
    
Direct selling
 $- 
Commercial coffee
  - 
Commercial hemp
  - 
  1,133 
  - 
Total capital expenditures acquired through acquisitions
 $- 
 $1,133 
 $- 
 
 
 
As of
 
 
 
September 30, 2017
 
 
December 31, 2016
 
Total assets
 
 
 
 
 
 
   Direct selling
 $47,020 
 $40,127 
   Commercial coffee
  26,977 
  25,881 
      Total assets
 $73,997 
 $66,008 
-46-
 
 
As of
 
 
 
June 30,
2019
(unaudited)
 
 
December 31,
2018
 
Total assets
 
(Restated)*
 
 
 
 
   Direct selling
 $40,315 
 $38,947 
   Commercial coffee
  48,552 
  37,026 
   Commercial hemp
  22,447 
  - 
      Total assets
 111,314 
 $75,973 
  * Segment results and total assets as of and for the three and six months ended June 30, 2019 has been restated. See Note 2.
 
Total tangible assets, net located outside the United States were approximately $5.3$8.0 million and $5.4$6.2 million as of SeptemberJune 30, 20172019 and December 31, 2016,2018, respectively.
 
The Company conducts its operations primarily in the United States. For the three months ended SeptemberJune 30, 20172019 and 20162018 approximately 12%15% and 9%14%, respectively of the Company’s sales were derived from sales outside the United States. For both the ninesix months ended SeptemberJune 30, 20172019 and 20162018 approximately 11% and 9%14%, respectively, of the Company’s sales were derived from sales outside the United States.
 
The following table displays revenues attributable to the geographic location of the customer (in thousands):
 
 
Three months ended
 
 
Nine months ended
 
 
Three months ended
 
 
Six months ended
 
 
September 30,
 
 
June 30,
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
Revenues
 
 
 
 
(Restated)*
 
 
 
 
 
(Restated)*
 
 
 
 
United States
 $39,013 
 $39,630 
 $111,524 
 $113,332 
 $32,635 
 $37,980 
 $68,417 
 $75,373 
International
  5,382 
  3,932 
  13,131 
  10,932 
  5,582 
  6,275 
  10,992 
  11,876 
Total revenues
 $44,395 
 $43,562 
 $124,655 
 $124,264 
 $38,217 
 $44,255 
 $79,409 
 $87,249 
 
* Revenue for the three and six months ended June 30, 2019 has been restated. See Note 11.  Subsequent Events2.
 
Note 13.  Subsequent Events
None.
 
 
-25--47-
 
 
ITEM 2. MANAGEMENT’SMANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Restatement of previously reported unaudited condensed consolidated financial statements
This “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” has been amended and restated to give effect to the restatement of our unaudited condensed consolidated financial statements as more fully described in “Note 2. Restatement of previously reported unaudited condensed consolidated financial statements” in “Item 1. Financial Statements.”
 
FORWARD LOOKING STATEMENTS
 
This quarterly report on Form 10-Q contains forward-looking statements. The words “expects,” “anticipates,” “believes,” “intends,” “plans” and similar expressions identify forward-looking statements. In addition, any statements which refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. We undertake no obligation to publicly disclose any revisions to these forward-looking statements to reflect events or circumstances occurring subsequent to filing this Form 10-Q with the Securities and Exchange Commission. These forward-looking statements are subject to risks and uncertainties, including, without limitation, those risks and uncertainties discussed in Part I, Item 1A, “Risk Factors” and in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K/A10-K filed with the Securities and Exchange Commission on August 14, 2017April 15, 2019 and herein and as reported under Part II Other Information, Item 1A. Risk Factors. In addition, new risks emerge from time to time and it is not possible for management to predict all such risk factors or to assess the impact of such risk factors on our business. Accordingly, our future results may differ materially from historical results or from those discussed or implied by these forward-looking statements. Given these risks and uncertainties, the reader should not place undue reliance on these forward-looking statements.
 
In the following text, the terms “we,” “our,” and “us” may refer, as the context requires, to Youngevity International, Inc. or collectively to Youngevity International, Inc. and its subsidiaries.
Overview
 
We operate in twothree segments: (i) the direct selling segment where products are offered through a global distribution network of preferred customers and distributors, and(ii) the commercial coffee segment where products are sold directly to businesses.businesses, processed green coffee beans are processed and milling services are provided for unprocessed green coffee beans, and (iii) the commercial hemp segment provides end to end extraction and processing via our proprietary systems that allow for the conversion of hemp feed stock into hemp oil and hemp extracts.
 
Segment revenue as a percentage of total revenue is as follows (in thousands):
Domestic direct selling network is operated through the following (i) domestic subsidiaries: AL Global Corporation, 2400 Boswell LLC, MK Collaborative LLC, and Youngevity Global LLC and (ii) foreign subsidiaries: Youngevity Australia Pty. Ltd., Youngevity NZ, Ltd., Youngevity Mexico S.A. de CV, Youngevity Israel, Ltd., Youngevity Russia, LLC, Youngevity Colombia S.A.S, Youngevity International Singapore Pte. Ltd., Mialisia Canada, Inc. and Legacy for Life Limited (Hong Kong). We also operate through the BellaVita Group LLC, with operations in Taiwan, Hong Kong, Singapore, Indonesia, Malaysia and Japan. We also operate subsidiary branches of Youngevity Global LLC in the Philippines and Taiwan.
 
 
 
Three months ended
 
 
Nine months ended
 
 
 
September 30,
 
 
September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
    Direct selling
 $37,954 
 $38,576 
 $106,734 
 $110,393 
As a % of Revenue
  85%
  89%
  86%
  89%
    Commercial coffee
  6,441 
  4,986 
  17,921 
  13,871 
As a % of Revenue
  15%
  11%
  14%
  11%
        Total revenues
 $44,395 
 $43,562 
 $124,655 
 $124,264 
Commercial coffee business is operated through CLR and its wholly owned subsidiary, Siles Plantation Family Group S.A. (“Siles”).
 
Commercial hemp business is operated through our wholly owned subsidiary, Khrysos Industries, Inc., a Delaware corporation. Khrysos Industries, Inc. (“KII”) acquired the assets of Khrysos Global Inc. a Florida corporation in February 2019 and the wholly-owned subsidiaries of Khrysos Global Inc., INXL Laboratories, Inc., a Florida corporation and INX Holdings, Inc., a Florida corporation.
We conduct our operations primarily in the United States. For both the three months ended June 30, 2019 and 2018 approximately 15% of our sales were derived from sales outside the United States. For both the six months ended June 30, 2019 and 2018 approximately 14%, respectively, of our sales were derived from sales outside the United States.
-48-
Direct Selling Segment
 
In the direct selling segment, we sell health and wellness products on a global basis and offer a wide range of products through an international direct selling network of independent distributors. Our multiple independent selling forces sell a variety of products through friend-to-friend marketing and social networking.  In the direct selling segment, we sell health and wellness, beauty product and skin care, scrap booking and story booking items, packaged food products and other service-based products on a global basis and more recently our Hemp FX™ hemp-derived cannabinoid product line and offer a wide range of products through an international direct selling network. Our direct sales are made through our network, which is a web-based global network of customers and distributors. Our independent sales force markets a variety of products to an array of customers, through friend-to-friend marketing and social networking. We consider our company to be an e-commerce company whereby personal interaction is provided to customers by our independent sales network. Initially, our focus was solely on the sale of products in the health, beauty and home care market through our marketing network; however, we have since expanded our selling efforts to include a variety of other products in other markets. Our direct selling segment offers more than 5,600 products to support a healthy lifestyle including: 
 
Nutritional supplementsGourmet coffee
Weight managementSkincare and cosmetics
Health and wellnessPackaged foods
Lifestyle products (spa, bath, home and garden)Pet care
Digital products including scrap and memory booksTelecare health services
Apparel and fashion accessoriesBusiness lending
Since 2012 we have expanded our operations through a series of acquisitions of the assets and equity of twenty-four (24) direct selling companies including their product lines and sales forces. We have also engage insubstantially expanded our distributor base by merging the commercial sale of coffee.  assets that we have acquired under our web-based independent distributor network, as well as providing our distributors with additional new products to add to their product offerings.
Commercial Coffee Segment
We own a traditional coffee roasting business, CLR, that sells roasted and unroasted coffee and produces coffee under its own Café La Rica brand, Josie’s Java House brand, Javalution brands and Javalution brands.Café Cachita. CLR produces coffee under a variety of private labels through major national sales outlets and major customers including cruise lines and office coffee service operators. In April 2017, CLR reached an agreement with Major League Baseball's Miami Marlins to feature CLR’s Café La Rica Gourmet Espresso coffee as the "Official Cafecito of the Miami Marlins" at Marlins Park in Miami, Florida. The current agreement with the Miami Marlins continues through the 2019 baseball season with an option to renew for the 2020 season. In January 2019, CLR acquired the Café Cachita Brand of espresso and in February we announced the expansion of our recently acquired Café Cachita Brand of espresso into over 500 retail stores throughout Southeastern Grocers.  The new distribution footprint now includes all Winn Dixie, Bi-Lo, Fresco Y Mas, Save Mart and Harvey stores. In June 2019, we announced all-store distribution for CLR’s Javalution™ Hemp Infused Coffee Brand, scheduled to ship in the fourth quarter with the distribution footprint including 400 Winn Dixie stores, 96 Bi-Lo stores, 25 Fresco Y Mas stores, and 50 Harvey stores.
During fiscal 2014 CLR acquired the Siles Plantation Family Group, a coffee plantation and dry-processing facility located in Matagalpa, Nicaragua, an ideal coffee growing region that is historically known for high quality coffee production. The dry-processing facility is approximately 26 acres and the plantation is approximately 500 acres and produces 100 percent Arabica coffee beans that are shade grown, Rainforest Alliance Certified™ and Fair Trade Certified™. CLR is also in the process of expanding its capabilities in Nicaragua by constructing a large processing mill. The plantation, the dry-processing facilityfacilities and existing U.S. based coffee roaster facilities allowsallow CLR to control the coffee production process from field to cup.
 
Commercial Hemp Segment
In the commercial hemp segment, we are engaged in the CBD hemp extraction technology and equipment business. We develop, manufacture and sell equipment and related services to clients which enable them to extract CBD oils from hemp stock. In addition, through INX Laboratories, Inc., a wholly owned subsidiary of KII, we own a laboratory testing facility that provides us with capabilities in regard to formulation, quality control, and testing standards with its CBD products. KII is now producing tinctures, balms, bath bombs, creams, ointments, in various potencies, as well as Javalution™ Hemp Infused Coffee Brand CBD coffee for CLR. KII has also entered into various supply contracts with clients to provide extraction services and end-to-end processing to produce water soluble isolate, distillate, and water-soluble distillate hemp derived products. These supply agreements include a five-year supply contract with revenues forecasted at $60 million through 2024 (based on current market conditions and, among other things, our ability to secure buyers for the produced product and the supplier's ability to supply the biomass for extraction and processing), and a one-year supply agreement expected to generate $19 million in revenues (based on current market conditions). KII also offers clients turnkey manufacturing solutions in extraction services and end-to-end processing systems.
-49-

Recent Events
New Acquisitions During the six months ended June 30, 2019
New Acquisitions - Khrysos Global, Inc.
(See Note 2 and Note 5, to the condensed consolidated financial statements)
On February 12, 2019, we and Khrysos Industries, Inc., a Delaware corporation and our wholly owned subsidiary (“KII”) entered into an Asset and Equity Purchase Agreement (the “AEPA”) with, Khrysos Global, Inc., a Florida corporation (“Seller”), Leigh Dundore (“LD”), and Dwayne Dundore (the “Representing Party”) for KII to acquire substantially all the assets of Seller and all the outstanding equity of INXL Laboratories, Inc., a Florida corporation (“INXL”) and INX Holdings, Inc., a Florida corporation (“INXH”). The business of the Seller, INXL and INXH acquired by us provides end to end extraction and processing via company's proprietary systems that allow for the conversion of hemp feed stock into hemp oil and hemp extracts. Additionally, the company offers various rental, sales, and service programs of the company's extraction and processing systems.
The consideration payable for the assets of the Seller and the equity of INXL and INXH is an aggregate of $16,000,000, to be paid as set forth under the terms of the AEPA and allocated between the Seller and LD in such manner as they determine at their discretion.
At closing, Seller, LD and the Representing Party received an aggregate of 1,794,972 shares of our common stock which have a value of $14,000,000 for the purposes of the AEPA or $12,649,000 fair value for the acquisition valuation and $500,000 in cash. Thereafter, we agreed to pay the Seller, LD and the Representing Party an aggregate of: $500,000 in cash thirty (30) days following the date of closing; $250,000 in cash ninety (90) days following the date of closing; $250,000 in cash one hundred and eighty (180) days following the date of closing; $250,000 in cash two hundred and seventy (270) days following the date of closing; and $250,000 in cash one (1) year following the date of closing.
In addition, we agreed to issue to Representing Party, subject to the approval of the holders of at least a majority of the issued and outstanding shares of our common stock and the approval of The Nasdaq Stock Market (collectively, the “Contingent Consideration Warrants”) consisting of six (6) six-year warrants, to purchase 500,000 shares of common stock each, for an aggregate of 3,000,000 shares of common stock at an exercise price of $10 per share exercisable upon reaching certain levels of cumulative revenue or cumulative net income before taxes by the business during the any of the years ending December 31, 2019, 2020, 2021, 2022, 2023 or 2024.

The AEPA contains customary representations, warranties and covenants of Youngevity, KII, the Seller, LD and the Representing Party. Subject to certain customary limitations, the Seller, LD and the Representing Party have agreed to indemnify us and KII against certain losses related to, among other things, breaches of the Seller’s, LD’s and the Representing Party’s representations and warranties, certain specified liabilities and the failure to perform covenants or obligations under the AEPA.
Related Party Transaction
Carl Grover is the sole beneficial owner of in excess of five percent (5%) of our outstanding common shares. On July 31, 2019, Mr. Grover acquired 600,242 shares of our common stock, $.001 par value, upon the partial exercise at $4.60 per share of a July 31, 2014 warrant to purchase 782,608 shares of common stock held by him. In connection with such exercise, we received $2,761,113 from Mr. Grover, issued to Mr. Grover 50,000 shares of restricted common stock as an inducement fee and agreed to extend the expiration date of the July 31, 2014 warrant held by him to December 15, 2020 with respect to 182,366 shares of common stock remaining for exercise thereunder.
-50-
Overview of Significant Events
At-the-Market Equity Offering Program
On January 7, 2019, we entered into an At-the-Market Offering Agreement (the “ATM Agreement”) with The Benchmark Company, LLC (“Benchmark”), as sales agent, pursuant to which we may sell from time to time, at its option, shares of our common stock, par value $0.001 per share, through Benchmark, as sales agent (the “Sales Agent”), for the sale of up to $60,000,000 of shares of our common stock. We are not obligated to make any sales of common stock under the ATM Agreement and we cannot provide any assurances that it will issue any shares pursuant to the ATM Agreement. We will pay the Sales Agent 3.0% commission of the gross sales proceeds.During the six months ended June 30, 2019, the Company sold a total of 1,000 shares of common stock under the ATM Agreement and received $6,612 at a purchase price of $6.6118 per share pursuant to the ATM Agreement.  
Cross-Marketing Agreement
On January 10, 2019, we entered into an exclusive cross-marketing agreement with Icelandic Glacial™ an Iceland based spring water drinking water company and is now available for customers to purchase.
Mill Construction Agreement
On January 15, 2019, CLR entered into the CLR Siles Mill Construction Agreement (the “Mill Construction Agreement”) with H&H and H&H Export, Alain Piedra Hernandez (“Hernandez”) and Marisol Del Carmen Siles Orozco (“Orozco”), together with H&H, H&H Export, Hernandez and Orozco, collectively referred to as the Nicaraguan Partner, pursuant to which the Nicaraguan Partner agreed to transfer a 45 acre tract of land in Matagalpa, Nicaragua (the “Property”) to be owned 50% by the Nicaraguan Partner and 50% by CLR. In consideration for the land acquisition the Company issued to H&H Export, 153,846 shares of common stock. In addition, the Nicaraguan Partner and CLR agreed to contribute $4,700,000 each toward construction of a processing plant, office, and storage facilities (“Mill”) on the property for processing coffee in Nicaragua. As of June 30, 2019, the Company had made deposits of $3,350,000 towards the Mill, which is included in construction in process in property and equipment, net on the Company’s consolidated balance sheet.
Amendment to Operating and Profit-Sharing Agreement
On January 15, 2019, CLR entered into an amendment to the March 2014 operating and profit-sharing agreement with the owners of H&H. CLR engaged Hernandez and Orozco, the owners of H&H as employees to manage Siles. In addition, CLR and H&H, Hernandez and Orozco have agreed to restructure their profit-sharing agreement in regard to profits from green coffee sales and processing that increases the CLR’s profit participation by an additional 25%. Under the new terms of the agreement with respect to profit generated from green coffee sales and processing from La Pita, a leased mill, or the new mill, now will provide for a split of profits of 75% to CLR and 25% to the Nicaraguan Partner, after certain conditions are met. We issued 295,910 shares of our common stock to H&H Export to pay for certain working capital, construction and other payables. In addition, H&H Export has sold to CLR its espresso brand Café Cachita in consideration of the issuance of 100,000 shares of our common stock. Hernandez and Orozco are employees of CLR. The shares of common stock issued were valued at $7.50 per share.
Stock Offering
On February 6, 2019, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with one accredited investor that had a substantial pre-existing relationship with us pursuant to which we sold 250,000 shares of our common stock, par value $0.001 per share, at an offering price of $7.00 per share. Pursuant to the Purchase Agreement, we also issued to the investor a three-year warrant to purchase 250,000 shares of common stock at an exercise price of $7.00. The proceeds to us were $1,750,000. Consulting fees for arranging the Purchase Agreement include the issuance of 5,000 shares of restricted shares of our common stock, par value $0.001 per share, and 100,000 3-year warrants priced at $10.00. No cash commissions were paid.
-51-
On June 17, 2019, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with one accredited investor that had a substantial pre-existing relationship with the Company pursuant to which the Company sold 250,000 shares of common stock, par value $0.001 per share, at an offering price of $5.50 per share. The proceeds were $1,375,000. The Company conducts its operations primarilydid not pay consulting fees in this transaction.
Convertible Notes
Between February 15, 2019 and May 23, 2019, we closed four tranches of our 2019 January Private Placement debt offering, pursuant to which we offered for up to a maximum of $10,000,000 in principal amount of notes (the “2019 PIPE Notes”), with each investor receiving 2,000 shares of common stock for each $100,000 invested. We entered into subscription agreements with thirty (30) accredited investors that had a substantial pre-existing relationship with us pursuant to which we received aggregate gross proceeds of $2,890,000 and issued 2019 PIPE Notes in the United States. Foraggregate principal amount of $2,890,000 and an aggregate of 57,800 shares of common stock. The placement agent received 14,450 shares of common stock for the threeclosed tranches and can receive up to 50,000 shares of common stock in the offering. Each 2019 PIPE Note matures 24 months ended September 30, 2017after issuance, bears interest at a rate of six percent (6%) per annum, and 2016 approximately 12% and 9%, respectively,the outstanding principal is convertible into shares of common stock at any time after the 180th day anniversary of the Company’s sales were derived from sales outside the United States. For the nine months ended September 30, 2017 and 2016 approximately 11% and 9%, respectively,issuance of the Company’s sales were derived2019 PIPE Notes, at a conversion price of $10 per share (subject to adjustment for stock splits, stock dividends and reclassification of the common stock).
Promissory Notes
On March 18, 2019, we entered into a two-year Secured Promissory Note (the “8% Note or Notes”) with two accredited investors that we had a substantial pre-existing relationship with and from sales outsidewhom we raised cash proceeds in the United States.aggregate of $2,000,000. In consideration of the 8% Notes, we issued 20,000 shares of our common stock par value $0.001 for each $1,000,000 invested as well as for each $1,000,000 invested five-year warrants to purchase 20,000 shares of our common stock at a price per share of $6.00. The 8% Notes pay interest at a rate of eight percent (8%) per annum and interest is paid quarterly in arrears with all principal and unpaid interest due at maturity on March 18, 2021.

 
Results of Operations
 
The comparative financials discussed below show the condensed consolidated financial statements of Youngevity International, Inc. as of and for the three and nine months ended September 30, 2017 and 2016.

-26-
Three months ended SeptemberJune 30, 20172019 compared to three months ended SeptemberJune 30, 20162018
 
Revenues
 
For the three months ended SeptemberJune 30, 2017,2019, our revenue increased 1.9%revenues decreased 13.6% to $44,395,000$38,217,000 as compared to $43,562,000$44,255,000 for the three months ended SeptemberJune 30, 2016.2018. During the three months ended SeptemberJune 30, 2017,2019, we derived approximately 85%84.1% of our revenue from our direct salesselling segment and approximately 15%15.2% of our revenue from our commercial coffee sales. Directsegment and approximately 0.7% from our hemp segment. 
For the three months ended June 30, 2019, direct selling segment revenues decreased by $622,000$4,722,000 or 1.6%12.8% to $37,954,000$32,124,000 as compared to $38,576,000$36,846,000 for the three months ended SeptemberJune 30, 2016.2018. This decrease was primarily attributedattributable to a decrease in the number of $5,366,000 in revenues from existing businessordering distributors and customer, partially offset by additional revenues of $4,744,000 derived from the Company’s 2016an increase in average order amount per distributor and 2017 acquisitions compared to the prior period. The decrease in existing business was primarily due to reduction in revenues related to key management and distributors moving to another direct selling company. customer.
For the three months ended SeptemberJune 30, 2017,2019, commercial coffee segment revenues increaseddecreased by $1,455,000$1,590,000 or 29.2%21.5% to $6,441,000$5,819,000 as compared to $4,986,000$7,409,000 for the three months ended SeptemberJune 30, 2016.2018. This increasedecrease was primarily attributedrelated to increased revenues in our green coffee business of $3,559,000, attributable to the change in recognition of H&H Export revenue in 2019 to milling and processing services related to the green coffee business. The decrease in sales from green coffee was offset by revenues from milling and processing services of approximately $1,561,000 and an increase in roasted coffee business of $408,000.
Our new commercial hemp segment, the acquisition of which closed on February 15, 2019, recorded approximately $274,000 in revenues for the three months ending June 30, 2019.
-52-
 
The following table summarizes our revenue in thousands by segment:
 
 
 
For the three months
ended September 30,
 
 Percentage  
Segment Revenues
 
2017
 
 
2016
 
 
change
 
Direct selling
 $37,954 
 $38,576 
  (1.6)%
Commercial coffee
  6,441 
  4,986 
  29.2%
Total
 $44,395 
 $43,562 
  1.9%
 
 
Three Months Ended June 30,
 
 
 
2019
 
 
2018
 
 
Percentage
Change (2)
 
 
 
(Restated) (1)
 
 
 
 
 
 
 
Direct selling
 $32,124 
 $36,846 
  (12.8)%
As a % of Revenue
  84.1%
  83.3%
  0.8%
Commercial coffee:
    
    
    
Processed green coffee
  968 
  4,527 
  (78.6)%
As a % of Segment Revenue
  16.6%
  61.1%
  (44.5)%
Milling and processing services
  1,561 
  - 
  N/A 
As a % of Segment Revenue
  26.8%
  -%
  N/A 
Roasted coffee and other
  3,290 
  2,882 
  14.2%
As a % of Segment Revenue
  56.5%
  38.9%
  17.6%
Total commercial coffee
  5,819 
  7,409 
  (21.5)%
As a % of Revenue
  15.2%
  16.7%
  (1.5)%
Commercial hemp
  274 
  - 
  N/A 
As a % of Revenue
  0.7%
  -%
  N/A 
Total Revenues
 $38,217 
 $44,255 
  (13.6)%
 
(1) See Note 2 to the unaudited condensed consolidated financial statements.
(2) Percentages denoted as N/A do not contain prior period comparatives

Cost of Revenues
 
For the three months ended SeptemberJune 30, 2017,2019, overall cost of revenues increaseddecreased 33.6% to approximately 8.4% to $18,631,000$12,537,000 as compared to $17,194,000$18,873,000 for the three months ended SeptemberJune 30, 2016. 2018.
The direct selling segment cost of revenues increased 1.1%decreased 15.9% to approximately $9,884,000 when compared to $11,759,000 for the same period last year, as a result of product mix. primarily due to the decrease in revenues.
The commercial coffee segment cost of revenues increased 26.8%decreased 67.2% to approximately $2,330,000 when compared to $7,114,000 for the same period last year. This was primarily attributable to the shift in revenue increases from processed green coffee sales to milling and processing services year on year. As revenue for milling services does not contain a cost of goods sold component, related to processed green coffee, this shift in revenues to milling and processing services lowers our cost of revenue.Cost of revenuesfrom the sale ofprocessed green coffee was a credit of approximately $864,000 or 120.9% of commercial coffee segment revenues for the three months ended June 30, 2019. This was primarily due to pricing true ups related to fluctuations in market coffee pricing on current period final invoicing related to prior period sales recorded, which can have a negative effect on margins.
During the three months ended June 30, 2018, cost of revenues on processed green coffee business.sales were $4,127,000 or 54.9% of commercial coffee segment revenues. Cost of revenue for roasted coffee increased 6.9% to $3,194,000 for the three months ended June 30, 2019.
The commercial hemp segment cost of revenues was $323,000.
 
Cost of revenues includes the cost of inventory including green coffee, shipping and handling costs incurred in connection with shipments to customers, direct labor and benefits costs, royalties associated with certain products, transaction merchant fees and depreciation on certain assets.
  
-53-
Gross Profit (Loss)
 
For the three months ended SeptemberJune 30, 2017,2019, gross profit decreased 1.2% to approximately 2.3% to $25,764,000$25,680,000 as compared to $26,368,000$25,382,000 for the three months ended SeptemberJune 30, 2016.2018. Overall gross profit as a percentage of revenues decreasedincreased to 58.0%67.2%, compared to 60.5%57.4% in the same period last year.
 
Gross profit in the direct selling segment decreased by 2.9%11.3% to $25,472,000$22,240,000 from $26,233,000$25,087,000 in the priorsame period last year primarily as a result of the changesdecrease in revenues and costs discussed above. Gross profit as a percentage of revenues in the direct selling segment decreasedincreased by approximately 0.9%1.1% to 67.1%69.2% for the three months ended SeptemberJune 30, 2017,2019, compared to 68.0%68.1% in the same period last year. This was primarily due to increased social selling discounts offered in the current period.
 
Gross profit in the commercial coffee segment increased by 116% to $292,000$3,489,000 compared to $135,000$295,000 in the prior period.same period last year. Gross profit as a percentage of revenues in the commercial coffee segment increased to 60.0% for the three months ended June 30, 2019, compared to 4.0% in the same period last year. The increase in gross profit in the commercial coffee segment was primarily due to the overall increase in the processing and milling of unprocessed green coffee at our mill that in turn drove higher gross profits from the combination of processed green coffee sales and revenues discussed above.on milling and processing services during the three months ended June 30, 2019. Gross profit as a percentagefrom the sales of processed green coffee was $1,832,000 or 31.5% of total revenues in the commercial coffee segment. Gross profits from milling and processing services was $1,561,000 or 26.8% of total revenues in the commercial coffee segment. Gross profit from our roaster business increased $201,000 to approximately $96,000 or 1.6% of total revenues in the commercial coffee segment, increased by 1.8% to 4.5% for the period ended September 30, 2017, compared to 2.7%a loss of approximately $105,000 during the three months ended June 30, 2018.
Gross profit in the same period last year.commercial hemp segment, the acquisition of which closed on February 15, 2019, recorded a loss of approximately $49,000.
 
Below is a table of gross profit (loss) by segment (in thousands) and gross profit (loss) as a percentage of segment revenues:
 
 
For the three months
ended September 30,
 
 Percentage 
 
Three Months Ended June 30,
 
Segment Gross Profit
 
2017
 
 
2016
 
 
change
 
 
2019
 
 
2018
 
 
Percentage
Change (2)
 
 
(Restated) (1)
 
 
 
 
Direct selling
 $25,472 
 $26,233 
  (2.9)%
 $22,240 
 $25,087 
  (11.3)%
Gross Profit % of Revenues
  67.1%
  68.0%
  (0.9)%
Commercial coffee
  292 
  135 
  116.3%
Gross Profit % of Revenues
  4.5%
  2.7%
  1.8%
Gross Profit % of Segment Revenues
  69.2%
  68.1%
  1.1%
Commercial coffee:
    
Processed green coffee
  1,832 
  400 
  358.0%
Gross Profit % of Segment Revenues
  31.5%
  5.4%
  26.1%
Milling and processing services
  1,561 
  - 
  N/A 
Gross Profit % of Segment Revenues
  26.8%
  -%
  N/A 
Roasted coffee and other
  96 
  (105)
  191.4%
Gross Loss % of Segment Revenues
  1.6%
  (1.4)%
  3.1%
Total commercial coffee
  3,489 
  295 
  1,082.7%
Gross Profit % of Segment Revenues
  60.0%
  4.0%
  56.0%
Commercial hemp
  (49)
  - 
  N/A 
Gross Loss % of Segment Revenues
  (17.9)%
  -%
  N/A 
Total
 $25,764 
 $26,368 
  (2.3)%
 $25,680 
 $25,382 
  1.2%
Gross Profit % of Revenues
  58.0%
  60.5%
  (2.5)%
  67.2%
  57.4%
  9.8%
(1) See Note 2 to the unaudited condensed consolidated financial statements.
(2) Percentages denoted as N/A do not contain prior period comparatives

 
 
-27--54-
 
 
Operating Expenses
 
For the three months ended SeptemberJune 30, 2017,2019, our operating expenses increased approximately 6.9%3.3% to $27,581,000$25,534,000 as compared to $25,792,000$24,729,000 for the three months ended SeptemberJune 30, 2016. Included in operating expense is2018.
For the three months ended June 30, 2019, the distributor compensation paid to our independent distributors in the direct selling segment. For the three months ended September 30, 2017, distributor compensationsegment decreased 3.9%12.1% to $17,391,000$14,497,000 from $18,101,000$16,487,000 for the three months ended SeptemberJune 30, 2016.2018. This decrease was primarily attributable to the decrease in revenues and lower commissions paid on discounted items.revenues. Distributor compensation as a percentage of direct selling revenues decreasedincreased to 45.8%45.1% for the three months ended SeptemberJune 30, 20172019 as compared to 46.9%44.7% for the three months ended SeptemberJune 30, 2016.2018.
 
For the three months ended SeptemberJune 30, 2017,2019, total sales and marketing expense decreased 9.4% to $2,786,000 from $3,076,000 for the three months ended June 30, 2018.
In the direct selling segment, sales and marketing expense decreased by 12.6% to $2,490,000 in the current quarter from $2,849,000 for the same period last year. In the commercial coffee segment, sales and marketing expense increased 28.1%by $39,000 to $4,074,000 from $3,181,000 for$266,000 in the three months ended September 30, 2016 primarily due to expenses relatedcurrent quarter compared to the Company’s twentieth anniversary convention held in Dallas, Texas in August 2017 and increase in wages and related benefits. Sales and marketing expenses also increased in the commercial coffee segmentsame period last year, primarily due to increased wagesadvertising costs and advertisingcompensation expense. Sales and marketing expense related towere $30,000 in the agreement with the Miami Marlins.commercial hemp segment.
 
For the three months ended SeptemberJune 30, 2017, the2019, total general and administrative expense increased 35.6%59.7% to $6,116,000$8,251,000 from $4,510,000$5,166,000 for the three months ended SeptemberJune 30, 20162018.
In the direct selling segment, general and administrative expense increased by 38.8% to $6,071,000 in the current quarter from $4,375,000 for the same period last year. This increase was primarily due to increasesan increase in costs related to legal fees,accounting, computer expense and internet related costs, international expansion, investor relations, wages and related benefits, amortization and stock basednon-cash equity-based compensation costs.expense. In addition, the Company revalued the contingent liability which resultedrevaluation adjustment in the current quarter was a benefitreduction in expense of $339,000 for the three months ended September 30, 2017$433,000 compared to a reduction in expense of $1,246,000 for the same period last year. In the commercial coffee segment, general and administrative costs increased by $557,000 or 70.4% to $1,348,000 in the current quarter compared to $791,000 in the same period last year. This was primarily due to an increase in wages, warehouse storage costs and profit-sharing expense of $193,000, compared to a profit-sharing benefit of $315,000 for$249,000 in the three months ended September 30, 2016.same period last year. General and administrative expense was $832,000 in the commercial hemp segment, mostly related to wages, supplies and general office costs.
 
Operating (Loss) Income
 
For the three months ended SeptemberJune 30, 2017, operating loss increased to $1,817,000 compared to2019, the Company reported operating income of $576,000$146,000 as compared to $653,000 for the three months ended SeptemberJune 30, 2016. This was primarily due to the lower gross profit and the increase in operating expenses discussed above.2018.  
 
Total Other Expense
 
For the three months ended SeptemberJune 30, 2017,2019, total other expense decreased by $36,000$696,000 to $541,000$661,000 as compared to other expense of $577,000$1,357,000 for the three months ended SeptemberJune 30, 2016.2018. Total other expense includes net interest expense, the change in the fair value of warrant derivative liabilities and extinguishment loss on debt.
 
Net interest expense increaseddecreased by $806,000$487,000 for the three months ended SeptemberJune 30, 20172019 to $1,752,000 as$1,062,000, compared to $946,000$1,549,000 for the three months ended SeptemberJune 30, 2016. Interest expense includes interest payments related to acquisitions and other operating debt, interest payments to investors associated with the 2014, 2015 and 2017 Private Placement transactions of $1,043,000 and related non-cash amortization costs of $710,000 and other non-cash costs of $8,000. Net interest expense also includes $9,000 in interest income.2018.
 
Change in fair value of warrant derivative liabilityliabilities increased by $1,150,000$209,000 for the three months ended SeptemberJune 30, 20172019 to $1,519,000$401,000 in other income compared to $369,000$192,000 for the three months ended SeptemberJune 30, 2016.2018. Various factors are considered in the pricing models we use to value the warrants including our current stock price, the remaining life of the warrants, the volatility of our stock price, and the risk freerisk-free interest rate. Future changes in these factors may have a significant impact on the computed fair value of the warrant liability.Company’s derivative liabilities. As such, we expect future changes in the fair value of the warrants to continue and may vary significantly from yearperiod to yearperiod (see Note 7,Notes 8 & 9, to the condensed consolidated financial statements.)statements).
 
We recorded a non-cash extinguishment loss on debt of $308,000 in the current quarter ended September 30, 2017 as a result of the repayment of $4,200,349 in notes including interest to the three investors from the November 2015 Private Placement through issuance of a new July 2017 note. This loss represents the difference between the reacquisition value of the new debt to the holders of the notes and the carrying amount of the holder’s extinguished debt (see Note 6, to the condensed consolidated financial statements.)  
-55-
 
Income Taxes 
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company hasWe have determined through consideration of all positive and negative evidenceevidences that the US deferred tax assets are not more likely than not to be realized. The Company does not have a valuation allowance in the US Federal tax jurisdiction. A valuation allowance remains on the U.S., state and foreign tax attributes that are likely to expire before realization. We have approximately $146,000 in AMT refundable credits, and we expect that $73,000 will be refunded in 2019. As such, we do not have a valuation allowance relating to the refundable AMT credit carryforward. We have recognized an income tax benefit of $1,290,000,$226,000 which is our estimated federal, state and foreign income tax benefitexpense for the three months ended SeptemberJune 30, 2017.2019. The income tax benefit fordifference between the three months ended September 30, 2016 was $68,000. The current effective tax rate forand the three months ended September 30, 2017 was 54.7% comparedfederal statutory rate of 21% is due to the Federal statutorypermanent differences, change in valuation allowance, state taxes (net of federal benefit), and foreign tax rate of 35%.
-28-
differential.
 
Net (Loss) IncomeLoss
 
For the three months ended SeptemberJune 30, 2017, the Company2019, we reported a net loss of $1,068,000$289,000 as compared to net incomeloss of $67,000$614,000 for the three months ended SeptemberJune 30, 2016.2018. The primary reason for the increasedecrease in net loss when compared to the prior period was due to a net loss beforethe decrease in total other expense of $696,000 and the increase in income taxestax benefit of $2,358,000$136,000, off-set by the decrease in 2017operating income of $507,000 discussed above. .
Six months ended June 30, 2019 compared to a net loss before income taxes in 2016 of $1,000.
Ninesix months ended SeptemberJune 30, 2017 compared to nine months ended September 30, 20162018
 
Revenues
 
For the ninesix months ended SeptemberJune 30, 2017,2019, our revenues increased 0.3%decreased 9.0% to $124,655,000$79,409,000 as compared to $124,264,000$87,249,000 for the ninesix months ended SeptemberJune 30, 2016.2018. During the ninesix months ended SeptemberJune 30, 2017,2019, we derived approximately 86%82.5% of our revenue from our direct selling sales and approximately 14%17% of our revenue from our commercial coffee sales. Directsales and approximately 0.4% from our hemp segment. 
For the six months ended June 30, 2019, direct selling segment revenues decreased by $3,659,000$6,613,000 or 3.3%9.2% to $106,734,000$65,544,000 as compared to $110,393,000$72,157,000 for the ninesix months ended SeptemberJune 30, 2016. 2018. This decrease was primarily attributed to a decrease of $13,242,000$7,034,000 in revenues from existing business, partially offset by additional revenues from new acquisitions of $9,583,000 derived from our Company’s 2016 and 2017 acquisitions compared to the prior period.$421,000. The decrease in existing business was primarily due to reductiona decline in revenues related to key managementthe number of ordering distributors and distributors moving to another direct selling company. customers, partially offset by an increase in average order amount per distributor and customer.
For the ninesix months ended SeptemberJune 30, 2017,2019, commercial coffee segment revenues increaseddecreased by $4,050,000$1,568,000 or 29.2%10.4% to $17,921,000$13,524,000 as compared to $13,871,000$15,092,000 for the ninesix months ended SeptemberJune 30, 2016.2018. This increasedecrease was primarily attributed to increased revenues inrelated decreased sales recorded for our processed green coffee business of $8,444,000, attributable to the change in recognizing H&H Export revenue in 2019 at net to milling and processing services related to the green coffee roasting business. This decrease was offset by revenues recorded for milling and processing services of approximately $6,387,000 and an increase in roasted coffee business of $489,000.
Our new commercial hemp segment recorded $341,000 in revenues from sales made by KII.
-56-
 
The following table summarizes our revenue in thousands by segment:
 
 
 
For the nine months
ended September 30,
 
 Percentage
Segment Revenues
 
2017
 
 
2016
 
 
 change
 
Direct selling
 $106,734 
 $110,393 
  (3.3)%
Commercial coffee
  17,921 
  13,871 
  29.2%
Total
 $124,655 
 $124,264 
  0.3%
 
 
Six Months Ended June 30,
 
 
 
2019
 
 
2018
 
 
Percentage Change (2)
 
 
 
(Restated) (1)
 
 
 
 
 
 
 
Direct selling
 $65,544 
 $72,157 
  (9.2)%
As a % of Revenue
  82.5%
  82.7%
  (0.2)%
Commercial coffee:
    
    
    
Processed green coffee
  1,068 
  9,512 
  (88.8)%
 As a % of Segment Revenue
  7.9%
  63.0%
  (55.1)%
Milling and processing services
  6,387 
  - 
  N/A 
 As a % of Segment Revenue
  47.2%
  -%
  N/A 
Roasted coffee and other
  6,069 
  5,580 
  8.8%
As a % of Segment Revenue
  44.9%
  37.0%
  7.9%
Total commercial coffee
  13,524 
  15,092 
  (10.4)%
As a % of Revenue
  17.0%
  17.3%
  (0.3)%
Commercial hemp
  341 
  - 
  N/A 
As a % of Revenue
  0.4%
  -%
  N/A 
Total Revenues
 $79,409 
 $87,249 
  (9.0)%
(1) See Note 2 to the unaudited condensed consolidated financial statements.
(2) Percentages denoted as N/A do not contain prior period comparatives
 
Cost of Revenues
 
For the ninesix months ended SeptemberJune 30, 2017,2019, overall cost of revenues increaseddecreased approximately 7.8%27.1% to $52,923,000$26,880,000 as compared to $49,102,000$36,855,000 for the ninesix months ended SeptemberJune 30, 2016. 2018.
The direct selling segment cost of revenues decreased 1.4%8.0% to $20,549,000 when compared to $22,335,000 for the same period last year, primarily as a result of lowerdue to the decrease in revenues and lower shipping costs during the nine months ended September 30, 2017. discussed above.
The commercial coffee segment cost of revenues increased 32.2%decreased 58.9% to $5,968,000 when compared to $14,520,000 for the same period last year. This was primarily attributable to the shift in revenue increases from processed green coffee processed salesto milling and processing services year on year. As revenue for milling services does not contain a cost of goods sold component, related to unprocessed green coffee, this shift in revenues related to milling and processing services lowers our cost of revenue. Cost of revenuesfrom the sale ofprocessed green coffee business, and additional costs incurred duewas a credit of $257,000 or 102.9% of commercial coffee segment revenues for the six months ended June 30, 2019. During the six months ended June 30, 2018, cost of revenues on processed green coffee sales were $8,936,000 or 93.9% of commercial coffee segment revenues. Cost of revenue for roasted coffee increased 11.5% to inventory adjustments, increased direct labor costs, repairs and maintenance and depreciation expense.$6,225,000 for the six months ended June 30, 2019.
The commercial hemp segment cost of revenues was $363,000.
 
Cost of revenues includes the cost of inventory including green coffee, shipping and handling costs incurred in connection with shipments to customers, direct labor and benefits costs, royalties associated with certain products, transaction merchant fees and depreciation on certain assets.
 
-57-
Gross Profit
 
For the ninesix months ended SeptemberJune 30, 2017,2019, gross profit decreasedincreased approximately 4.6%4.2% to $71,732,000$52,529,000 as compared to $75,162,000$50,394,000 for the ninesix months ended SeptemberJune 30, 2016.2018. Overall gross profit as a percentage of revenues decreasedincreased to 57.5%66.1%, compared to 60.5%57.8% in the same period last year.year, primarily due to the increased revenues in the lower margin commercial coffee segment.
 
Gross profit in the direct selling segment decreased by 4.2%9.7% to $71,522,000$44,995,000 from $74,690,000$49,822,000 in the prior period primarily as a result of the changesdecrease in revenues and costs discussed above. Gross profit as a percentage of revenues in the direct selling segment decreased by approximately 0.7%0.4% to 67.0%68.6% for the ninesix months ended SeptemberJune 30, 2017,2019, compared to 67.7%69% in the same period last year. This was primarily due to increased social selling discounts offered in the current year compared to the prior year.
 
-29-

 
Gross profit in the commercial coffee segment decreased by 55.5% to $210,000 compared to $472,000 in the prior period. The decrease in gross profit in the commercial coffeehemp segment was primarily duea loss of $22,000 related to an increase in costs discussed above. Gross profit as a percentagethe February 15, 2019 acquisition of revenues in the commercial coffee segment decreased by 2.2% to 1.2% for the period ended September 30, 2017, compared to 3.4% in the same period last year.Khrysos.
 
Below is a table of gross profit (loss) by segment (in thousands) and gross profit as a percentage of segment revenues:
 
 
For the nine months
ended September 30,
 
 Percentage
 
Six Months Ended June 30,
 
Segment Gross Profit
 
2017
 
 
2016
 
 
 change
 
 
2019
 
 
2018
 
 
Percentage Change (2)
 
 
(Restated) (1)
 
 
 
 
Direct selling
 $71,522 
 $74,690 
  (4.2)%
 44,995 
 49,822 
  (9.7)%
Gross Profit % of Revenues
  67.0%
  67.7%
  (0.7)%
Commercial coffee
  210 
  472 
  (55.5)%
Gross Profit % of Revenues
  1.2%
  3.4%
  (2.2)%
Gross Profit % of Segment Revenues
  68.6%
  69%
  (0.4)%
Commercial coffee:
    
Processed green coffee
  1,325 
  576 
  130.0%
Gross Profit % of Segment Revenues
  9.8%
  3.8%
  6.0%
Milling and processing services
  6,387 
  - 
  N/A 
Gross Profit % of Segment Revenues
  47.2%
  -%
  N/A 
Roasted coffee and other
  (156)
  (4)
  3800.0%
Gross Loss % of Segment Revenues
  (1.2)%
  0.0%
  (1.1)%
Total commercial coffee
  7,556 
  572 
  1221.0%
Gross Profit % of Segment Revenues
  55.9%
  3.8%
  52.1%
Commercial hemp
  (22)
  - 
  N/A 
Gross Loss % of Segment Revenues
  (6.5)%
  0%
  N/A 
Total
 $71,732 
 $75,162 
  (4.6)%
 52,529 
 50,394 
  4.2%
Gross Profit % of Revenues
  57.5%
  60.5%
  (3.0)%
  66.1%
  57.8%
  8.4%
(1) See Note 2 to the unaudited condensed consolidated financial statements.
(2) Percentages denoted as N/A do not contain prior period comparatives

-58-
 
Operating Expenses
 
For the ninesix months ended SeptemberJune 30, 2017,2019, our operating expenses increased approximately 6.6%29.4% to $76,625,000$64,324,000 as compared to $71,899,000$49,717,000 for the ninesix months ended SeptemberJune 30, 2016. Included2018. This increase included an increase of $12,892,000 in non-cash equity-based compensation expense related to stock options issued in the first quarter of the current year. Excluding the increase in equity-based compensation expense, the increase in our operating expense iswould have been 3.4%.
For the six months ended June 30, 2019, the distributor compensation paid to our independent distributors in the direct selling segment. Forsegment decreased 8.4% to $29,387,000 from $32,065,000 for the ninesix months ended SeptemberJune 30, 2017, distributor compensation decreased 2.7% to $49,496,000 from $50,871,000 for the nine months ended September 30, 2016.2018. This decrease was primarily attributable to the decrease in revenues. Distributor compensation as a percentage of direct selling revenues increased to 46.4%44.8% for the ninesix months ended SeptemberJune 30, 20172019 as compared to 46.1%44.4% for the ninesix months ended SeptemberJune 30, 2016. This increase was primarily attributable to an increase in incentive payouts.2018.
 
For the ninesix months ended SeptemberJune 30, 2017, the2019, total sales and marketing expense increased 39.8%3.5% to $10,650,000$6,805,000 from $7,619,000$6,575,000 for the ninesix months ended SeptemberJune 30, 20162018. This increase included an increase of $471,000 in equity-based compensation expense in the first quarter of the current year. Excluding the increase in equity-based compensation expense, sales and marketing expense would have decreased by 3.7%.
In the direct selling segment, sales and marketing expense increased by 1.0% to $6,204,000 for the six months ended June 30, 2019, compared to $6,141,000 for the same period last year. This increase included an increase of $471,000 in equity-based compensation expense. Excluding the increase in equity-based compensation expense, sales and marketing expense would have decreased by 6.6%. In the commercial coffee segment, sales and marketing costs increased by $123,000 to $557,000 in the current year compared to the same period last year, primarily due to increasesincreased advertising costs and compensation expense. Sales and marketing expense was $44,000 in convention and distributor events costs, increased wages and related benefits and increased marketing expenses.the commercial hemp segment for the six months ended June 30, 2019.
 
For the ninesix months ended SeptemberJune 30, 2017, the2019, total general and administrative expense increased 22.9%154.0% to $16,479,000$28,132,000 from $13,409,000$11,077,000 for the ninesix months ended SeptemberJune 30, 20162018. This increase included an increase of $12,421,000 in equity-based compensation expense in the first quarter of the current year. Excluding the increase in equity-based compensation expense, the increase in general and administration expense would have been 41.8%.
In the direct selling segment, general and administrative expense increased by 138.2% to $22,530,000 in the current year from $9,460,000 for the same period last year. This increase included an increase of $10,995,000 in equity-based compensation expense in the first quarter of the current year. Excluding the increase in equity-based compensation expense, general and administrative expense would have increased by 21.9%. This increase was primarily due to legal fees,an increase in accounting and computer and internet related costs, international expansion, investor relations, depreciation, amortization and stock based compensation costs.consulting fees. In addition, the contingent liability revaluation adjustment in the current period resulted in a benefitreduction in expense of $1,019,000 for the nine months ended September 30, 2017$433,000 compared to a reduction in expense of $1,459,000 for the same period last year. In the commercial coffee segment, general and administrative costs increased by $2,623,000 or 162.2% to $4,240,000 in the current year compared to $1,617,000 in the same period last year. This increase included an increase of $1,425,000 in equity-based compensation expense. Excluding the increase in stock-based compensation expense, general and administration expense in the commercial coffee segment would have increased by 74.1%. This was primarily due to an increase in wages, incentives, warehouse storage costs and profit-sharing expense of $436,000, compared to a profit-sharing benefit of $1,185,000 for$472,000 in the nine months ended September 30, 2016.same period last year. General and administrative expense was $1,362,000 in the commercial hemp segment, and was mostly related to wages, supplies and general office costs.

-59-
 
Operating Income (Loss) Income
 
For the ninesix months ended SeptemberJune 30, 2017,2019, the Company reported an operating loss increased to $4,893,000of $11,795,000 as compared to an operating income of $3,263,000$677,000 for the ninesix months ended SeptemberJune 30, 2016.2018. This was primarily due to the lower gross profit andincrease of $12,966,000 in non-cash equity-based compensation expense discussed above. Excluding the increase in equity-based compensation expense, the Company would have reported an operating expenses discussed above. income of $1,171,000 for the six months ended June 30, 2019.
 
Total Other Expense
 
For the ninesix months ended SeptemberJune 30, 2017,2019, total other expense increaseddecreased by $1,123,000$2,757,000 to $3,727,000$682,000 as compared to $2,604,000other expense of $3,439,000 for the ninesix months ended SeptemberJune 30, 2016.2018. Total other expense includes net interest expense, the change in the fair value of warrant derivative liabilities and extinguishment loss on debt.
 
Net interest expense increaseddecreased by $1,068,000$692,000 for the ninesix months ended SeptemberJune 30, 20172019 to $4,207,000$2,569,000, compared to $3,139,000 in 2016. Interest expense includes interest payments related to acquisitions and other operating debt, interest payments to investors associated with our Private Placement transactions of $2,773,000, $1,270,000 non-cash amortization costs and $22,000 of other non-cash interest. In addition we recorded $231,000 related to issuance costs associated with our 2017 Private Placement. Net interest expense also includes $67,000 in interest income.$3,261,000 for the six months ended June 30, 2018.
 
Change in fair value of warrant derivative liabilityliabilities increased by $253,000$983,000 for the ninesix months ended SeptemberJune 30, 20172019 to $788,000$1,887,000 in other income compared to $535,000$904,000 for the ninesix months ended SeptemberJune 30, 2016.2018. Various factors are considered in the pricing models we use to value the warrants including our current stock price, the remaining life of the warrants, the volatility of our stock price, and the risk freerisk-free interest rate. Future changes in these factors may have a significant impact on the computed fair value of the warrant liability.Company’s derivative liabilities. As such, we expect future changes in the fair value of the warrants to continue and may vary significantly from yearperiod to yearperiod (see Note 7,Notes 8 & 9, to the condensed consolidated financial statements.)statements).
 
-30-
We recorded a non-cash extinguishment loss on debt of $308,000 in$1,082,000 for the current quartersix months ended SeptemberJune 30, 20172018 as a result of the repaymenttriggering of $4,200,349 in notes including interest to the three investors fromautomatic conversion of the November 20152017 Notes associated with our July 2017 Private Placement through issuance of a new July 2017 note.to common stock. This loss representsrepresented the difference between the reacquisitioncarrying value of the new debt to2017 Notes and embedded conversion feature and the holdersfair value of the notes and the carrying amountshares that were issued. The fair value of the holder’s extinguishedshares issued were based on the stock price on the date of the conversion. There was no loss on debt (see Note 6, toextinguishment for the condensed consolidated financial statements.)  
six months ended June 30, 2019.
 
Income Taxes 
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company hasWe have determined through consideration of all positive and negative evidenceevidences that the US deferred tax assets are not more likely than not to be realized. The Company does not have a valuation allowance in the US Federal tax jurisdiction. A valuation allowance remains on the U.S., state and foreign tax attributes that are likely to expire before realization. We have approximately $146,000 in AMT refundable credits, and we expect that $73,000 will be refunded in 2019. As such, we do not have a valuation allowance relating to the refundable AMT credit carryforward. We have recognized an income tax benefitexpense of $2,763,000,$72,000 which is our estimated federal, state and foreign income tax benefit for the nine months ended September 30, 2017. The income tax expense for the ninesix months ended SeptemberJune 30, 2016 was $550,000.2019. The currentdifference between the effective tax rate forand the nine months ended September 30, 2017 was 32.1% comparedfederal statutory rate of 21% is due to the Federal statutorypermanent differences, change in valuation allowance, state taxes (net of federal benefit), and foreign tax rate of 35%.differential.
 
Net Income (Loss)Loss
 
For the ninesix months ended SeptemberJune 30, 2017,2019, the Company reported an increase in net loss of $9,627,000 to a net loss of $5,857,000$12,549,000 as compared to net incomeloss of $109,000$2,922,000 for the ninesix months ended SeptemberJune 30, 2016.2018. The primary reason for the decreaseincrease in net income to a loss when compared to the prior period was due to a netthe increase in operating loss beforeof $12,472,000, offset by the decrease in other expense of $2,757,000 and decrease in income taxestax expense of $8,620,000$88,000. The primary reason for the increase in 2017 compared to net income before income taxesoperating loss was the increase of $12,966,000 in 2016 of $659,000.stock and equity-based compensation expense.
-60-
 
Adjusted EBITDA
 
EBITDA (earnings before interest, income taxes, depreciation and amortization) as adjusted to remove the effect of stock basedequity-based compensation expense and the non-cash loss on extinguishment of debt and the change in the fair value of the warrant derivative and extinguishment loss on debtderivatives or "Adjusted EBITDA," decreasedincreased to a negative $359,000$2,362,000 for the three months ended SeptemberJune 30, 20172019 compared to $1,620,000$2,203,000 in 20162018 and decreasedincreased to a negative $851,000$4,769,000 for the ninesix months ended SeptemberJune 30, 20172019 compared to $6,420,000$3,723,000 in 2016, respectively.2018.
 
Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period growth. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management team.
 
Adjusted EBITDA is a non-GAAP financial measure. We calculate adjusted EBITDA by taking net income, and adding back the expenses related to interest, income taxes, depreciation, amortization, stock basedequity-based compensation expense extinguishment loss on debt and the change in the fair value of the warrant derivative, as each of those elements are calculated in accordance with GAAP.  Adjusted EBITDA should not be construed as a substitute for net income (loss) (as determined in accordance with GAAP) for the purpose of analyzing our operating performance or financial position, as Adjusted EBITDA is not defined by GAAP.
 
A reconciliation of our adjusted EBITDA to net income (loss)loss for the three and ninesix months ended SeptemberJune 30, 20172019 and 20162018 is included in the table below (in thousands):
 
 
Three months ended
 
 
Nine months ended
 
 
Three months ended
 
 
Six months ended
 
 
September 30,
 
 
June 30,
(unaudited)
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
 
2019
(Restated) (1)
 
 
2018
 
 
2019
(Restated) (1)
 
 
2018
 
 
 
 
 
 
Net (loss) income
 $(1,068)
 $67 
 $(5,857)
 $109 
Net loss
 $(289)
 $(614)
 $(12,549)
 $(2,922)
Add/Subtract:
    
    
Interest, net
  1,752 
  946 
  4,207 
  3,139 
  1,062 
  1,549 
  2,569 
  3,261 
Income taxes (benefit) provision
  (1,290)
  (68)
  (2,763)
  550 
  (226)
  (90)
  72 
  160 
Depreciation
  419 
  341 
  1,183 
  1,119 
  602 
  470 
  1,077 
  902 
Amortization
  712 
  537 
  2,047 
  1,746 
  586 
  865 
  1,256 
  1,692 
EBITDA
  525 
  1,823 
  (1,183)
  6,663 
  1,735 
  2,180 
  (7,575)
  3,093 
Add/Subtract:
    
    
Stock based compensation – options and warrant issuance
  327 
  166 
  812 
  292 
Equity-basedcompensation
  1,028 
  215 
  14,231 
  452 
Loss on extinguishment of debt
  - 
  1,082 
Change in the fair value of warrant derivative
  (1,519)
  (369)
  (788)
  (535)
  (401)
  (192)
  (1,887)
  (904)
Extinguishment loss on debt
  308 
  - 
  308 
  - 
Adjusted EBITDA
 $(359)
 $1,620 
 $(851)
 $6,420 
 $2,362 
 $2,203 
 $4,769 
 $3,723 
 
-31-
(1) EBITDA and Adjusted EBITDA for the three and six months ended has been restated as a result of the restatement of the net loss to each respective period. See Note 2 to the unaudited condensed consolidated financial statements.
 
Liquidity and Capital Resources
 
Sources of Liquidity  
 
At SeptemberJune 30, 20172019 we had cash and cash equivalents of approximately $1,373,000$2,088,000 as compared to cash and cash equivalents of $869,000$2,879,000 as of December 31, 2016.2018.
 
Cash Flows
 
Cash used in operating activities. Net cash used in operating activities for the ninesix months ended SeptemberJune 30, 20172019 was $1,783,000$5,381,000 as compared to net cash used in operating activities of $697,000$1,676,000 for the ninesix months ended SeptemberJune 30, 2016.2018. Net cash used in operating activities consisted of a net loss of $5,857,000, offset by net non-cash operating activity of $1,101,000$12,549,000 and by $2,973,000$8,190,000 in changes in operating assets and liabilities.liabilities, offset by net non-cash operating expenses of $15,358,000.
-61-
 
Net non-cash operating expenses included $3,230,000$2,333,000 in depreciation and amortization, $471,000$11,757,000 in stock basedstock-based compensation expense, $281,000 related to the amortization of deferred financing costs associated with our Private Placements, $799,000 related to the$534,000 in amortization of debt discounts $172,000and issuance costs, $2,541,000 in equity issuance costs, $159,000 in increase in inventory reserves, $281,000 in stock issuance cost related to the amortization of warrant issuance costs, $200,000 for stock issued for services, $106,000 related to stock issuance costs associated with debt financing, $341,000 related to warrant issuance costs for other compensation, $308,000true-up shares, and $73,000 in extinguishment of debt and $42,000 in other non-cash items,deferred taxes, offset by $788,000$1,887,000 related to the change in the fair value of warrant derivative liability $195,000 in expenses allocated in profit sharing agreement that relates to contingent debt, $1,020,000and $433,000 related to the change in the fair value of contingent acquisition debt and $2,846,000 related to the change in deferred taxes.liability.
 
Changes in operating assets and liabilities were attributable to decreases in working capital, primarily related to changes in accounts receivable of $1,452,000and decrease in$5,965,000, inventory of $1,916,000, prepaid expenses and other current assets of $282,000.$844,000, accounts payable of $1,065,000, deferred revenues of $52,000, and income taxes receivable of $157,000. Increases in working capital primarily related to changes in inventory of $440,000, changes in, accounts payable of $2,143,000, accrued distributor compensation of $515,000, changes in deferred revenues of $129,000$451,000 and changes in accrued expenses and other liabilities of $1,480,000.$1,358,000.
 
Cash used in investing activities. Net cash used in investing activities for the ninesix months ended SeptemberJune 30, 20172019 was $865,000$3,694,000 as compared to net cash used in investing activities of $1,026,000$210,000 for the ninesix months ended SeptemberJune 30, 2016.2018. Net cash used in investing activities included $2,150,000 in payments made towards the construction of a large mill in Nicaragua, $500,000 in cash paid related to the acquisition of Khrysos, offset by cash acquired of $75,000 and $288,000 for the purchase of land for Khrysos. The remaining expenditures consisted of primarily leasehold improvements and other purchases of property and equipment, leasehold improvements and cash expenditures related to business acquisitions.   equipment.
 
Cash provided by financing activities. Net cash provided by financing activities was $3,154,000$8,244,000 for the ninesix months ended SeptemberJune 30, 20172019 as compared to net cash provided by financing activities of $34,000$1,684,000 for the ninesix months ended SeptemberJune 30, 2016.2018.
 
Net cash provided by financing activities consisted of net proceeds of $7,809,000 from issuance of equity and convertible notes, $1,742,000 from the exercise of stock options $28,000, proceedsand warrants and $6,000 from factoringat the market issuance of $1,723,000 and $2,720,000 of net proceeds related to the Convertible Notes Payable associated with our July 2017 Private Placement,shares, offset by $159,000net payments on line of credit of $254,000, $68,000 in payments to reduce notes payable, $440,000$235,000 in payments related to contingent acquisition debt, and $718,000$734,000 in payments related to capital lease financing obligations.obligations and $22,000 in dividends paid.
 
Future Liquidity Needs
 
The accompanying condensed consolidated financial statements have been prepared and presented on a basis assuming we will continue as a going concern. We have sustained significant operating losses for the nine months ended September 30, 2017 of $4,893,000, compared to operating income in the prior year of $3,263,000. The losses in the current year were primarily due to lower than anticipated revenues, increases in legal fees, distributor events and sales and marketing costs. Net cash used in operating activities was $1,783,000$5,381,000 for the six months ended June 30, 2019 compared to net cash used in operating activities of $1,676,000 for the current year.six months ended June 30, 2018. We do not currently believe that our existing cash resources are sufficient to meet our anticipated needs over the next twelve months from the date hereof. Based on our current cash levels and our current rate of cash requirements, we will need to raise additional capital and we will need to significantlyfurther reduce our expenses from current levels to be ablelevels. These factors raise substantial doubt about our ability to continue as a going concern.
 
During the six months ended June 30, 2019, our operations did not generate sufficient cash to meet our operating needs and we supplemented the revenue generated from operations with cash proceeds of debt and equity offerings. We have already commenced the process to increase our Crestmark line of creditraised additional capital through equity and convertible notes offerings during the fourth quartercurrent period. We also entered into an At-the-Market Offering Agreement (the “ATM Agreement”) with The Benchmark Company, LLC (“Benchmark”), as sales agent, pursuant to which we may sell from time to time, at its option, shares of this year andits common stock, par value $0.001 per share, through Benchmark, as sales agent (the “Sales Agent”), for the sale of up to $60,000,000 of shares of our common stock.
However, despite such actions, we do not believe that our existing cash resources are sufficient to meet our anticipated needs over the next twelve months from the date hereof. We are also considering multipleadditional alternatives, including, but not limited to additional equity financings and debt financings. Depending on market conditions, we cannot be sure that additional capital will be available when needed or that, if available, it will be obtained on terms favorable to us or to our stockholders.
  

-32-
We believe our legal fees will decrease in the future from the levels spent in the current year. Furthermore, we expect to get reimbursements from our insurance company for legal fees already incurred. We expect costs related to distributor events will decrease next year from current year levels as our costs in the current year were unusually high due to the twentieth anniversary convention held in Dallas in August and one-time events held at the beginning of the year to stabilize the sales force due to the departure of the previous president and high-level sales management and distributors. We anticipate revenuesour bottom line, excluding non-cash expenses, will continue to start growing againimprove and we intend to make necessaryadditional cost reductions related to our international programs that are not performing and also reducein non-essential expenses.
-62-
 
Failure to raise additional funds from the issuance of equity securities and failure to implement cost reductions could adversely affect our ability to operate as a going concern. There can be no assurance that any cost reductions, implemented will correct our going concern issue. The financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.
 
Off-Balance Sheet Arrangements
 
There were no off-balance sheet arrangements as of SeptemberJune 30, 2017.2019.
 
Contractual Obligations
 
Subsequent to the filing of our Annual Report for the year ended December 31, 2016, we have entered into Convertible Notes Payable by way of our 2017 Private Placement and contingent debt associated with the 2017 acquisitions; see Note 4 and Note 6, respectively, to the condensed consolidated financial statements. There were no other material changes from those disclosed in in our most recent annual report.
 
Critical Accounting Policies
 
The unaudited interimcondensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements and revenues and expenses during the periods reported. Actual results could differ from those estimates. Information with respect to our critical accounting policies which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K/A10-K for the year ended December 31, 2016.2018.
 
NewRecent Accounting Pronouncements
 
In January 2017, the FASB issued Accounting Standard Update (“ASU”) No. 2017-04, Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies the test for goodwill impairment by removing Step 2 from the goodwill impairment test. Companies will now perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value not to exceed the total amount of goodwill allocated to that reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendmentsRecent accounting pronouncements are disclosed in this update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019, with early adoption permitted for goodwill impairment tests performed after JanuaryNote 1 2017. We are evaluating the potential impact of this adoption on our consolidated financial statements.
In October 2016, the FASB issued ASU 2016-17, Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control. This standard amends the guidance issued with ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis in order to make it less likely that a single decision maker would individually meet the characteristics to be the primary beneficiary of a Variable Interest Entity ("VIE"). When a decision maker or service provider considers indirect interests held through related parties under common control, they perform two steps. The second step was amended with this ASU to say that the decision maker should consider interests held by these related parties on a proportionate basis when determining the primary beneficiary of the VIE rather than in their entirety as was called for in the previous guidance. This ASU was effective for fiscal years beginning after December 15, 2016, and early adoption was not permitted. We adopted ASU 2016-17 effective the quarter ended March 31, 2017. The adoption of ASU 2016-17 did not have a significant impact on our consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. We expect to adopt the standard no later than January 1, 2019. The Company is currently assessing the impact that the new standard will have on our consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases. We have not evaluated the impact of this new standard will have on our consolidated financial statements; however it is expected to gross-up the consolidated balance sheet as a result of recognizing a lease asset along with a similar lease liability.
In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. This guidance requires that entities with a classified statement of financial position present all deferred tax assets and liabilities as noncurrent. This update is effective for annual and interim periods for fiscal years beginning after December 15, 2016, which required the Company to adopt the new guidance in the first quarter of fiscal 2017. Early adoption was permitted for financial statements that have not been previously issued and may be applied on either a prospective or retrospective basis. We adopted ASU 2015-17 effective the quarter ended March 31, 2017. The adoption of ASU 2015-17 did not have a significant impact on our consolidated financial statements other than the netting of current and long-term deferred tax assets and liabilities in the non-current section of the balance sheet and footnote disclosures.
-33-
In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory (Topic 330): Simplifying the Measurement of Inventory.”  The amendments in ASU 2015-11 require an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. The amendments do not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method.  The amendments apply to all other inventory, which includes inventory that is measured using first-in, first-out (FIFO) or average cost.  The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.  Management is currently assessing the effect that ASU 2015-11 will have on ouraccompanying condensed consolidated financial statements and related disclosures.  Included in management’s assessment is the determination of an effective adoption date and transition method for adoption. We expect to complete our initial assessment process, including the selection of an effective adoption date and transition method for adoption, by December 31, 2017.  
this Quarterly Report on Form 10-Q/A.   
 
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). The new revenue recognition standard provides a five-step analysis of contracts to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB deferred the effective date of ASU No. 2014-09 for all entities by one year to annual reporting periods beginning after December 15, 2017. The FASB has issued several updates subsequently including implementation guidance on principal versus agent considerations, on how an entity should account for licensing arrangements with customers, and to improve guidance on assessing collectability, presentation of sales taxes, noncash consideration, and contract modifications and completed contracts at transition. The amendments in this series of updates shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. Early adoption is permitted. We continue to assess the impact of this ASU, and related subsequent updates, will have on our consolidated financial statements. As of September 30, 2017, we are in the process of reviewing the guidance to identify how this ASU will apply to our revenue reporting process. The final impact of this ASU on our financial statements will not be known until the assessment is complete. We will update our disclosures in future periods as the analysis is completed.
In August 2014, the FASB issued ASU No. 2014-15 regarding ASC topic No. 205, Presentation of Financial Statements - Going Concern. The standard requires all companies to evaluate if conditions or events raise substantial doubt about an entity’s ability to continue as a going concern and requires different disclosure of items that raise substantial doubt that are, or are not, alleviated as a result of consideration of management’s plans. The new guidance is effective for annual periods ending after December 15, 2016. The adoption ofASU No. 2014-15 did not have a significant impact on our consolidated financial statements.  
ITEM 3. QuantitativeQuantitative and Qualitative Disclosures About Market Risk
 
As a Smaller Reporting Company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item 3 of Part I.
 
ITEM 4. Controls and Procedures
 
(a)   Evaluation of Disclosure Controls and Procedures
 
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of SeptemberJune 30, 2017,2019, the end of the quarterly fiscal period covered by this quarterly report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that there was a material weakness in the Company’s internal control over financial reporting that was identified during the fourth quarter of 2018 and the first and second quarters of 2019 for the commercial coffee segment relating to not having proper processes and controls in place to require sufficient documentation of significant agreements and arrangements in accounting for significant transactions with respect to certain operations within our coffee segment.
Additionally, in conjunction with our 2019 annual audit, management concluded that there was a material weakness in the Company’s internal control over financial reporting that was identified during the first quarter of 2019 for the commercial hemp segment relating to not having proper processes and controls in place in regard to accounting for significant transactions related to acquisitions.
Based on the evaluation of our disclosure controls and procedures as of September 30, 2017, suchthe end of the period covered by this report and upon that discovery, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report, although we have made improvements, our disclosure controls and procedures were still not effective in ensuringto ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act, of 1934, as amended, is (i) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’sSEC’s rules and forms, and (ii)that such information is accumulated and communicated to our management, including our principal executive officerChief Executive Officer and principal financial officer,Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 
-63-
(b)   Changes in Internal Control Over Financial Reporting
Management’s Remediation Efforts
Commercial Coffee Segment
During our 2019 annual review of internal controls we reviewed revenues related to our commercial coffee segment, specifically the 2019 green coffee sales program. We concluded that specific 2019 green coffee revenue recorded at gross should have been recorded at net which equates to processing revenue for milling “wet” green coffee and which reflects the value of the performance obligation to provide green coffee milling services. As a result, we did not have an adequate review process over revenue recognition which resulted in an error in our financial statements.
 
ThereIn addition, during our 2019 annual audit, we reviewed revenues related to CLR with regard to sales made to major independent customers, we focused on if recognition of revenue thresholds were no changesmet and if we had satisfied our performance obligation and could reasonably expect payment for fulling these performance obligations. We determined that for certain sales made to Rothfos Corporation, a major customer, these thresholds were not met, and therefore revenue should not have been recognized. As a result, we have restated revenue related to the three and six months ended June 30, 2019 for sales recorded during the three months ended June 30, 2019 in the aggregate of approximately $2,116,000 and related cost of revenue of $1,874,000.
This represented a material weakness in our internal controlscontrol over financial reporting. We have restated our Unaudited Condensed Consolidated Balance Sheet and Unaudited Condensed Consolidated Statement of Cash Flows as of June 30, 2019. In addition, we have restated our Unaudited Condensed Consolidated Statements of Operations, Unaudited Condensed Consolidated Statements of Comprehensive Loss and Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2019.

The restatement corrected the error in the presentation of revenue activity related to the specific green coffee sales to properly reflect net revenue where applicable. To remediate the issue, we have added an additional review process for oversight and review of the revenue recognition policy to ensure revenue transactions are appropriately recorded. We will continue to assess the effectiveness of its internal control over financial reporting that occurred duringand take steps to remediate any potentially material weaknesses expeditiously.
Commercial Hemp Segment
During our third quarter2019 annual review of fiscal year 2017 thatinternal controls, we concluded our acquisition of Khrysos Global, Inc., the commercial hemp segment, specifically the valuation of certain fixed assets and the valuation of stock issued as consideration related to the acquisition was not appropriately fair valued. As a result, we did not have materially affected,an adequate review process or are reasonably likelyprocedures over acquisitions resulting in a misstatement to materially affect,our financial statements. This represented a material weakness in our internal controlscontrol over financial reporting. Related to the quarter ended March 31, 2019 we have restated our Unaudited Condensed Consolidated Balance Sheet, the Unaudited Condensed Consolidated Statement of Stockholders’ Equity, and the Unaudited Condensed Consolidated Statement of Cash Flows as of June 30, 2019.
The restatement corrected the error related to property and equipment, net, goodwill and shareholders’ equity. To remediate the issue, we have added an additional review process for oversight and review of the acquisition process to ensure acquisition transactions are appropriately recorded. We will continue to assess the effectiveness of its internal control over financial reporting and take steps to remediate any potentially material weaknesses expeditiously.
During 2020, management implemented a remediation plan that included updating our current policies and implementing procedures and controls over future acquisitions. Until the material weaknesses are remediated, and our associated disclosure controls and procedures improve, there is a risk that a material error could occur and not be detected.

 
 
-34--64-
 
 
PARTPART II. OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
We are from time to time, the subject of claims and suits arising out of matters occurring during the operation ofrelated to our business. We are not presentlya party to any legal proceedingslitigation at the present time and may become party to litigation in the future. In general, litigation claims can be expensive, and time consuming to bring or defend against and could result in settlements or damages that if determined adverselycould significantly affect financial results. It is not possible to us, would individually or taken together have a material adverse effectpredict the final resolution of the current litigation to which we are party to, and the impact of certain of these matters on our business, operating results of operations, and financial condition or cash flows.could be material. Regardless of the outcome, litigation has adversely impacted our business because of defense costs, diversion of management resources and other factors.
 
ITEM 1A. RISKRISK FACTORS
 
Any investment in our common stock involves a high degree of risk. Investors should carefully consider the risks described in our Annual Report on Form 10-K/A10-K as filed with the SEC on August 14, 2017,April 15, 2019, and all of the information contained in our public filings before deciding whether to purchase our common stock. The following information and updates should be read in conjunction with the information disclosed in Part 1, Item 1A, “Risk Factors,” contained in our Annual Report on Form 10-K/A10-K as filed with the SEC on March 30, 2017.April 15, 2019. Except as set forth below, there have been no material revisions to the “Risk Factors” as set forth in our Annual Report on Form 10-K/A10-K as filed with the SEC on August 14, 2017.
We cannot assure you that the common stock will remain listed on the NASDAQ Capital Market.
Our shares of common stock are currently listed on the NASDAQ Capital Market. Although we currently meet the listing standards of the NASDAQ Capital Market, we cannot assure you that we will be able to maintain the continued listing standards of the NASDAQ Capital Market.  If we fail to satisfy the continued listing requirements of the NASDAQ Capital Market, such as the corporate governance requirements, minimum bid price requirement or the minimum stockholder’s equity requirement, the NASDAQ Capital Market may take steps to de-list our common stock. If we are delisted from the NASDAQ Capital Market then our common stock will trade, if at all, only on the over-the-counter market, such as the OTC Bulletin Board securities market, and then only if one or more registered broker-dealer market makers comply with quotation requirements. In addition, delisting of our common stock could depress our stock price, substantially limit liquidity of our common stock and materially adversely affect our ability to raise capital on terms acceptable to us, or at all. Delisting from the NASDAQ Capital Market could also have other negative results, including the potential loss of confidence by suppliers and employees, the loss of institutional investor interest and fewer business development opportunities.
The reverse stock split that was effected in June 2017 may decrease the liquidity of the shares of the Common Stock.
The liquidity of the shares of our Common Stock may be affected adversely by the reverse stock split given the reduced number of shares that are now outstanding. In addition, the reverse stock split increased the number of shareholders who own odd lots (less than 100 shares) of the Common Stock, creating the potential for such shareholders to experience an increase in the cost of selling their shares and greater difficulty effecting such sales.
There can be no assurance that the reverse stock split, improved the trading liquidity of the Common Stock.
Although we believe that a higher market price of our Common Stock may help generate greater or broader investor interest, there can be no assurance that the reverse stock split will result in a share price that will attract new investors, including institutional investors.April 15, 2019.
 
There is substantial risk about our ability to continue as a going concern, which may hinder our ability to obtain future financing.
 
The accompanying condensed consolidated financial statements as of June 30, 2019 have been prepared and presented on a basis assuming we will continue as a going concern. We have sustained significant operatingnet losses induring the current yearsix months ended June 30, 2019 of $4,893,000, compared to operating income in the prior year of $3,263,000. The losses in the current year were primarily due to lower than anticipated revenues, increases in legal fees, distributor events and sales and marketing costs.$12,549,000. Net cash used in operating activities was $1,783,000$5,381,000 for the six months ended June 30, 2019 compared to net cash used in operating activities of $1,676,000 for the current year.six months ended June 30, 2018. We do not currently believe that its existing cash resources are sufficient to meet our anticipated needs over the next twelve months from the date hereof. Based on our current cash levels andas of June 30, 2019, our current rate of cash requirements, we will need to raise additional capital and we will need to significantly reduce our expenses from current levels to be able to continue as a going concern. There can be no assurance that we can raise capital upon favorable terms, if at all, or that we can significantly reduce our expenses.
 
The failureWe have identified a material weakness in our internal controls, and we cannot provide assurances that this weakness will be effectively remediated or that additional material weaknesses will not occur in the future. If our internal control over financial reporting or our disclosure controls and procedures are not effective, we may not be able to comply with the terms ofaccurately report our outstanding Notes could resultfinancial results, prevent fraud, or file our periodic reports in a default under the terms of the notestimely manner, which may cause investors to lose confidence in our reported financial information and if uncured, it could potentially resultmay lead to a decline in action against the pledged assets of CLR.our stock price.
 
Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. Due to errors in our financialstatements for the three and six months ended June 30, 2019 we have restated our Unaudited Condensed Consolidated Balance Sheet, Unaudited Condensed Consolidated Statements of Operations, Unaudited Condensed Consolidated Statements of Stockholders’ Equity and the Unaudited Condensed Consolidated Statement of Cash Flows. We currently have outstanding convertible notescommenced measures to remediate the identified material weaknesses in our internal controls: however, there can be no assurance that the weaknesses will be effectively remediated or that additional material weaknesses will not occur in the principal amount of $3,000,000 (the “November 2015 Notes) that we issued to investors in November 2015 that are secured by certain of our assets and those of CLR other than its inventory and accounts receivable. We have also issued an additional $4,750,000 in principal amount of notes (the “September 2014 Notes”) in September 2014 Offering (the “September 2014 Offering”) secured by CLR’s pledge of  the Nicaragua green coffee beans acquired with the proceeds, the contract rights under a letter of intent and all proceeds of the foregoing (which lien is junior to CLR’s factoring agreement and equipment lease but senior to all of its other obligations), In July and August of 2017, we issued notes in the aggregate principal amount of $7,254,349, all of which are outstanding. Stephan Wallach, our Chief Executive Officer, has also personally guaranteed the repayment of the November 2015 Notes and the September 2014 Notes, and has agreed not to sell, transfer or pledge 30 million shares of our common stock that he owns so long as his personal guaranty is in effect. The November 2015 Notes mature in 2018, the September 2014 Notes mature in 2019 and the 2017 notes mature in 2020. The November 2015 Notes and the September 2014 Notes require us, among other things, to maintain the security interest given by CLR for the notes and all of the notes require us to make quarterly installments of interest, reserve a sufficient number of our shares of common stock for conversion requests and honor any conversion requests made by the investors to convert their notes into shares of our common stock. If we fail to comply with the terms of the notes, the note holders could declare a default under the notes and if the default were to remain uncured, as secured creditors they would have the right to proceed against the collateral secured by the loans. Any action by secured creditors to proceed against CLR assets or our assets would likely have a serious disruptive effect on our coffee and direct selling operations.future.

 
-35--65-
 
 
ITEM 2. UNREGISTEREDUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
All sales of unregistered securities duringour common stock that were not registered under the three months ended September 30, 2017Securities Act have been previously reporteddisclosed in our filings with the Securities and Exchange Commission except for the sales of unregistered securities set forth below.below during the three months ended June 30, 2019;
 
ProActive Capital Group, LLC.On September 1, 2015,June 17, 2019, we entered into a Securities Purchase Agreement with one accredited investor that had a substantial pre-existing relationship with us to which we sold 250,000 shares of common stock, par value $0.001 per share, at an offering price of $5.50 per share. The proceeds were $1,375,000. We issued the Companysecurities in reliance on the exemption from registration provided for under Section 4(a)(2) of the Securities Act. We relied on this exemption from registration for private placements based in part on the representations made the investors with respect to their status as accredited investors, as such term is defined in Rule 501(a) of the Securities Act.
On May 2, 2019 and May 23, 2019 we closed our third and fourth tranches of our 2019 January Private Placement debt offering pursuant to which we entered into subscription agreements with six (6) additional credited investors that had a substantial pre-existing relationship with us pursuant to which we received aggregate gross proceeds of $450,000 and we issued to such investors notes in the aggregate principal amount of $450,000 and an aggregate of 9,000 shares of common stock. The placement agent received 2,250 shares of common stock in aggregate for the third and fourth tranches. Each note matures 24 months after issuance, bears interest at a rate of six percent (6%) per annum. We issued the securities in reliance on the exemption from registration provided for under Section 4(a)(2) of the Securities Act. We relied on this exemption from registration for private placements based in part on the representations made the investors with respect to their status as accredited investors, as such term is defined in Rule 501(a) of the Securities Act.
On April 5, 2019, we entered into an agreement with I-Bankers, pursuant to which I-Bankers agreed to provide financial advisory services for a period of 12 months in exchange for 100,000 shares of restricted common stock which were issued in advance of the service period. In addition, we agreed to pay in cash a base fee for debt arrangements and equity offerings in conjunction with any transactions I-Bankers closes with us in accordance with the agreement.
ProActive On January 9, 2019, we executed the second amendment to the July 1, 2018 agreement with Capital Group, LLCMarket Solutions, LLC. or PCG Advisory Group (“PCG”Capital Market”), pursuant to which PCGCapital Market agreed to provide investor relations servicesservices. Subsequent to the initial agreement, we extended the July 1, 2018 agreement for six (6)an additional 24 months in exchange for fees paid in cash of $6,000 per month and 5,000 sharesthrough December 31, 2021. In accordance with the second amendment we issued an additional 75,000 of restricted common stock to be issued upon successfully meeting certain criteria in accordance with the agreement. Subsequent to September 1, 2015 this agreement has been extended under the same terms with the monthly cash payment remaining at $6,000 per month and 5,000 shares of restricted common stock for every six (6) months of service performed. As of September 30, 2017, the Company has issued 15,000 shares of restricted common stock in connection with this agreement and accrued for the estimated per share value on each subsequent six (6) month periods based on the price of Company’s common stock at each respective date.stock.
 
In May 2017, the Company issued a warrant as compensation to an associated Youngevity distributor to purchase 37,500 shares of the Company’s Common Stock at a price of $4.66 with an expiration date of three years. The warrant was exercised on a cashless basis and 21,875 shares of common stock were issued during the three months ended September 30, 2017.
On December 11, 2012, the Company authorized a share repurchase program to repurchase up to 750,000 of the Company's issued and outstanding shares of Common Stock from time to time the open market or via private transactions through block trades. The initial expiration date for the stock repurchase program was December 31, 2013. On October 7, 2013, the Board voted to extend the stock repurchase program until a date is set to revoke the program.
As of September 30, 2017 the total number of shares that may yet be purchased under the share repurchase program was 553,406. There were no shares repurchased during the nine months ended September 30, 2017.
The offers, sales and issuances of the securities described above were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and Rule 506 promulgated under Regulation D promulgated thereunder as transactions by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited investor within the meaning of Rule 501 of Regulation D under the Securities Act and had adequate access, through employment, business or other relationships, to information about the Registrant.
ITEM 3. DEFAULTSDEFAULTS UPON SENIOR SECURITIES
 
None.
 
ITEM 4. MINEMINE SAFETY DISCLOSURES
 
Not applicable.

-36-
ITEM 5. OTHER INFORMATION
 
None.
 
-66-
ITEM 6. EXHIBITSEXHIBITS
 
The following exhibits are filed as part of this Report:
 
EXHIBIT INDEX
 
Exhibit No. Exhibit
Form of Note Purchase Agreement (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 000-54900) filed with the Securities and Exchange Commission on August 3, 2017).
Form of Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 000-54900) filed with the Securities and Exchange Commission on August 3, 2017).
Form of Series D Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 000-54900) filed with the Securities and Exchange Commission on August 3, 2017).
Form of Registration Rights Agreement (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 000-54900) filed with the Securities and Exchange Commission on August 3, 2017).
31.1* Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
 
  *Filed herewith.
 
-37--67-
 
 
SIGNATURESSIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 YOUNGEVITY INTERNATIONAL INC.
 (Registrant)
  
Date:  November 14, 2017September 13, 2021/s/ Stephan Wallach
 Stephan Wallach
 Chief Executive Officer
 (Principal Executive Officer)
  
  
Date:  November 14, 2017September 13, 2021/s/ David BriskieWilliam Thompson
 David BriskieWilliam Thompson
 Chief Financial Officer
 (Principal Financial Officer)
  
 
 
-38--68-